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ABSTRACT

Accessibility of infertility services is disproportionately experienced in the United States.
Although there exist state-based health insurance mandates for infertility services, these
mandates contain language that disqualify people from using them. In order to better understand
why these mandates are not able to reduce the financial burden and bridge the income disparity
for using infertility services, the purpose of this study is to add context to the applicability of
these insurance mandates through qualitative and quantitative inquiry. Using the Glass and
McAtee model of risk regulators as an operational paradigm, this research explores the role of
environmental context, or “place”, as a risk regulator for accessing infertility services. The
qualitative inquiry consists of informal interviews with people using those services and expert
interviews with representatives from organizations providing types of financial assistance for
infertility services. The quantitative inquiry consists of a survey instrument observing aspects of
travel, health insurance, residence, health education, and self-efficacy in relation to seeking
infertility services. The quantitative spatial analysis includes cluster analyses of CDC reporting
fertility clinics in the United States, and spatial autocorrelation of census-tract level fertility
estimates to give context to future spatial analyses of the use of infertility services.
Based on the survey results (n=134), only 20.41% of people living in a mandated state
reported having all infertility services covered by health insurance. The results from 66 informal
interviews and eight expert interviews suggests that both place and policy (infertility insurance
mandates) act as risk regulators that affect levels of insurance coverage for, and decisions
regarding, infertility services. Having residence in a mandated state does not mean one will have
xii

access to their state’s mandated coverage, but residence of the individual and of their employer’s
headquarters can regulate degrees of insurance coverage provided by a state’s infertility
insurance mandate. Spatial distribution of “All women with births” suggests that human
reproduction is a highly spatially autocorrelated phenomenon based on age, education, ethnicity,
nativity, and poverty status (p<0.0001 for all variables), however the directional distributions
show different directional patterns. Spatial distribution of fertility clinics shows significant
spatial clustering of clinics in metropolitan areas, regardless of the presence of an infertility
insurance mandate, and qualitative accounts of travel related to using infertility services suggests
that placement of clinics near business centric areas is beneficial for patients.
The existing infertility insurance mandates place the state directly in the way of
reproductive autonomy. Greater attention should be paid to the role of employers in facilitating
insurance benefits for infertility services, considering employers establish insurance policies for
their employees and can therefore mitigate the degree of infertility insurance benefits available to
them. Due to the nature of the state-based insurance mandates, both place and policy will
continue to be intra-active risk regulators that mitigate the access of infertility services and will
be differently experienced at the individual level.

xiii

CHAPTER ONE:
INTRODUCTION

Infertility services, such as assisted reproductive technologies (ARTs), provide an
alternative to procreation via sexual intercourse for those who were otherwise unable to procreate
through sexual intercourse (American Society for Reproductive Medicine (ASRM), 2015). It is
the basis for which assisted reproduction is necessary that generates stigma: it is a deviation from
what the majority, and related laws, deem to be normal (Slade et al., 2007; Whiteford & Gonzalez,
1995). Through this stigma, laws and social practices were constructed to ill-favor those who seek
infertility services to fulfill their desire for a family, especially those who seek to develop a family
outside of the heteronormative paradigm (Bell, 2016). As a result, there exists a disparity in
accessing infertility services, and some of those barriers are due to policies that are based on
interpretations of infertility, family planning, and medical need for assisted reproduction that do
not reflect the entire spectrum of people who need access (Greil et al., 2011).
In 1977, the United States had the first state-based insurance policies that required certain
types of employers to either offer or cover some degree of infertility services (Table 1.1) (National
Conference of State Legislatures, 2019b). Now in 2020, 19 of 50 states have some type of
insurance mandate for infertility services. Some of these new policies are inclusive to nontraditional family development and utilize definitions of infertility that are not exclusive to a single
sexual orientation or marital status (Adashi, 2015; Centanni, 2019). However, there are still vast
disparities in the utilization of these services. Important questions to ask are: How efficacious are
these existing policies? Are state-based insurance policies the answer to solve the disparity issue?
1

Although the infertility insurance mandates should increase access to residents of mandated
states, there are no data to suggest the mandates increase financial accessibility to infertility
services. Observing the efficacy of public policy is encouraged when disparities exist in the
accessibility of infertility services, and even more so when legislation infringes upon the
reproductive autonomy of underrepresented groups. Due to their nationally increased use, not
addressing this issue could lead to accessibility disparities for infertility services, resulting in a
demographic shift of human health and reproduction rates.

Problem Statement
Current research shows rates of infertility service use, psychosocial issues from using
infertility services, and birth outcomes from these services either quantitatively or qualitatively,
without linking the contextual qualitative information that could help explain the quantitative
patterns of infertility service use. Research shows there are many possible factors that influence
accessibility to infertility services, such as sexual orientation (Conrad, 2007; The Ethics
Committee of the American Society for Reproductive Medicine, 2013), ethnicity (Kelley et al.,
2019; Lynch, 2019), presence of insurance (Hamilton & Mcmanus, 2012; Wu et al., 2017), and
income (Hammarberg & Kirkman, 2013; J.R. Ho et al., 2017). Due to population-level shifts in
postponing family development and the makeup of families themselves (single parents, same-sex
parents), unequal access to infertility services could create unanticipated demographic shifts in the
American population. What is more, the current infertility insurance mandates are written in such
a way that they will not provide comprehensive coverage for these services. The limitations
embedded in the language of the current infertility insurance mandates infringes on the
reproductive autonomy for those who require infertility services but cannot afford to pay for them

2

out of pocket. Research show this disproportionately affects social and racial minorities (Insogna
& Ginsburg, 2018).

Purpose of the Study
The purpose of this study is to add context to the use of infertility services in the United
States by exploring the role of environmental context (place) as a risk regulator in accessing those
services. A risk regulator is variable that has inconsistent contextual influence on health behavior
or health outcomes and is not considered deterministic, but rather influential – maintaining a
regulatory effect on health outcomes that affect different people in different ways (Glass &
McAtee, 2006). From here on, anything related to “environment” or “environmental context” will
be referred to as “place”. For the purpose of this study, place refers to any influence outside of an
individual’s own behavior, but that may affect an individual’s behavior. This research assumes
that place is socially constructed through politics and culture (Rodman, 1992). An overarching
place-based context studied in this research are the state-based infertility insurance mandates
because they are meant to increase accessibility to infertility services by residents whose state has
one of those mandates. However, there are no data to substantially support the proposition that
residence – the place someone lives – in a state with an infertility insurance mandate will increase
one’s access to infertility services.
Data collection used to observe place includes both qualitative and quantitative methods in
order to fill the contextual gaps in the current literature related to the access of infertility services.
The qualitative inquiry observes place as a factor in the reciprocal interplay between person,
behavior, and environment (Bandura, 2004). The context of place in qualitative inquiry consists of
aspects of travel and residence, use and presence of health insurance, and the role of organizations

3

providing infertility-specific insurance or other financial assistance for infertility services. The
quantitative inquiry includes a survey instrument inquiring about reasons for seeking infertility
services, aspects of travel, residence, presence of health insurance, and self-efficacy in the face of
accessing infertility services. The quantitative spatial analyses observe place in terms of spatial
patterns of fertility based on sociodemographic variables of women who had a birth in the last 12
months, and location of fertility clinics reporting data to the Centers for Disease Control and
Prevention (CDC).

Research Questions
There are a total of seven research questions included in this research, and each question
refers to aspects of place and human reproduction. Research questions were constructed in a way
that permits these data to complement each other, allowing some questions to be answered with
both qualitative and quantitative sources. The alignment matrix in Appendix A lists the research
questions, data collection instrument, and item on that instrument used to answer the research
question. More detailed rationale for each research question is located in Chapter Three.
•

R1: Why do people access infertility services in the United States?

•

R2: What influence does geographic location have on access to infertility services?

•

R3: What influence does living in a state with mandated insurance have on access to
infertility services?

•

R4: What are the roles of specialized infertility specific insurance or other financial aid
organizations in increasing access to infertility services in the United States?

•

R5: What is the spatial relationship between fertility of women between the years of 20132017 based on age, education, ethnicity, nativity, and income?
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•

R6: What is the spatial relationship between fertility of women between the years of 20132017 and states with or without infertility insurance mandates?

•

R7: What is the spatial relationship between fertility of women age 15-50 and the spatial
distribution of Society of Reproductive Technology (SART) reporting clinics between the
years of 2013-2017?

Significance of the Study
Many of the current state-based infertility insurance mandates, and state-based definitions
of human infertility, represent institutionalized discrimination against non-traditional family
development (Abel, 2004; Mastroianni, 2016; Pendo, 2005). There are still 31 more state-based
infertility mandates that could be developed. With new information about the utilization of current
mandates by individuals and employers, and the geospatial spread of fertility clinics across the
United States in relation to local fertility trends, legislatures can have the data to create mandates
that truly do facilitate equitable access to infertility services.

Conceptual Framework
This research operates under the social-ecological model (SEM) of human health and
observes place (environmental context) as it is defined in social cognitive theory (SCT), as a
dynamic factor within reciprocal interaction between person, environment, and behavior (Bandura,
2004). This research also uses social constructionism, which observes the social environment as
an objective reality from which knowledge and meaning are created, and assumes that reality is
socially constructed and differently experienced at the individual level (Berger & Luckmann,
1967). The ways infertility services are accessed, researched, and practiced, are complex and do
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not function the same way as some other public health concerns (Craig, 2020). Such complexity
may be due to the high priority human society places on human reproduction, and how uncontested
the heteronormative paradigm of human reproduction has been over time (Boutell, 2018).
Due to this complexity, observing the social ecological model of health will be helpful in
determining factors affecting the accessibility of infertility services that are not necessarily
deterministic, but are rather influential and differently experienced across the spectrum of people
who want to use them. Not only can micro-level intrapersonal factors differently influence the
disease state of infertility, such as the degree of infertility manifestation based on one’s own
biology (it does not affect everyone to the same degree) (Humphries et al., 2016; Silva & Machado,
2008), there are varying degrees of influence from the interpersonal and community levels, where
fertility is constructed as an adulthood milestone (Cousineau et al., 2007), and

excessive

reinforcement of reaching that milestone from social circles can have bidirectional influence on
health behaviors taken to access infertility services (or not). There are also macro level pressures
such as workplace policies and state-level policies that affect the degree of accessibility the
healthcare system provides to its citizens (Boutell, 2018).
The concept of embeddedness within the social ecological model should be emphasized,
especially considering that a disparity perspective must consider the nonlinear interaction between
levels of influence. Embeddedness refers to the affect that each level of influence exerts on the
level within and around it (Simons-Morton et al., 2012). Embeddedness could also be argued to
be present in Bandura’s reciprocal determinism in social cognitive theory, which allows these
theories to further complement each other.
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Summary of Methodology
This research utilizes a mixed-method, pragmatist research design, where both quantitative
and qualitative data are used to understand a phenomenon more fully (Biesta, 2015; Feilzer, 2010).
In review of the literature surrounding the experience of using infertility services, there is much
of discussion about social environment and its effect on the psychological impact of using
infertility services (Adashi & Dean, 2016; Hershberger & Kavanaugh, 2008). However
environmental influence has not been directly observed as a variable of direct inquiry related to
the use of infertility insurance mandates. Place is usually tangentially referred to as an influence,
but no research has critically reviewed or analyzed environmental context (place) regarding access
to infertility services in the United States. It may be because place encompasses many potential
domains of everyday life (Clark, 1990; Saker & Evans, 2016). What is needed, then, is an approach
that is designed to observe type of place from different perspectives – from different points along
the cycle of reciprocal causation.
The mixed-method research design is sectioned into two parts: Part 1: Interviews and
Online Survey, and Part 2: Spatial Analyses. Part 1 includes the qualitative inquiry and a
quantitative survey. There are 66 informal interviews with male and female U.S. residents who are
between the age of 18 to 45. Expert interviews are also included in this research, consisting of
eight interviews with representatives of organizations that offer some type of insurance, financial,
or informational service specific to infertility services. Social Cognitive Theory (SCT) guided the
construction of the informal interview questions. Interviews were audio recorded and the PI
transcribed the interviews verbatim. Interview transcripts were analyzed using applied thematic
analysis through the mixed method analysis software MaxQDA. The quantitative survey was
developed to observe risk regulators that affect people’s ability to access infertility services, such
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as the state of residence, type of employment, presence of insurance, aspects of travel, fertility
education, and perceived self-efficacy measured using the validated Infertility Self-efficacy Scale
(Cousineau et al., 2006).
Part 2 consists of quantitative spatial analysis of fertility data from the 2013-2017
American Community Survey 5-year estimates on women who had a birth in the last 12 months.
Spatial analyses are based on census tract-level fertility estimates stratified by demographics of
age, ethnicity, poverty status, education, and nativity. This section also consists of spatial analysis
of geocoded fertility clinics that report their data to the SART via the CDC, observing their location
and spatial clustering in relation to fertility and population density. This type of a location
intelligence approach allows for the observation of spatial dynamics related to the placement of
fertility clinics that assumes: medicine is a business, and businesses need clients to survive, so
these types of medical businesses will be located in areas of high population density.
A strength of this research will be the dynamic integration of qualitative and quantitative
data in order to add context to the use of infertility services when state-based infertility insurance
mandates are present or absent.

Terms and Definitions
ART – assisted reproductive technology; refers to the high-tech options for human reproduction
outside of sexual intercourse; in vitro fertilization (IVF), intrauterine cytoplasmic sperm injection
(ICSI), etc (Centers for Disease Control and Prevention [CDC], 2017c).
Aspatial – not related to or associated with a space or area; social dimensions of potential influence
(Bissonnette et al., 2012)
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Bayesian statistics (inference) – a statistical method that applies Bayes’ theorem to enhance the
probability of a hypothesis when more information becomes available (Theodoridis, 2015)
Biopedagogy: biopedagogies; meaning associated with the body, where those meanings are
constructed in multiple areas of influence and power by a majority – thereby making social
practices referring to the human body normalized or acceptable and by result condemning
deviations from that norm to be abnormal (Wright, 2009)
Biopower – the political and social enactment of structures based on the paradigm of the majority
to influence the reality of living life “that endeavors to administer, optimize, and multiply it,
subjecting it to precise controls and comprehensive regulations” (Foucault, 1984a, pg 136; Wright,
2009)
Environment – (environmental) in the context of this research, relates to a mode of regulatory
influence in the use of infertility services; also referred to as place
Euclidean distance – the straight-line distance between two points, assuming no obstructions exist
(Liberti & Lavor, 2017); “as the crow flies” (“As the Crow Flies,” 2020)
Geographic variable – a variable used to define geographic context (ie. state of residence, census
tract boundary, geolocated fertility clinic)
GIS – A Geographic Information System (GIS) is a framework to gather, manage, and analyze
spatial and aspatial data (Envirnomental Systems Research Institute [ESRI], 2019)
Habitus – [sociology] social habits, norms, assumptions of the individual that affect how they
perceive their reality but that are also based on one’s social environment (socialization) (Bourdieu,
1977)
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Heteronormative – heteronormativity; idea that heterosexual attraction is the preferred and
normal form of human sexuality, linked to a dichotomous interpretation of sexuality and gender –
unchanging (Barker, 2014).
Heteroskedasticity – occurs when the assumption that all variables relate to X in the same way;
the errors vary based on the effect on the value of one or more of the independent variables (Barreto
& Howland, 2005)
Hotspot, coldspot – spatially defined areas of significantly high (hotspot) or significantly low
(coldspot) areas or points of interest in relation to each other, given a set of weighted features
(Lessler et al., 2017)
Infertility services - healthcare services provided to people attempting to conceive through
methods other than sexual intercourse; includes ARTs (Kaiser Permanente, 2019)
Insurance mandate – also termed a mandated benefit; “benefits that are required to cover the
treatment of specific health conditions, certain types of healthcare providers, and some categories
of dependents, such as children placed for adoption. A number of health care benefits are mandated
by either state law, federal law – or in some cases – both” (National Conference of State
Legislatures, 2019a, pg 1)
Mixed-methods – type of research methodology that utilizes both qualitative and quantitative
methods in combination to understand a certain topic (Creswell & Plano-Clark, 2011)
Multicollinearity – a statistical phenomenon that occurs when a predictor variable in a
multivariate model can be predicted by other values in the model with high accuracy; variables are
too similar (Farrar & Glauber, 2006)
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Place – a contextual concept that represents aspects of spatial and aspatial subjects; in this research,
it can be referred to as environment or environmental context; socially constructed through politics
and culture (Rodman, 1992)
Pronatalist – pronatalist society; advocacy and support of high birth rate; socially encouraging
sexual reproduction as a means of social responsibility (Heitlinger, 1991)
Risk regulator – a variable that has inconstant contextual influence on some health behavior, and
is not deterministic but rather influential – maintaining a regulatory effect on health outcomes
(Glass & McAtee, 2006)
Self-efficacy – the perceived and actual ability of an individual to complete some task (Bandura,
2003)
Shapefile – A collection of geographic information within a compressed file to be used in ArcPro
2.4; allows for visualization of spatial variables and quantification of spatial statistics (ESRI,
2020c)
Spatial autocorrelation – values of a variable have a spatial relationship or are related to each
other in some way in space (Getis, 2001)

Limitations
Quantifying health-related estimations based on geographic boundaries has a degree of
error associated with it due to the plasticity of influence that a place can have on different people
and at different times. However, some statistical tests can account for the potential error in over or
underestimating spatial relationships, such as the Poissonian and Negative Binomial regressions
which are linear regression statistics that affect overdispersion and unequal mean and variance
differently that a log transformation of the data – which is important when the integrity of the count
variables must be maintained (Haight, 1967; Jacob, Alwiss, et al., 2013).
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A limitation to the majority of reproductive health data is that they are linked to spatial
variables that is the most recent available data-representing the previous year or later. This is due
to the need to de-identify the data, which is a requirement due to the protections to health
information defined in HIPPA policy (U.S. Department of Health and Human Services, 2015). As
a result, the analyses may not reflect patterns that exist in the current year, however those patterns
may still be present and relevant.
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Chapter One Tables
Table 1.1 Types of coverage among state-based infertility insurance mandates
Includes
Fertility
Includes Excludes IVF
Pres. For
Date
Mandate Mandate IVF
IVF
Coverage Iatrogenic
State
Enacted to Cover to Offer Coverage Coverage Only
Infertility
Arkansas
1987
x (1)
x
California
1989
x
x (2)
x
Colorado
2020†
x
x
x
Connecticut
1989
x
x
x
Delaware
2018
x
x
x
Hawaii
1987
x
x (3)
Illinois
1991
x
x (4)
x
Louisiana
2001
x
Maryland
1985
x (5)
x
x
Massachusetts 1987
x
x
Montana
1987
x (6)
New
2020
x
x
x
Hampshire
New Jersey
2001
x
x
x
New York
1990
x
x
x
(7)
Ohio
1991
x
Rhode Island 1989
x
x
x
Texas
1987
x
x
Utah
2018
x (8)
West Virginia 1977
x (9)
*adapted from ASRM (2020) State Infertility Insurance Laws.
https://www.reproductivefacts.org/resources/state-infertility-insurance-laws/ and (RESOLVE, 2020)
†
effective 2022
(1) Includes a lifetime maximum benefit of not less than $15,000.
(2) Excludes IVF but covers gamete intrafallopian transfer (GIFT).
(3) Provides a one-time only benefit covering all outpatient expenses arising from IVF.
(4) Limits first-time attempts to four oocyte retrievals. If a child is born, two complete oocyte retrievals
for a second birth are covered. Businesses with 25 or fewer employees are exempt from having to provide
the coverage specified by the law.
(5) Businesses with 50 or fewer employees do not have to provide coverage specified by law.
(6) Applies to HMOs only; other insurers specifically are exempt from having to provide the coverage.
(8) Applies to HMOs only.
(9) Allows for adoption indemnity benefit to be used for infertility treatment.
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CHAPTER TWO:
LITERATURE REVIEW

Research Review
This review of the literature begins with explanations of what infertility services are,
types of infertility services used to circumvent human infertility, current rates of infertility in the
United States, and a brief history of the infertility insurance mandates. Next, there are summaries
of quantitative and qualitative approaches used to observe the use of infertility services in the
United States, and research designs that observe aspects of place related to the use of infertility
services. At the end of this review is a section dedicated to the conceptual framework under
which this research operates, which includes the Glass and McAtee model of risk regulators, an
analysis of the SEM, SCT, and Social Constructionism as they relate to the use of infertility
services described in the current literature.

Defining Infertility Services
Currently there is no definition for infertility services, however the phrase appears in state
legislation. The term is associated with data categories from national surveys such as the
National Survey of Family Growth which describe infertility services to be healthcare services
provided to people attempting to conceive through methods other than sexual intercourse. In
academic and medical literature, however, the term assisted reproductive technologies, or ARTs,
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typically describe research referring to infertility services. These two phrases are used
interchangeably, but they do not define the same things.
While ARTs are the high-tech options considered invasive, infertility services include
ARTs but also non-invasive techniques such as physician visits and hormone therapies. As an
example, information from the insurance company Kaiser Permanente describe infertility
services they cover as: an initial office visit that includes pelvic exam, any routine blood tests,
cultures, and Pap smears, as well as health education on taking basal body temperature,
reviewing test results, checking temperature charts, and making referrals (Kaiser Permanente,
2019). They also warn that several other infertility services that are typically necessary may not
be covered by most insurance plans, which include semen analysis, hysterosalpingogram (HSG),
hysteroscopy, endometrial biopsy, and hormone therapy to induce ovulation (Kaiser Permanente,
2019). Due to the lexical uncertainty in the literature, herewith infertility services will refer to
healthcare services provided to people attempting to conceive through methods other than sexual
intercourse.
At times ARTs may be discussed specifically due to the fact that data relating to the use
of those services are collected by national health agencies such as the CDC, and it is important to
include the frequency of use of those services to observe changes over time. There are numerous
factors that affect the use of infertility services, and those factors act as facilitators for some, and
barriers to others. There is a considerable amount of literature that draws attention to specific
factors that serve as barriers to accessing infertility services, which include but are not limited to:
the presence of insurance (Kissil & Davey, 2012), race and ethnicity, where there exists a higher
frequency of Caucasian patients (Dieke et al., 2017), the use of ARTs for people with diseases
such as cancer (Panagiotopoulou et al., 2018) and HIV (Cook & Dickens, 2014; Hagey et al.,
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2015; Leech et al., 2018), religious restriction (Collins & Chan, 2017; Jones, 2014), and
physician bias against ethnicity and sexual orientation (White et al., 2006).
Multiple health agencies collect prevalence data on the types of infertility services, but to
date the most detailed data on infertility services are those for ARTs. However not all agencies
report those data in the same way (Collura & Stevenson, 2016). While some clinics report all use
of ARTs, some only report successful pregnancies from using an ART. Based on a 2016 report
published by the ASRM, the number of ART clinics in the United States continues to rise but has
slowed some since the year 2000 (Toner et al., 2016). Clinics in the United States can report their
data to SART, or via the National ART Surveillance System (NASS) housed by the CDC. There
are currently 463 clinics reporting to the CDC, 82% of which are SART members and 92% of
which have verified lab accreditation (CDC, 2018). Among some of the trends observed from the
surveillance data are: 1) maternal age is the most influential factor in successful pregnancies
through ARTs, 2) single embryo transfers are increasing, and more so for younger patients, 3) a
reduction in the number of twins, and, 4) a reduction in the number of ovarian hyperstimulation
syndrome (OHHS) as a result of taking fertility hormone treatments (Toner et al., 2016).

Rates and Types of Infertility Service Use
Based on the preliminary 2018 SART annual report, there were 271,398 initiated cycles
in the United States. A cycle begins once a woman begins medications in preparation for starting
an ART procedure (SART, 2020). Patient characteristics for using ARTs suggest that patients
under the age of 35 use ARTs most frequently and have the highest birth rate (47.6%), compared
to those who are 35-37 (30.7%), 38-40 (19.7%), 41-42 (9.7%), and >42 (2.9%) years old.
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Infertility Rates. Multiple agencies collect data on infertility diagnoses both in the
United States and internationally, however these agencies do not collect or present data in the
same way. This diminishes an accurate view of the status of human infertility. For example, the
National Survey of Family Growth (NSFG) observes infertility rates based on self-reports from
women of reproductive age (15-49), whereas SART observes infertility diagnoses based on
clinical data. SART observes success rates from different ARTs within the reporting clinics and
observes success rates based on the type of infertility diagnosis.
Current rates of infertility produced by the NSFG estimate that, in the United States
between the years 2015-2017, the percentage of all married women 15-49 years of age who had
impaired fecundity was 13.1% (σ=0.59), and those diagnosed as infertile was 8.8% (σ=1.09).
However when looking at parity, there are differences, where the rate of infertility for married,
childless women 15-49 years of age was 19.0% (3.16), and at 6.5% (1.13) for married women of
the same age who had at least one e child (NSFG, 2020). The percentage of women 15-49 years
of age who have ever received any infertility services was 12.7% (0.93). Women aged 40-49
were the highest users of any type of infertility service, at 20.5% (4.25).
According to SART, rates of infertility types within reporting SART clinics listed from
highest frequency to lowest, are as follows: diminished ovarian reserve (30%), male factor
(28%), ovulatory dysfunction (14%), “other” factor (24%), unexplained (11%), endometriosis
(7%), and uterine factor (6%) (SART, 2020). Unfortunately, it is difficult to determine an actual
prevalence of human infertility due to the different ways these agencies collect data. Further
complicating research on the prevalence and incidence of infertility is the multiple types and
levels of human infertility.
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Types of human infertility. Defining, and thus diagnosing, infertility remains a
challenging task, and affects the research, policies, and practices associated with ART (CDC,
2014). Infertility was only recently acknowledged as a disease (Berg, 2017), Presently infertility
is considered a disability due to its categorization under the Convention on the Rights of Persons
with Disabilities Act due to the impairment of male or female reproductive function [see
Macaluso et al., (2010); World Health Organization [WHO], (2011)]. Human infertility is a
complex disease with many etiologies, ranging from genetic mutations, such as deletions of
certain genes on the azoospermic factor regions (AZFs) of the Y-chromosome in men (Esteves &
Agarwal, 2011; Lee et al., 2011; Lee et al., 2003), physiological issues with ovulation or
fallopian tube function in women (Meng et al., 2015), a result of menopause in women (Friese et
al., 2006; Lemoine & Ravitsky, 2015), STDs (Tsevat et al., 2017) chemotherapy treatments for
cancer (Loren et al., 2013), and occupational hazards, such as injury or being exposed to certain
chemicals (Benoff et al., 2000).
The WHO (2018) lists six types of infertility: clinical, demographic, epidemiological,
disability, primary, and secondary. Clinical definitions of infertility include unsuccessful clinical
pregnancy after having unprotected sexual intercourse for at least 12 months. Demographic
definitions include individuals incapable of becoming pregnant who are of reproductive age (1549 years), or who are not able to carry a live birth. The difference between primary and
secondary infertility is that primary infertility refers to when a woman is unable to become
pregnant and is nulliparous (never had children), while in secondary infertility is defined as a
woman who was previously pregnant and is unable to become pregnant now (WHO, 2018).
Beyond the definitions of human infertility, there are also levels of infertility, such as
fertile, infertile, subfertile, and impaired fecundity. Both subfertility and impaired fecundity refer
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to a period of time when becoming pregnant is either difficult or not wanted (Wilcox & Mosher,
1994). Due to the many definitions, types, and degrees of human infertility, assessing an accurate
prevalence or incidence is difficult (CDC, 2014), especially due to the findings that stress can
cause impaired fecundity that is misdiagnosed as infertility. This potentially overestimates rates
of infertility, resulting in a spontaneous pregnancy once the couple stops medical intervention to
become pregnant (Kupka et al., 2003).
How infertility is defined can have social effects as well, such as the provision of
infertility services for same sex couples – where diagnosed infertility is not necessarily the
reason the couple wishes to use assisted reproduction. The way(s) in which infertility is defined
will have effects on the methods used to track the frequencies of use of the infertility services,
and more importantly the influence of the many co-factors contributing to why medical
intervention is necessary to achieve pregnancy. A person or couple do not have to have an
infertility diagnosis to need to use infertility services. For instance, same sex couples may seek
infertility services in order for at least one in the couple to have a genetic connection to their
offspring, or to use surrogacy. Regardless of sexual orientation, there might be a genetic disorder
that could be circumvented through the use of infertility services such as the three-parent IVF
procedure to remove mitochondrial disease from an embryo (Amato et al., 2014).
Types of ARTs. ARTs are included under the definition of infertility services. There are
several types of ARTs, ranging from invasive, high-tech options such as in vitro fertilization
(IVF) to low tech options such as ovarian stimulation, to third-party options such as adoption or
surrogacy. Often, a successful pregnancy resulting from ARTs requires multiple high- and lowtech options, increases the risk of multiples (twins, triplets), and presents an increased maternal
and child mortality risk (Chambers et al., 2007). Also, at times a couple or individual may
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require the use of a high-tech option along with a third-party option, such as using a gestational
carrier due to complications that inhibit the ability to carry a child that manifest from using
hormone therapy, which can cause ovarian cysts.
High-tech options. Artificial insemination (AI)/Intrauterine insemination (IUI). Artificial
insemination, also referred to as intrauterine insemination, uses a tube inserted into the vagina to
release sperm into the uterus, and is often used in conjunction with ovarian stimulants due to the
increased chances of success (National Institute of Child Health and Human Development
[NICHD], Child Development and Behavior Branch [CDBB], 2017). Before the semen is
injected into the uterus, it goes through a washing process that removes the seminal fluid
(ASRM, 2015). Multiple failed attempts at IUI often result in patients pursuing IVF or
intracytoplasmic sperm injection (ICSI) (Victorian Assisted Reproductive Treatment Authority
[VARTA], 2016).
IUI and IVF tend to be combined when observing statistics. Based on the 2017 annual
report on ART Success Rates from SART, IVF success rates reached 51.6% for achieving live
birth per cycle for persons age 35 and younger (Centers for Disease Control and Prevention
[CDC], 2017a).
In-vitro fertilization (IVF). In-vitro fertilization (IVF), or in-vitro fertilization with
embryo transfer (IVF-ET), is one of the most common types of ART, and it was the method used
with the birth of the first baby born from assisted reproduction. (Kamel, 2013). There are three
types of IVF, and they differ in that amount of ovarian stimulation. These types are natural,
where the mother does not receive fertility medication to induce ovulation; conventional, the
most commonly performed method where the ovaries are downregulated up to 10 days and then
stimulated to form multiple follicles – the ultimate goal being to increase success by increasing
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the quantity of embryos released; and mild, a more recent development that does not downgrade
the ovaries, but instead uses the natural cycle and low amount of fertility medication to produce
higher quality eggs – going for quality over quantity (CREATE Fertility, 2015).
There are four stages of IVF: superovulation, also referred to as ovarian stimulation,
ovarian induction, where hormone treatments taken for 8-14 days stimulate growth of follicles
and eggs, following an injection of human chorionic gonadotropin (hCG) to initiation ovulation;
egg retrieval, where the mature eggs are removed for fertilization ex-utero by use of an
ultrasound probe and a needle that goes through the wall of the vagina to retrieve the eggs;
fertilization, where the removed, mature eggs are fertilized ex-utero in a petri dish with semen
and placed in an incubator; and embryo transfer, where a long tube inserted into the vagina
released the embryos into the uterus with the intention of an embryo attaching to the uterine wall
within 6-10 days (NICHD Child Development and Behavior Branch (CDBB), 2017). The advent
of oocyte and embryo cryopreservation allows patients to preserve removed oocytes and
embryos for later use, so not all gametes have to be used at once (Gook, 2011).
The latest development in IVF is the three-parent IVF procedure, first used in the United
Kingdom in 2016 and most recently used by an American doctor in Mexico in 2017 (Scutti,
2017). Also termed mitochondrial donation, the three-parent IVF procedure was developed to
overcome mitochondrial disease for women, a disease that is difficult and expensive to treat
(Senger et al., 2016). The disease is due to a mutation in the mitochondrial DNA (mtDNA),
which is inherited maternally (Liu & Chu, 2015). The use of preimplantation genetic diagnosis
has not proved successful in detecting mitochondrial disease pre-procedure (Liu & Chu, 2015).
Currently there are two procedures used to create a three-parent embryo: pronuclear transfer,
where both of the normal pronuclei from the infected mtDNA are transferred to the donor
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zygote; and spindle transfer, involving the transfer of the mutated mtDNA nuclear genome to the
mtDNA of the donor oocyte (Liu & Chu, 2015).
In-vitro maturation (IVM). IVM does not use any ovulation hormones and is a specialized
procedure practice in a few areas of Europe (CREATE Fertility, 2015). The process of IVM
involves removal of immature eggs during a woman’s natural cycle, and maturing them ex-utero
and performing ICSI for fertilization (Child et al., 2002). SART does not publish results on IVM,
but some research suggests that it has comparable success rates to IVF (Ellenbogen et al., 2014).
Gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). GIFT is
a procedure not widely used, but it was created as a way to avoid using the petri dish for
fertilization, and is one of the few procedures approved by the Vatican due to it being so close to
normal conception compared to other ARTs (Gilson, 2008; Victorian Assisted Reproductive
Treatment Authority (VARTA), 2016) Similar to IVF, hormone treatments occur before the
procedure begins (Gilson, 2008). The sperm and unfertilized egg are moved into the fallopian
tube for fertilization to start, so the procedure requires that the woman have healthy fallopian
tubes and that the sperm be of good quality (Aurora, 2017). Research suggests that GIFT has
similar success rates to IVF, and some statistics report that women age <38 tend to have a 37%
chance of a successful pregnancy, and women age >39 have about 24% chance of a successful
pregnancy (Ding, 2016).
ZIFT is a similar procedure to GIFT, but it is the fertilized zygote that is moved into the
fallopian tube (Aurora, 2017). It combines processes in IVF and GIFT (Zhu, 2011). ZIFT can
often overcome failed GIFT procedures, or issues with male factor infertility (Aurora, 2017).
Fertilization occurs either in-utero or ex-utero, requiring ICSI (Zhu, 2011). Rather than wait until
the oocytes divide as in IVF, the oocytes are placed into the fallopian tube once cell division
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starts, using a laparoscopy (Zhu, 2011). The success rates for ZIFT are also comparable to IVF,
but they are highly variable based on the type of infertility to be overcome and the ages of the
patients (Ding, 2017).
Intra-cytoplasmic sperm injection (ICSI). ICSI is a procedure that becomes necessary
when the sperm is not able to fertilize the mature eggs during the fertilization phase of IVF (De
Vos, 2000). A needle injects the mature eggs with sperm in order to overcome lack of motility.
This procedure occurs in about 60% of all IVF done in the United States (NICHD Child
Development and Behavior Branch (CDBB), 2017). Rates for ICSI tend to focus on fertilization
success, where the Advanced Fertility Center of Chicago reports that fertilization with ICSI is
successful in about 75-85% of eggs (Advanced Fertility Center of Chicago, 2017).
Low-tech options. Low-tech ARTs are those infertility services that are not considered
invasive medical technologies such as those discussed above. Research by Messerlian, et al
(2015) include low-tech ART in their epidemiological analysis of preterm birth risk among ART
types. They define “low-tech” as any non-IVF method, such as ovarian stimulation. Based on
that definition, it is most likely that people utilize both high- and low-tech ART procedures.
However, this definition is not standard. Although “low-tech” ARTs have no supporting
evidence for efficacy, or definition for what exactly constitutes as low-tech, empirical research
brings up the importance to consider the existence and active searching for low-tech options.
Infertility patients navigate the high cost of existing, invasive ARTs (Messerlian et al., 2015),
and the leniency some religious institutions have for low-tech ARTs as opposed to high-tech,
invasive procedures make review of these options important (Klitzman, 2018).
Third-party options. Third party reproduction includes the use of gametes or embryos
donated from an individual other than the intended parents of the potential offspring and is often
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considered an altruistic act on behalf of the donor (ASRM, 2012; Pennings, 2015). Types of
third-party reproduction include sperm, egg, embryo and oocyte donation, surrogacy, and
gestational carriers(ASRM, 2012). Mitochondrial donation, for the three-parent IVF procedure,
is also considered under third party conception (Liu & Chu, 2015).
Gamete donation. SART tracks the number of births from use of donor eggs and
separates those rates by whether they were fresh (non-frozen) or frozen. Based on their 2016
annual report, the rate of live, normal weight, singleton births from transferring fresh embryos
was 32%, and with frozen embryos 26.7% (CDC, 2016). The rates for transfers resulting in
pregnancies were 65.9% for fresh embryos, and 52.3% for frozen embryos.
The anonymity of donors varies by country and type of gamete and continues to be an
ethical consideration due to rights to privacy and risks of consanguinity (Gong et al., 2009).
Other ethical considerations raised by third party reproduction are parentage designation laws
that are not standard, especially in the United States (Tsfati & Ben-Ari, 2018), compensation for
gametes (Lee et al., 2017), and risks of taking advantage of low-income donors in medical
tourism exchange (Inhorn, 2011; Neri et al., 2016).
Surrogacy. A surrogate is a woman who donates her egg to another couple and carries
that pregnancy to term. The main difference between surrogates and gestational carriers are that
surrogates use their own eggs and maintain a genetic link to the child, but gestational carriers use
the egg from another women and carry that child, without having a genetic link to the child
(ASRM, 2018). Some research observes the difficulty in determining parenthood with surrogacy
cases, due to some legislative definitions of “parent” and “mother” under the Uniform Parentage
Act referring to the existence of genetic links between the two women. Often times, surrogate
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mothers will be referred to as “natural” mothers, and the woman who is using the surrogate is the
intended mother or parent (Surrogate online, 2018).
Gestational carriers. Gestational carriers are different from surrogates in that they do not
have any genetic relation to the baby they carry, however gestational carriers can be relatives of
the intended parents – sometimes referred to as gestational surrogates (Daar et al., 2017). The
Ethics Committee of the ASRM defines intrafamilial gamete donation and gestational surrogacy
as being within ethical parameters, but the risks of consanguinity (incest) are still cautioned due
to the risk of not knowing who one’s paternal father is (ASRM Ethics Committee, 2018).
Research by Perkins et al, (2016) on trends in gestational carriers between 1999-2013 show that
rates of gestational carriers in ART is increasing, where in 1999 gestational carrier cycles were at
727, in 2013 the number increased to 3,432.
Adoption. Child adoption is not necessarily a third-party reproduction method, but it is a
solution some individuals and couples pursue to achieve their parenthood aspiration(s)
(Hoffman-Reim, 1990). Adoption existed before the development of ARTs, and although it can
satisfy the desire to be a parent, it does not satisfy the desire to be a parent to a child whom you
carried, birthed, and is genetically related to you (Petersen et al., 2015). Data from the NSFG
show that the rate of people adopting a child decreased from 1.1% of respondents (0.6 million) in
2002, to 0.7% (0.4 million) in 2015; and that people who took steps to adopt fluctuated between
3.4% (1.9 million) 2002, to 4.4% (2.5 million) in 2010, to 3.7% (2 million) in 2015 (National
Survey of Family Growth, 2017). The greatest debate between choosing ART or adoption has to
do with comparative costs and perceived power over outcomes of the situation. Some couples
perceive to have more control over what they do to their own bodies than relying on an agency to
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determine whether or not they are suitable as parents, and hoping that the natural mother does
not change her mind (Gumus & Lee, 2012).
In terms of cost, a single IVF cycle in the United States costs an average of $12,400, with
an additional $2,000-$6,000 for the IVF medications (Jain et al., 2019). There are some
insurance mandates that offer varying degrees of coverage for infertility services, but the
problem is that the language in the policies to not increase accessibility for everyone. The
policies inform people of the services that are covered (or, more often services that are not
covered) based on their residency. However, they do not equitably empower people to access
those services.
The effect of the existing insurance mandates in reducing costs associated with using
ARTs is also tenuous. Research by Boulet et al. (2019) found that women fully insured with per
member per month (PMPM) in states with infertility reimbursement mandates experienced 3.1x
more expenses than women fully insured with PMPM in states without infertility reimbursement
mandates. On the other hand, some research also found that women in states without an
insurance mandate had greater pregnancy rates than women using ARTs in states with infertility
insurance mandates (Martin et al., 2011). These types of discrepancies may be the result of
researchers choosing to focus on certain types of ARTs, certain age ranges, and specific fertility
clinics due to research demands or funding.

History of State-based Infertility Insurance Mandates
The development of the infertility insurance mandates is directly linked to the development
and increased ART use in multiple countries. Experimentation using ARTs first occurred with
animals such as mice and rabbits, and many of the methods used today for cryopreservation are
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based on the historical development of assisted reproduction using animals (Gook, 2011; Passos,
2004). The Scottish surgeon John Hunter is often cited as the first to preform human artificial
insemination, around the 1790s and supposedly using a syringe (Clarke, 2006; Harvard Medical
School Center for Mental Health and Media, 2017). However, some researchers speculate the
technology could have occurred successfully before this time, but was never publicized due to the
private nature of the topic of human infertility (Clarke, 2006). Even the success by Dr. Hunter was
not made public until after his death in 1799 by Sir Everard Home (Clarke, 2006; Poynter, 1968).
The first published success of human artificial insemination came from France in 1838 by Dr.
Girault, which included 12 cases (Clarke, 2006; Girault, 1868; Poynter, 1968).
The first in-vitro fertilization (IVF) on an ovum was conducted by John Rock and Miriam
Menkin in 1944 in Boston, MA. In 1978 the United Kingdom saw the first successful IVF
pregnancy and birth (Kamel, 2013). The first baby born from IVF in the United States, Elizabeth
Jordan Carr, occurred in 1981 in Virginia (Kamel, 2013). Multiple successful pregnancies and
births using ARTs occurred in several other countries starting in the early 1980s, including
Australia (1980), France (1982), Sweden (1982), Germany (1982), Austria (1982), and Nigeria
(1998) (Kamel, 2013). Towards the end of 1980 and continuing today, more methods of ART
started to develop, including successful births using frozen embryos and donated eggs in 1984,
GIFT and ZIFT in 1986, ICSI in 1992, and use of frozen eggs in 1997 (Harvard Medical School
Center for Mental Health and Media, 2017; Kamel, 2013).
Some of the first government oversight specific to infertility services in the United States
occurred in 1977 from recommendations from the National Commission for the Protection of
Human Subjects of Biomedical and Behavioral Research, the same organization that appointed the
requirement of Institutional Review Boards for federally funded research (Brinsden, 1999). The
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Committee called for Congress to establish an Ethics Advisory Committee for the Secretary of
Health, Education, and Welfare to assist in the oversight of in-vitro fertilization research
(Brinsden, 1999). In 1979, the Ethics Advisory Committee gave the official option that IVF was
ethically acceptable (Brinsden, 1999). This brief history of ART shows that, through continued
use and legitimization of assisted reproduction, came laws protecting both the persons using the
technology and holding those practicing the technology ethically accountable for their methods.
The first infertility insurance mandates were established during the creation of the 1989
Human Embryo Laboratories – Standards Favored to Ensure Quality

(Brinsden, 1999).

Beginning in 1977, the first state to pass the initial infertility insurance mandate was West Virginia,
followed by Maryland in 1985 and Arkansas, Hawaii, Massachusetts, and Texas in 1987. The most
recent mandates come from Delaware and Utah in 2018, and New Hampshire and Colorado in
2020, however some states such as California, New York, and Utah passed amendments to their
mandates since their initial passing. In 2019, North Dakota attempted to pass an infertility
insurance mandate (SB 2233) that would increase the coverage for infertility services to $20,000
and could include egg extraction and diagnostic services such as lab tests (Hyatt, 2019). However
this bill failed in the North Dakota Senate as it was met with opposition, and some speculate it was
due to assumptions that mandated insurance coverage for a service that few people in the state
utilize would result in increases in insurance premiums for all residents (Hyatt, 2019).

Current Research on Infertility Insurance Mandates
A common salient topic in research regarding infertility services is that financial
accessibility will increase in the 19 states (Figure 2.1) that now have mandated insurance for
infertility services, (Martin et al., 2011). However, current research that explores the extent of
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increased access to infertility services have conflicting results, where some previously highlight
increases in use (Jain & Gupta, 2007), and some suggest negligent positive benefits at alleviating
the financial burden of infertility services (Adashi & Dean, 2016). The majority of these research
designs utilizes a frequentist perspective that quantitatively observes utilization of infertility
services in states with vs states without mandated insurance for infertility services. Without
qualitative accounts of how people who live in states with mandated insurance navigate the
financial burden of these services, the benefit of living in a state with mandated infertility services
insurance could be masking other factors that people have to overcome in order to obtain that
coverage. What is more, much of the research does not observe all types of people who utilize
these services. While women of reproductive age are typically the staple population to observe,
current research leaves out marginalized groups such as same sex couples. The following are a
collection of research designs that observe the effect of state mandated insurance for infertility
services.
Quantitative approaches. Research by Martin et al. (2011) observed the effect of embryo
transfers of fresh non-donor IVF cycles in 2006, using retrospective analysis of data from the
SART and CDC. They acknowledged the differences within each state’s insurance mandate, where
some were more comprehensive than others, and to account for those differences that included at
least one cycle of vitro fertilization (IVF), specifically. Of the 426 reporting clinics, they found
that 74 (17%) were in states with mandated insurance for at least one IVF cycle, and of the 91,753
non-donor IVF cycles performed in the United States, 64,188 (70%) were in states that had
mandated insurance for at least one IVF cycle (Martin et al., 2011). They observed multiple
processes and outcomes from the IVF cycles, such as the frequency of the cycles, rates of fertility,
multiple births, cancelation rates, embryos transferred, and live births. They found that women
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whose cycles were performed in states without mandated insurance for infertility services had
higher pregnancy rates, live birth rates, cancellation rates, and multiple birth rates (Martin et al.,
2011).
In their discussion, they reduced their results to the significant increases in multiples for
women between the ages of 35-37 (being the age range where multiples are highest) in states
without mandated insurance to mean that insurance mandates might reduce the number of cycles
performed (because only one cycle might be covered) and thereby reduce the number of multiple
births resulting from IVF and embryo transfers. They interpreted their results to mean that states
with mandated insurance coverage “is strongly and consistently associated with responsible
embryo transfer practices in the United States…”, which also means that insurance mandates might
not actually increase the accessibility of these services (Martin et al., 2011, pg 968). Although their
results suggest increased access to infertility services are not affected by insurance mandates, they
suggest that the insurance mandates might reduce the risk of multiples from IVF, which is
associated with increased mortality risks to the mother and infant as well as places more economic
pressure on the State to provide long-term care for large families (Carson et al., 2013; Martin et
al., 2011). In their analysis, they are not able to ascertain to what degree an infertility insurance
mandate alleviated the economic burden of the individual.
Schmidt (2007) observed the effect of the enactment of state mandates on birth outcomes
over time and across states to observe state mandates on access to infertility services, using the
Vital Statistics Detail Natality Data from the National Center of Health Statistics. The researcher
utilized a differences-in-differences-in-differences (DDD) model to observe the effect that
insurance mandates have on birth rates coming from ARTs and takes into account when the statute
was enacted, and the female population aged 35+ who delayed childbearing. In her analyses, age
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was considered to be an important factor due to variations in outcomes. This type of statistical
model is suited to observe potential causal relationships between variables and assumes
“confounders varying across the groups are time invariant, and time-varying confounders are
group invariant”, meaning the confounding variables do not change after transformations are
applied (Wing et al., 2018, pg 455). In order to account for the variability of coverage in the
existing state mandates, the researcher grouped the mandates into those that cover infertility
services, meaning the statutes require insurance companies to provide coverage for infertility as a
benefit in all policies; and those that offer coverage, meaning that insurance companies can make
purchasable policies available that might cover some costs associated with infertility services
(Schmidt, 2007). The researcher also observed differences between Caucasian and African
American women in those groups.
Results from Schmidt (2007) revealed weak statistical significance for women living in
states with mandated insurance, where the presence of a mandate increased overall birth rates (this
outcome was for all women, not grouped by ethnicity or age). However, when observing women
over age 35, the significance was greater, meaning that women over 35 who live in a state with
mandated insurance had an increased birth rate than women over 35 living in a state without
mandated insurance for infertility services. A more interesting result is that, when ethnicity is
integrated into the equation, the same effects occur for white women aged 35+, (DD=0.0071
[0.0131]), but not for black women (DD=-0.0655, [0.0485]) no matter the age or if they lived in a
state with or without mandated insurance coverage for infertility services. When observing the
type of mandate (cover vs offer), it was hypothesized that there would be a positive correlation
between mandates that cover and overall birth rates from IVF, however there were no statistically
significant results that showed that mandates that cover certain infertility services are more
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facilitative than mandates that require certain infertility services to be offered. She also observed
the outcomes for white and black women and found the same association, where accessibility was
perceivably increased for white women but not for black women, no matter the age, type of
mandate, or if IVF was included or not (Schmidt, 2007).
In sum, the results from Schmidt (2007) revealed that insurance mandates do increase
accessibility of infertility services, but only for those women who are white, older, and highly
educated. Some limitations to this research were that there were only two types of demographic
characteristics observed, white and black races Although there is mention that education is also
associated, it was not included in the research design and may had been haphazardly added in order
to show similarity to other research. The other limitation was that the study design is retrospective,
where the research was published in 2007 but used data from between 1980-1999 – so its
application to practice is limited. There are some strengths, however, in that the types of mandates
were grouped into categories of cover vs offer, which are important distinctions to make in order
to observe a more robust association between their presence and absence. This research identified
that state mandates do not solve the disparity problem for accessing infertility services for minority
groups, specifically African American women.
Another frequentist approach comes from Boulet et al. (2019), where they applied linear
regression in a retrospective cohort study to observe expenditure differences in states with or
without insurance mandates. This study is different than the previous ones in that the foci of the
research was to observe expenditures using actual health insurance claims from the 2011 Truven
Health Market Scan Commercial Claims and Encounters Database, observing aggregate and permember-per-month (PMPM) costs in states with and without insurance mandates. They included
women 19-45 years of age and limited the observed time to 12 months. From their total of
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6,006,017 women, 48.1% were enrolled in fully insured plans. They separated those claims into
groups based on three types of infertility service: one or more IVF claim (9,199; 0.15%), one or
more IUI claim (10,112; 0.17%), and one or more ovulation inducing medication (OI) (23,736;
0.40%). No matter which claims group was reviewed, the expenditure was significantly higher in
states with mandated insurance for infertility services, where average expenditure for infertility
services was at $12,337 compared to $11,422 in states without insurance mandates for infertility
services (Boulet et al., 2019).
Although their research used actual health insurance claims and was able to distinguish
between self-insured vs fully insured employer-funded plans, it was limited by the way they
describe the significance of their results. The results were limited to significance of expenditure
by those who already accessed services; and in that there are no other demographics observed – it
is not possible to determine if insurance alleviates the disparity in access to infertility services.
They acknowledge in their discussion that a limitation was that they could not account for state
differences regarding the type of insurance mandates, such as in the Schmidt (2007) research.
Their geographic variables were limited to 4 regions: Northeast, North Central, South, and West –
none of which provide meaningful spatial associations due to the existing states with mandates not
centralizing in any one of those regions.
Qualitative approaches. Interestingly, there are no qualitative studies that directly observe
the use of health insurance for infertility services. Instances of qualitative and survey-based
research that identify cost and presence/absence of insurance as factors in whether someone will
seek infertility services (Greil et al., 2020) or are reported as barriers to access services (Goossen
et al., 2018) have been done, and there are law and policy reviews that observe the language in the
current infertility insurance mantes to see what is included and excluded.
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In a review by Dupree (2016), the absence of inclusive infertility insurance benefits for
males is highlighted through observing the language of existing infertility insurance mandates. The
review found that six of the then 16 states with infertility insurance mandates included coverage
specific to male factor infertility, but those provisions are mainly for diagnostic testing. Dupree
posits that the exclusion of male infertility benefits in those mandates places an undue burden on
female partners and can delay knowing the etiology of an infertility issue by only focusing on
female diagnosis and treatment.
In a law review by Centanni (2019), the language of Rhode Island’s infertility insurance
mandate is called into question, highlighting the heteronormative language that limits the ability
for same-sex couples to access the benefits of the mandate. For same-sex couples, there is no
diagnosed infertility in the disease sense, but the couple is considered “structurally infertile” due
to not being able to conceive through sexual intercourse. In the first iteration of Rhode Island’s
mandate in 1989, the language described infertility in a way many state’s still do: a married man
and woman who cannot conceive after 1 year of unprotected sexual intercourse. In 2007, the
mandate was amended to remove the “married” stipulation, and although the Governor vetoed the
bill at that time, the marriage stipulation was removed in 2017 (Centanni, 2019). However, there
remains the interpretable stipulation of “unprotected sex for at least 1 year”, which is not the reason
for infertility in all cases. Centanni (2019) reports that Rhode Island is not the only state to have
this type of restrictive language, in fact Hawaii still has the marriage requirement in their statute.
Although reviews and law reviews are not accounts of qualitative research, they bring to
light important factors to consider when attempting to observe the efficacy of a policy. The
language of the policy itself can provide explanatory context to why some disparities in accessing
infertility services exist to the degree that they do.
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Addressing Place in Infertility Services Research
Place is not linear; it is dynamic and not restricted to geographic location (MacEachren,
2017). In geography scholarship, it is however assumed that things close to each other tend to be
more related to each other than things far apart (Tobler, 1970). Many theories related to place and
health focus on the physical and built environment, but such dichotomization can ignore aspects
of place related to social context and change. This research attempts to apply current concepts of
place to the utilization of infertility services in the wake of changing public opinion and
technological advancement that circumvents barriers to natural cycles of human reproduction.
Attention must be paid to the contexts of place and the regulatory effect that sociodemographics
have on the degree of contextual influence on healthcare accessibility.
Much of the literature focused on the geographic aspects of place for infertility services
resort to comparing the distances to services. Research on the effect of living in an urban versus
rural area regarding access to infertility services tends to perceive accessibility through distance to
those services (Kunicki et al., 2018), costs associated with traveling to those services (Maxwell et
al., 2018), and the frequency of the workforce providing the service compared to the population
needing the health service in a specific area (like a county or city) (Nangia et al., 2010). Very little
research has observed disparity in access to infertility services through observing rural versus
urban residence. The CDC reports that in 2010, 1/5 of the U.S. population had residence in an area
considered rural (Daniels et al., 2017). The NSFG estimates between 2011-2015, rural women of
reproductive age had their first sexual encounter at an earlier age, had higher frequencies of
marriage and former marriage, exhibited a higher frequency of having at least one birth, and used
the most effective contraceptive methods (contraceptive sterilization or intrauterine device), when
compared to women of reproductive age living in urban areas (Daniels et al., 2017). These data
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suggest there are aspects of reproductive health that differ between rural and urban populations of
reproductive age, however the intricacies of those differences in terms of race/ethnicity, education,
annual income, and sexual orientation are difficult to observe quantitatively.
Research by Harris et al. (2017) observed the location of 510 CDC-reporting fertility
clinics that existed between 2009-2013 in the United States. They found that 442 of the clinics
existed in places with median populations of 1.45 million people (considered metropolitan), and
in 68 of those areas there was a single fertility clinic. They compared the clinic frequencies to the
number of women of reproductive age during that same time frame and found that 38.1 million
women of reproductive age lived in an area with more than one fertility clinic, 6.8 million lived in
an area with a single fertility clinic, and 18.2 million lived in an area with no fertility clinic. Their
overall result was that over 25 million women of reproductive age live in areas with limited to no
geographic access to fertility clinics, highlighting a disparity in geographic choice when seeking
infertility services. They summarize that expenses associated with long-distance travel for
specialized medical care can reduce the ability for some (Harris et al., 2017).
A potential strength from their research was that they used core-based statistical areas
(CBSAs), or geographic areas specified by social and economic influences within surrounding
counties, to define the geographic areas used in their analysis (Harris et al., 2017). This method
was an improvement on the previous methods of measuring the effect of distance to services on
disparity, which relied on measuring Euclidean distances from provider locations using spatial
buffers. A limitation to their research was that they did not include a variable to observe the effect
of state mandated insurance for infertility services, which could have influenced the frequencies
of people using those services. Another limitation was qualitative accounts of how place influences
accessibility, regarding a lack of knowledge about how far people are willing to travel for services,
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or if there are more people accessing those services who live in geographic proximity to those
services, compared to people who access those services and do not live in their geographic
proximity (Harris et al., 2017).
It is important to reiterate that place is not linear. However, geographic place can be
considered a risk regulator to the use of infertility services due to the state-specific nature of the
current mandates and lack of any federal mandate for these services. Measuring distances to
services to predict patters of use or levels of accessibility can be informative, but qualitative
accounts of travel associated with these services, as well as how residence affects access to these
services, could add important context to how people are qualified or disqualified from accessing
insurance coverage.
It is also important to consider natural boundaries and population distribution when
observing the locations of specialized medical practices. If there is a low population, there is less
incentive for business development because there are fewer projected potential patrons for the
services or product being offered (Adler & Florida, 2020). It may be beneficial to observe the
locations of fertility clinics through the lens of a business analysis, where rather than observing
few clinics in rural locations as a lack of perceived importance by the state, to interpret the accrual
of fertility clinics in larger metropolitan areas as logical due to the location of more people in those
areas. The observation that some metropolitan areas lack fertility clinics, then, becomes more
informative because those instances are not masked by a larger disparity of clinics in rural areas
where it would not make sense to build a fertility clinic.
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Conceptual Framework: Place as a Risk Regulator for Infertility Service Use
Glass & McAtee (2006) provided a conceptual framework (Figure 2.2) in which to observe
factors that influence health behavior change. The Glass and McAtee model is similar to the SEM,
however it addresses a different type of influence – the risk regulator – that positions itself not as
a determining factor that leads to a behavior, but that might influence a behavior in different ways
due to the differences that exist in people’s everyday reality. According to the Glass and McAtee
model of the social determinants of health, the risk regulators in this research are drivers of
disparity in access to infertility services that affect people in different ways, and they will change
over time. Place (where people live, where people travel to access services, where clinics are
based) is considered a risk regulator due to its affiliation with the environmental context of
everyday reality. The concept of place (often referred to as environment) is present in many health
behavior theories, but few research studies have directly observed the influence of place on health
behavior.
A main construct in theories of place posit that concepts of place are constructed, and that
constructions of place are dynamically influenced by culture, policy, individual cognition, and
social forces (Wolf et al., 2018). Concepts of place are “imbued with meaning, shaped by social
and political-economic forces” and therefore have and will continue to have an influence on human
health (Neely & Nading, 2017, pg 55). Due to these realities, an observation of the SEM as it
relates to the access of infertility services is required in order to better understand the multilevel
influence of human society and cognition in the construction of the infertility insurance mandates
and their use.
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Social Ecological Model of Infertility Service Use
Previous research on infertility services demonstrates that infertility services – the ways
they are accessed, researched, and practiced – are very complex, and that reproductive dysfunction
does not affect the public in the same way as some other public health concerns. This may be due
to the high priority human society places on human reproduction (Robertson, 1991) and how
uncontested the heteronormative paradigm of human reproduction has been over time (Boutell,
2018). Due to this complexity, it is beneficial to observe health disparity in accessing infertility
services through the SEM of health, specifically to observe factors affecting the lived experience
that are not necessarily deterministic but rather influential in terms of how accessible infertility
services are across the spectrum of people who want to use the technology – such as where people
live (place). The following section reviews infertility service accessibility through the SEM. Place
is not inherent at every level, but it is beneficial to observe possible influences at every level of
the SEM to derive meaning for place.
Intrapersonal: Physiology and cognition. At the intrapersonal, or individual, level, there
are beliefs and assumptions for what is considered “normal” in terms of human reproduction.
Human society established the acts of fathering children and giving birth as normative acts that
define masculinity and femininity, respectively (Paechter, 2006). These beliefs are observed,
learned starting at childhood and reinforced/reformed throughout the life of the individual based
on influences in their social environment– often referred to as primary socialization (Berger &
Luckmann, 1967). However, biology can inhibit the act of childbirth due to issues with infertility,
thus the need for infertility services. Biological factors such as age and diagnosed infertility inhibit
sexual reproduction, leading to a necessity to use infertility services in order to have one’s own
biological offspring (Albertini et al., 2017).
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According to Judith Butler’s explanation of performative acts of gender, we can postulate
that the act of “motherhood” is a repeated performance over time that solidified the idea that an
individual who is biologically female gives birth, “an identity instituted through a stylized
repetition of acts” (Butler, 1997, pg 519). As supporters of women’s rights continue to demand
equality for women in the workplace, society’s acceptance of women as career-driven individuals
and the tenacity of women to pursue careers outside of the home became a sociocultural movement,
especially in Western society (Fortin, 2015). However, women who choose to act against the
normative act of childbearing before career development are perceived as what Foucauldian
theorists could call deviant – because they act in opposition to normative acts (Foucault, 1984a).
This reveals a structurally founded biopedagogy leading to a socially constructed barrier to
accessing infertility services.
Much of the current research on infertility service use focuses on psychological factors that
could inhibit the ability to conceive, such as stress and depression (Cousineau et al., 2007; Purewal
et al., 2017; Slade et al., 2007). Although it is important to address the psychological impact of
needing to use infertility services in order to procreate, as well as the impact of failed attempts
using infertility services, a focus on psychological outcomes is often reduced to the need for
individualistic therapies to overcome psychological trauma (Lemoine & Ravitsky, 2015).
Regardless of the physiological inhibition those psychological factors have, they can reduce the
perceived ability (reduced self-efficacy) in achieving parenthood through the use of infertility
services (Altiparmak & Aksoy Derya, 2018). One important cognitive aspect of perceived ability
to access infertility services that is missing from the literature is qualitative accounts of how
accessibility is perceived by people living in states with or without mandated insurance for
infertility services. It is assumed that state mandated insurance coverage increases accessibility of
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infertility services, but it is not clear if they truly do increase access – and if they do, to what extent
they increase accessibility. Furthermore, are the presence of these mandates acknowledged by
those who need to use those services?
Interpersonal: Socialization through family, friends, time in life pressures. At the
interpersonal level, the individual experiences reinforcement or reframing of their beliefs based on
influences from their social reality (Glanz et al., 2015). These include a person’s social networks
– such as friends, co-workers, and extended family (Simons-Morton et al., 2012b). Missing out on
social gatherings associated with parenthood and motherhood creates a type of social isolation.
Interpersonal influences affect the individual identities of people who choose a method of
conception outside of how it has been done before, and the resulting isolation felt in going that
route (Cardenuto et al., 2020; Hochberg & Konner, 2020).
There are several influential forces on the individual and couple who begin the processes
of using infertility services – forces that are both consciously and unconsciously accepted and
rejected. A desire to reproduce is not a categorized phenomenon; it is a unique psychological
process born out of a personal history no theorist can comprehend unless they have observed it
from its very beginning. Just as renowned feminist scholar Judith Lorber (1993) emphasizes that
bodily functions such as lactation and menstruation are not rigid characteristics of female or
woman, reproductive desire should not be reduced to primal instinct or social responsibility. The
decisions made in the process of acting on those reproductive desires are intra-actively engaged in
the mind of the patient, and then further reinforced through interacting with others in society and
acting on those desires that are constructed to be normal (Langher et al., 2019).
Organizational: Employers, medical and legal organizations. Socio-ecological
influences at the organizational level include medical and legal organizations, and employers. The
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role of employers in making infertility services available has not been emphasized in the literature
as much as the focus of infertility insurance mandates on clinic activity. While it is important to
observe the effect these mandates have on clinic activity – essentially observing the effect of the
mandates on birth outcomes by state – the role of the employer in making these services part of
the company’s health insurance plan should not be understated. Should the employer not offer
infertility services under their health insurance policy, the infertility mandate will not be available
to the patient even if they live in a state that has an infertility insurance mandate. The applicability
of infertility insurance mandates are also influenced by the number of employees. For example,
the Federal Employee Retirement Income Security Act (ERISA) established that self-insuring
businesses (which offer private insurance) do not have to follow state insurance mandates
(RESOLVE: The National Infertility Association, 2019). In Illinois, employers that have fewer
than 25 employees do not have to offer the infertility mandate,, and employers in Maryland and
New Jersey that have fewer than 50 employees do not have to apply the infertility mandate in their
states. Another exception for Texas, Maryland, New Jersey, California, Connecticut, and Delaware
is that, regardless of the number of employees, religious employers do not have to apply the
infertility insurance mandate (RESOLVE: The National Infertility Association, 2020b).
Different religious and political affiliations and their associated ideological preconceptions
of human reproduction also have an impact on the preconceptions and opinions of individuals,
communities, employers, and governments enforcing laws regarding infertility services (Inhorn,
2006; Jones, 2014). In addition, gender, race/ethnicity, and age also play large roles in facilitating
access to infertility services (Sigillo et al., 2012). Provision of infertility health services are often
based on the ideological majority of the country in question, and accessibility to those reproductive
health services reflect those dominant ideologies (Żuk & Żuk, 2017). These social, religious, and
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political views all represent biopedagogies of human fertility, and emerging biopedagogies of
human infertility (Sigillo et al., 2012).
Community: Reinforcement of interpersonal social norms, online communities. At the
community level, there are pressures to reach adulthood milestones at a certain time in life
(Faircloth & Gürtin, 2017), coupled with increasing trends in postponing parenthood (Simoni et
al., 2017). Much of the research on psychological and psychosocial stressors for people dealing
with an infertility problem highlight the role of social pressures of meeting adulthood milestones.
These are identified as being facilitators of anxiety and depression while living in a pronatalist
society – being one that supports and emphasizes the importance of human reproduction through
policy and practice (Benyamini et al., 2017). Ironically, the cultural shift in postponing family
development started in the 1970s with the creation of birth control, giving women more autonomy
on when to decide to get pregnant. Now, however, the act of waiting to become pregnant creates
problems of infertility, thereby requiring new methods that preserve fertility options rather than
inhibit them (Bozzaro, 2018).
Some companies, such as Facebook and Microsoft, created programs for women to freeze
their eggs (cryopreservation) to facilitate more of an option for postponed family development –
the ability to circumvent the time restrains due to juggling higher education, work mobility, and
child rearing – without having to sacrifice genetic parenthood (Bozzaro, 2018). However, those
programs received scrutiny for still emphasizing a pronatalist mindset – reinforcing what ethicist
Bozzaro (2018) refers to as the “perpetual postponement of important life decisions” (pg. 600),
especially when considering the social and cultural factors that lead to a woman to freeze her eggs
– the lesser of which is the ability to overcome time-constraints. Although the gamete and embryo
freezing options provide a window of opportunity for future family development, the social
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pressures to start a family remain and negatively affect those who cannot access cryopreservation,
which is an increasing trend for infertility services due to advances in vitrification – the
cryopreservation of biological material into a glass-like state (Mandawala et al., 2016). These
programs suggest that employers have a role in increasing financial accessibility to infertility
services.
The development of the Internet opened the possibility for people to educate themselves
by looking for the information on ARTs and infertility services online (Culver et al., 1997; Diaz
et al., 2002; Fox & Duggan, 2013; Grunberg et al., 2018; Hesse et al., 2005; Omurtag et al., 2012;
Omurtag & Turek, 2013). There are many qualitative accounts with people diagnosed with
infertility or using infertility services who use online communities as sources for emotional and
informational support (Feasey, 2019). Research by Beeder & Samplaski (2019) observed male
infertility online discussion boards to explore the types of themes present in the posts and
discussion threads. They found the most common posts to be related to diagnosis and testing,
information forms of support, but also found instances of expressing emotions such as fear, anger
and frustration, and encouragement for others (Beeder & Samplaski, 2019).
According to research by Omurtag & Turek (2013), internet searches for gaining
information on reproductive health are increasing, and most people rely on internet sources alone
for such information. They identify a shift in doctor-patient information sharing, where social
media is used in higher frequency by SART member fertility clinics, creating a more complex
cyber-relationship between patients and providers of infertility services. Facebook and Twitter are
just two examples the authors used in the model, but the social media outlets also include forums,
blogs, and online news sources (Omurtag & Turek, 2013; Street et al., 2011). The existence of
these blogs and support resources shows a general desire for people wanting to know more about
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the possibility of infertility services, but also brings to light the problem that information being
accessed on those social sites may be providing medical misinformation, or information specific
to one individual’s experience that might not be transferable to others.
These online spaces allow people to vent emotions and discuss challenges and successes
with people who are going through a similar process. Sometimes, there are expressions from
people using those online spaces about not feeling they can discuss these issues with friends or
family for fear of rejection or judgement for seeking medical intervention (Billett & Sawyer,
2019).
Policy: Lack of legislation. The most prominent aspect of policy development regarding
access to infertility services is the development of statutes that specify the extent of infertility
services to be covered by insurance companies, ranging from no coverage to diagnostic tests for
fertility to a cap on numbers of IVF cycles. The Affordable Care Act (ACA) did not have much of
an effect on existing legislation due to the freedom states have in defining what types of infertility
services can be covered. However, the ACA does assume that if infertility treatments are not
mandated by a state, it is most likely covered under the “ambulatory patient services and maternity
and new-born care” essential health benefits (EHBs) as identified by the Institute of Medicine
report (Stapleton & Skinner, 2015, pg 652).
Research by Dieke et al., (2017) using the 2014 National ART Surveillance System
(NASS) data found that regardless of race/ethnicity, infertility service utilization was greater in
states with infertility insurance mandates. Although their research showed some higher use in
states with infertility service mandates, their research used a database that consisted of people who
had access to a fertility clinic and their services. Showing some geographic distribution of people
already accessing services is marginally useful in terms of epidemiological assessment, but it is
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also important to address the underlying regulators that influence the degree of access these
statutes actually offer.
Although there are 19 states that include statutes with infertility services, none of those
statutes require comprehensive coverage, and not all definitions of infertility services are the same
(National Conference of State Legislatures, 2019b). As can be seen from the adapted table from
the National Conference of State Legislatures (Table 2.1), the provisions, limitations, and
exclusions for the types of services, and the type of person accessing those services, differs from
state to state. States that currently have a statute referring to some form of coverage for infertility
services are Arkansas, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Louisiana,
Maryland, Massachusetts, Montana, New Hampshire, New Jersey, New York, Ohio, Rhode Island,
Texas, Utah, and West Virginia (RESOLVE, 2020).
The National Conference of State Legislatures (NCSL), a political advocacy organization
that assists state legislatures with improving quality and effectiveness of state legislatures, promote
policy innovation, and help maintain that state legislatures have a voice at the federal level. They
published a report on state level measures to decrease health disparities. In that report they
acknowledged the trickle-down effect that policy has on individual access to health services. They
posit that medical care is essential to one’s health, but that factors outside of the health care system
are also linked to health and health disparities. The report acknowledged the reciprocal causation
between social, economic and environmental circumstances that affect individual health behavior
(National Conference of State Legislatures, 2019b).
Under their key recommendation “Assess barriers in access to care”, the NCSL calls for
increased research in examining the drivers of disparities in access to health care services, such as
the ability to navigate the health care system and the presence or absence of insurance, gaining an

46

in depth look at what social determinants inhibit or facilitate access to health services (National
Conference of State Legislatures, 2019a, pg 8). Research by Klitzman (2017) observed the impact
of insurance mandates and economics for patients deciding on types of procedures for treating
infertility. He found that decisions made by patients, and jointly by patients and physicians, were
affected by insurance and economics to the extent that patients delayed the procedures, chose less
costly procedures with reduced efficacy, moved to a different area that had better insurance
coverage, actively sought cheaper and free methods, and used medications from others. The effects
of finances and insurance are cited in the literature to lead to disparities in access, where people
living below a certain socio-economic status (SES) or in a state where infertility insurance is nonexistent or limited for infertility services experience greater disparity in access than people with
higher annual income, private insurance, and in a state where insurance is mandated (Jain &
Hornstein, 2005; Stapleton & Skinner, 2015).
Reviewing the levels of influence from the SEM on disparity in access to infertility
services, reveals discourse about place or “environment” – where people live, work, and socialize
– and its effect on perceived and actual access to infertility services. However, through observation
and reflection on research regarding access to infertility services, the influence of place has not
been critically observed. It is usually tangentially referred to as an influence but there have been
no contributions in the literature which has critically analyzed its effect regarding access to
infertility services in the United States.
To identify new knowledge based on empirical evidence, theory and methods of research
need to be selected based on the imperative of the research, which should address the current gaps
on the topic in question. The use of theory facilitates reflection on public health practice, which
can maintain the existence of professional ethics and social justice within public health research
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and practice (Goodson, 2010). It also reduces the chance of ideological hegemony that can control
how health and illness are observed and thus acted upon, risking marginalization of groups of
people and stagnation of research innovation (Goodson, 2010). This is a present concern for
research on infertility services.

Social Cognitive Theory: Person, Place, and Seeking Infertility Services
SCT, originally termed Social Learning Theory, was developed in the 1960s by
psychologist Albert Bandura (LaMorte, 2016). At the core of SCT is the idea of triadic reciprocal
interaction (determinism), where personal factors, health behavior, and environment are effects
and are affected by each other (Korin, 2016). Bandura (2001) highlights the agential nature of the
individual in SCT, emphasizing that individuals do not simply exist in their environment, rather
they engage with, change, and are changed by their environment in a model of “emergent
interactive agency” (pg. 4).
SCT does not dismiss thought processes as ephemeral occurrences with no basis in the
physical world, because, in Banduras’ explanation, thoughts can determine actions we choose to
take, or not to take (Bandura, 2001). Bandura explains the interaction between the individual and
his/her learned experiences, the social environment, and behavioral responses of the individual as
triadic reciprocal causation (Bandura, 2001). A key concept in SCT is that individuals learn from
both their own experiences, but also from observations from their social environment (Office of
Behavioral and Social Sciences Research, 2018). The idea of reciprocal determinism characterizes
the individual as an initiator of change and a responder to change (Korin, 2016; Office of
Behavioral and Social Sciences Research, 2018). Principles of SCT include attention to social
context, retention of external stimuli, reproduction of the improved behavior, and motivation to
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pursue the change (Bandura, 1977). Here we can observe how important self-efficacy is to the
agency of the individual in SCT by observing the interplay between environmental influence (the
social environment) and psychological theories that interpret behavior: “social cognitive theory
rejects a dualism between personal agency and a disembodied social structure”, in other words, we
need to observe the social and psychological aspects of behavior (Bandura, 2001, pg 24).
SCT considers the very prominent psychological aspects of human infertility and the use
of infertility services. It positions those cognitive processes in the context for which behaviors
developed – stemming from observation of, retention of, reproduction of, and motivation to act on
influences from the social environment. The construct of self-efficacy is key to this research
because of the amount of the obstacles that inevitably ensue when attempting to access infertility
services. In fact, the reason for using infertility services can be because an obstacle was
encountered (issue with fertility). Therefore, inclusion of the triadic reciprocal causation between
the thoughts of the individual, their social influences, and the motivation to act on behaviors based
on the bidirectional exchange between those factors might be effective in explaining why some
people desire genetic parenthood to the extent that they sacrifice marriage, lifestyle, income, and
time to obtain it. This research will utilize the Infertility Self-Efficacy Scale (Cousineau et al.,
2006) to measure self-efficacy among people seeking and accessing infertility services.

Social Constructionism and Infertility Service Use
The origin of social constructionism comes from sociology and communication disciplines
and is considered a post-modern theory in qualitative research (Andrews, 2012). Two prominent
theorists who used social constructionism were Rom Harre and Michael Billig, who both wrote
seminal works that challenged individualistic psychology, which reduces identity to personal
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thought process without much attention to social environmental influence (Galbin, 2014). Also
having roots in the philosophy of knowledge, social constructionism is associated with rethinking
the practice of grounded theory by assuming that knowledge is constructed rather than created
(Andrews, 2012). Social constructionism has to do with “the shared social aspects of all that is
psychological”, emphasizing the agency of the individual in constructing their reality, but the near
impossibility of authentic behavior (authentic meaning uninfluenced by the social environment)
(Galbin, 2014, pg 82). The attention to individual interpretations of reality are embedded in social
construction, as Berger & Luckmann (1967) would define as the social construction of reality.
In a review of psychosocial effects of human infertility by Greil et al. (2010), they call for
a move away from viewing the psychological effects of infertility in a medicalized view. They
suggest moving from a focus on the prevalence of depression in those who suffer from infertility
to one that focuses on a lived experience approach, and views infertility as a socially constructed
reality. Attention to the construction of knowledge and individual reality can be very informative
in research for infertility services because social constructionism is sensitive to changes that
initiate new “practices and behaviors” (Galbin, 2014, pg 91). The emergence of new knowledge
relating to the legitimacy of reasons for using infertility services led to the reconstruction of some
of the existing infertility insurance mandates. This lead to more inclusive language for nontraditional family development (Centanni, 2019) – a reaction to emerging practices and behaviors.
Although infertility services have been used in practice for over 70 years, the influence of
reproductive technological advancements on society have been drastic, from changing the way we
view the nuclear family, to the degree of humanity the state gives to a maybe-baby cluster of cells.
The ability to circumvent a physiologically-based barrier to procreation creates the tenacity to act
in opposition to socially founded biopedagogies, leading to a Foucauldian idea of deviance, where
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the individual is perceived negatively by the majority in society as a result of engaging in new
practices and behaviors (Gillespie, 2000). Becker & Nachtigall (1994) conducted a qualitative
study with 275 persons undergoing infertility treatment to assess how risk is constructed while
seeking medical assistance for infertility. Although they do not specifically utilize social
constructionism, they do find that culture affects the way people construct disease. Since infertility
is a medicalized disease (although at that time it was not considered a disease, explicitly) it can be
circumvented. The ability to be treated for infertility is a possibility that overpowers financial and
at times physiological risk to the patient, due to the importance that human society places on
parenthood and motherhood and the reinforcement of those biopedagogies by one’s social
networks (Becker & Nachtigall, 1994).
Existing research that discusses the use of infertility services through a social
constructionist perspective highlights the effect that social environments have on the construction
of, and reinforcement of: infertility as a disease (Becker & Nachtigall, 1994; A. Greil et al., 2011),
infertility as a “problem” (Miall, 1996, pg 310), childlessness (Petersen et al., 2015), being infertile
(Scritchfield, 1995), motherhood (Mukherjee, 2016), and target populations for infertility policy
reform (Montpetit et al., 2005).
The qualitative and quantitative approaches so far used to observe the efficacy of the statebased infertility insurance mandates led to more questions than answers. Qualitative approaches
address the psychological trauma associated with living in a pronatalist society that established
heterosexual parenthood as an adulthood milestone, continuously reinforced by popular media.
Although these observations are important for understanding the lived experience of using
infertility services in the United States, they do not offer solutions as to reduce the psychological
strain placed on people accessing these services. They also do not address any aspects of the
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state-based infertility insurance mandates. Quantitative studies accounted for the use of certain
types of infertility services, comparing outcomes in states with and without an infertility insurance
mandate, but their designs do not allow us to observe the utility of the mandates themselves and
assume that if someone lives in a mandated state they will have coverage.
Social constructionism has not been widely used in the analysis of infertility services, but
aspects of cultural and social influence have been referenced as contributing contextual factors
that have some degree of influence (Becker & Nachtigall, 1994; Greil et al., 2010). SCT is useful
in observing the role of self-efficacy in seeking infertility services and there is a validated
psychometric tool used to measure self-efficacy in relation to seeking infertility services
(Cousineau et al., 2006). However, SCT used in infertility services has not been applied to the use
of infertility services in relation to aspects of place.
This research functions within the social-ecological perspective of human health, which
maintains two central concepts: multiple levels of influence affect human behavior; and reciprocal
causation, which is the idea that an individual’s behavior is shaped by their social environment,
which is also shaped by individual behavior (National Cancer Institute, 2005). Due to the objective
of a dissertation being the provision of new evidence and new knowledge, this research addresses
some of the missing contextual forces affecting the applicability of infertility service insurance
mandates in the United States.
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Chapter Two Tables
Table 2.1 State-based insurance mandates for infertility services in the United States
State
Summary of Statutes
Arkansas
Ark. Stat. Ann. § 23-79-510, specifies that the Arkansas Comprehensive
Health Insurance Pool shall not include coverage for any expense or charge
for in vitro fertilization, artificial insemination or any other artificial means
used to cause pregnancy.
Ark. Stat. Ann. § 23-85-137 and § 23-86-118 (1987, 2011) require
accident and health insurance companies to cover in vitro fertilization.
Services and procedures must be performed at a facility licensed or
certified by the Department of Health and conform to the guidelines and
minimum standards of the American College of Obstetricians and
Gynecologists and the American Society for Reproductive Medicine. (2011
SB 213)
California
Cal. Health & Safety Code § 1374.55 and Cal. Insurance Code §
10119.6 (1990, 2011) require specified group health care service plan
contracts and health insurance policies to offer coverage for the treatment
of infertility, except in vitro fertilization. The law requires every plan to
communicate the availability of coverage to group contract holders. The
law defines infertility, treatment for infertility and in vitro fertilization. The
law clarifies that religious employers are not required to offer coverage for
forms of treatment that are inconsistent with the organization's religious
and ethical principles. The law was amended by 2013 Cal. Stats., Chap.
644 (AB 460) to specify that treatment of infertility shall be offered and, if
purchased, provided without discrimination on the basis of age, ancestry,
color, disability, domestic partner status, gender, gender expression, gender
identity, genetic information, marital status, national origin, race, religion,
sex, or sexual orientation.
Colorado
No information from NCSL
(most recent mandate)
Connecticut
Conn. Gen. Stat. § 38a-509 and § 38a-536 (1989, 2005) require that
health insurance organizations provide coverage for medically necessary
expenses in the diagnosis and treatment of infertility, including in vitro
fertilization procedures. Infertility, in this case, refers to an otherwise
healthy individual who is unable to conceive or produce conception or to
sustain a successful pregnancy during a one-year period. Amended in 2005
to provide an exemption for coverage that is contrary to the religious
beliefs of an employer or individual.
Delaware
18 Del. C. §3556 (2018) requires all group and blanket health insurance
policies, contracts, or certificates that are delivered, issued for delivery,
renewed, extended, or modified in the state of Delaware by any health
insurer, health service corporation, or health maintenance organization and
that provide for medical or hospital expenses shall include coverage for
fertility care services, including in vitro fertilization services for
individuals who suffer from a disease or condition that results in the
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Table 2.1 (continued)
inability to procreate or to carry a pregnancy to live birth and standard
fertility preservation services for individuals who must undergo medically
necessary treatment that may cause iatrogenic infertility.
Hawaii
Hawaii Rev. Stat. § 431:10A-116.5 and § 432.1-604 (1989, 2003) require
all accident and health insurance policies that provide pregnancy-related
benefits to also include a one-time only benefit for outpatient expenses
arising from in vitro fertilization procedures. In order to qualify for in vitro
fertilization procedures, the couple must have a history of infertility for at
least five years or prove that the infertility is a result of a specified medical
condition.
Illinois

Louisiana

Maryland

Massachusetts

Ill. Rev. Stat. ch. 215, § 5/356m (1991, 1996) requires certain insurance
policies that provide pregnancy-related benefits to provide coverage for the
diagnosis and treatment of infertility. Coverage includes in vitro
fertilization, uterine embryo lavage, embryo transfer, artificial
insemination, gamete sperm artificial intrafallopian tube transfer, zygote
intrafallopian tube transfer and low tubal ovum transfer. Coverage is
limited to four completed oocyte retrievals, except if a live birth follows a
completed oocyte retrieval, then two more completed oocyte retrievals are
covered. (1996 Ill. Laws, P.A. 89-669)
La. Rev. Stat. Ann. § 22:1036 (2001, 2008, 2009) prohibits the exclusion
of coverage for the diagnosis and treatment of a medical condition
otherwise covered by the policy, contract, or plan, solely because the
condition results in infertility. The law does not require insurers to cover
fertility drugs, in vitro fertilization or other assisted reproductive
techniques, reversal of a tubal litigation, a vasectomy, or any other method
of sterilization. (2001 La. Acts, P.A. 1045)
Md. Insurance Code Ann. § 15-810 (2000) amends the original 1985 law
and prohibits certain health insurers that provide pregnancy-related benefits
from excluding benefits for all outpatient expenses arising from in vitro
fertilization procedures performed. The law clarifies the conditions under
which services must be provided, including a history of infertility of at
least a 2-year period and infertility associated with one of several listed
medical conditions. An insurer may limit coverage to three in vitro
fertilization attempts per live birth, not to exceed a maximum lifetime
benefit of $100,000. The law clarifies that an insurer or employer may
exclude the coverage if it conflicts with the religious beliefs and practices
of a religious organization, on request of the religious
organization. Regulations that became effective in 1994 exempt businesses
with 50 or fewer employees from having to provide the IVF coverage.
(2000 Md. Laws, Chap. 283; H.B. 350)
Md. Health General Code Ann. § 19-701 (2000) includes family
planning or infertility services in the definition of health care services.
Mass. Gen. Laws Ann. ch. 175, § 47H, ch. 176A, § 8K, ch. 176B, § 4J,
ch. 176G, § 4 and 211 Code of Massachusetts Regulations 37.00 (1987,
2010) require general insurance policies, non-profit hospital service
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Table 2.1 (continued)
corporations, medical service corporations and health maintenance
organizations that provide pregnancy-related benefits to also provide
coverage for the diagnosis and treatment of infertility, including in vitro
fertilization. This law was amended in 2010 to change the definition
of "infertility" to be a condition of an individual who is unable to conceive
or produce conception during a period of one year if the female is under the
age of 35, or during a period of six months if the female is over the age of
35. If a person conceives but cannot carry that pregnancy to live birth, the
period of time she attempted to conceive prior to achieving that pregnancy
shall be included in the calculation of the one year or six month period. (SB
2585)
Montana
Mont. Code Ann. § 33-22-1521 (1987) revises certain requirements of
Montana's Comprehensive Health Association, the state's high-risk pool,
and clarifies that covered expenses do not include charges for artificial
insemination or treatment for infertility. (SB 310)
Mont. Code Ann. § 33-31-102 et seq. (1987) requires health maintenance
organizations to provide basic health services on a prepaid basis, which
include infertility services. Other insurers are exempt from having to
provide the coverage.
New
New Hampshire Revised Statutes Annotated (RSA), Title XXXVII,
Hampshire
Chapter 417-G Access to Fertility Care. requires all insurance companies
subject to state law, which sell group policies, plans, or contracts providing
benefits for medical or hospital expenses, to provide coverage for the
diagnosis and medically necessary treatment of the disease of infertility.
Coverage is required as well for standard fertility preservation services for
patients undergoing treatments that may impair their ability to reproduce
New Jersey

New York

N.J. Stat. Ann. § 17:48-6x, § 17:48A-7w, § 17:48E-35.22 and § 17B:2746.1x (2001, 2013) require health insurers to provide coverage for
medically necessary expenses incurred in diagnosis and treatment of
infertility, including medications, surgery, in vitro fertilization, embryo
transfer, artificial insemination, gamete intrafallopian transfer, zygote
intrafallopian transfer, intracytoplasmic sperm injection and four
completed egg retrievals per lifetime of the covered person. The law
includes some restrictions as well as a religious exemption for employers
that provide health coverage to fewer than 50 employees. (SB 1076)
N.Y. Insurance Law § 3216 (13), § 3221 (6) and § 4303(1990, 2002,
2011) prohibit individual and group health insurance policies from
excluding coverage for hospital care, surgical care and medical care for
diagnosis and treatment of correctable medical conditions otherwise
covered by the policy solely because the medical condition results in
infertility. The laws were amended in 2002 to require certain insurers to
cover infertility treatment for women between the ages of 21 and 44 years.
The laws exclude coverage for in vitro fertilization, gamete intrafallopian
tube transfers and zygote intrafallopian tube transfers. The laws were
amended again in 2011 by N.Y. laws, Chap. 598 to require every policy
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Table 2.1 (continued)
that provides coverage for prescription fertility drugs and requires or
permits prescription drugs to be purchased through a network participating
mail order or other non-retail pharmacy to provide the same coverage for
prescription fertility drugs that are purchased from a network participating
non-mail order retail pharmacy provided that the network participating
non-mail order retail pharmacy agrees in advance to the same
reimbursement amount and the same terms and conditions that the insurer
has established for a network participating mail order or other non-retail
pharmacy. The policy is prohibited from imposing additional fees, copayments, co-insurance, deductibles or other conditions on any insured
person who elects to purchase prescription fertility drugs through a nonmail order retail pharmacy. (2011 AB 8900)
N.Y. Public Health Law § 2807-v (2002) creates a grant program to
improve access to infertility services, treatments and procedures from the
tobacco control and insurance initiatives pool.
Ohio
Ohio Rev. Code Ann. § 1751.01 (A)(1)(h) (1991) requires health
maintenance organizations (HMOs) to provide basic health care services,
which are defined to include infertility services, when medically necessary.
Rhode Island
R.I. Gen. Laws § 27-18-30, § 27-19-23, § 27-20-20 and § 27-41-33 (1989,
2007) require any contract, plan or policy of health insurance (individual
and group), nonprofit hospital service, nonprofit medical service and health
maintenance organization to provide coverage for medically necessary
expenses for the diagnosis and treatment of infertility. The law clarifies
that the co-payments for infertility services not exceed 20 percent.
Infertility is defined as the condition of an otherwise healthy married
individual who is unable to conceive or produce conception during a period
of one year. Rhode Island includes IVF coverage. Amended in 2007 to
increase the age of coverage for infertility from forty (40) to forty-two (42)
and redefines infertility to mean a woman who is unable to sustain
pregnancy during a period of one year. (2007 R.I. Pub. Laws, Chap. 411,
SB 453)
Texas
Tex. Insurance Code Ann. § 1366.001 et seq. (1987, 2003) requires that
all health insurers offer and make available coverage for services and
benefits for expenses incurred or prepaid for outpatient expenses that may
arise from in vitro fertilization procedures. In order to qualify for in vitro
fertilization services, the couple must have a history of infertility for at
least five years or have specified medical conditions resulting in
infertility. The law includes exemptions for religious employers.
Utah
2014 Utah Laws, Chap. 353 (HB 347) amended § 31A-22-610.1, which
requires insurers that provide coverage for maternity benefits to also
provide an adoption indemnity benefit of $4,000 for a child placed for
adoption with the insured within 90 days of the child’s birth. The law was
amended to allow an enrollee to obtain infertility treatments rather than
seek reimbursement for an adoption. If the policy offers optional maternity
benefits, then it must also offer coverage for these indemnity benefits under
certain circumstances.
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West Virginia W. Va. Code § 33-25A-2 (1995) amends the 1997 law and requires health
insurers to cover basic health care services, which include infertility
services. Applies to health maintenance organizations (HMOs) only.
*Table adapted from National Conference of State Legislatures. (2019). State Laws for Insurance
Coverage for Infertility Treatment. Retrieved September 2020, from
http://www.ncsl.org/research/health/insurance-coverage-for-infertility-laws.aspx
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Chapter Two Figures

Figure 2.1. States with and without an infertility insurance mandate
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Figure 2.2. Glass and McAtee model of risk regulators
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CHAPTER THREE:
RESEARCH DESIGN AND METHODOLOGY

Mixed Method Research Design
The current literature is missing a mixed method design specific to observing the effect of
state mandated insurance on accessibility to infertility services. The literature review described
some quantitative projects that attempt to observe the effect of insurance on increasing
accessibility to infertility services. However current quantitative research ignores one of the main
assumptions of place-based research: place-based context relating to where people live and where
they access infertility services affect people in different ways.
This research utilizes a mixed-method, pragmatist research design, using both quantitative
and qualitative data to understand this phenomenon more fully. Pragmatism is a philosophical idea
that suggests that “something is true only if it works”, meaning truth of a theory’s utility comes
from the theory confirming its constructs through its application (Goodson, 2010, pg. 172). The
pragmatist approach via mixed-method research design was a result of moving away from
methodological dichotomization of qualitative and quantitative methods, suggesting that research
is not a method of superiority reification, but rather research should observe qualitative and
quantitative paradigms as inclusive, contributing to a “continuum of scientific research”
(Onwuegbuzie & Leech, 2005, pg. 173).
This research uses qualitative and quantitative data in a multiphase design described by
Creswell & Plano-Clark (2011) which involves iterative analysis of the qualitative and quantitative
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data, and making analysis decisions based on how best to combine the results to answer the
research question. The design of this mixed method research was carefully planned as to collect
qualitative and quantitative data that would add context to the use of infertility insurance mandates
in the United States.
Limitations of mixed methods research can largely be due to using strategies that are not
complimentary to each other, causing issues of validity and generalizability. A still present debate
against mixed methods research is the applicability of multiple paradigms (Creswell & PlanoClark, 2011). The design of this research attempts to avoid these limitations by choosing theories
and operational paradigms that complement each other based on their constructs.

Research Questions
There are a total of seven research questions included in this research, and each question
refers to aspects of geographic place and human reproduction. Due to the need for these types of
data to complement each other, some questions will be able to be answered with both qualitative
and quantitative sources. The alignment matrix in Appendix A lists the research questions, data
collection instrument, and item on that instrument use to answer the research question. The
following are the rationale for each research question.
R1: Why do people access infertility services in the United States?
This question is important to add context of why people use infertility services. Some
people have issues with fertility, some people wish to circumvent recessive genetic traits, some
went through cancer treatment and require assisted reproduction, and some others are in same-sex
relationships. The identification of similar or different experiences can add context to facilitative
and prohibitive factors that are common or unique to certain groups. Data used to answer this
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question are both qualitative and quantitative. Qualitative data came from the informal interviews
with people in one of the three stages of infertility services: looking for information (Prospective),
currently using services (Active), and used in the past (Past). Data also was reported from the from
the survey instrument, specifically the demographic questions and the infertility self-efficacy scale
(ISE). The ISE can give context into the self-efficacy of continuing to access or try to access
infertility services, and how those experiences might be different based on reasons for using these
services.
R2: What influence does geographic location have on access to infertility services?
Missing from the current literature are qualitative accounts of how residence or travel affect
the ability to access infertility services. There are also missing quantitative observations of how
frequently people move residences or travel domestically or internationally to access infertility
services. Both qualitative and quantitative data was used to answer this research question.
Qualitative data came from the informal interviews, where participants were asked about where
they accessed services, and if they have ever traveled out of state or country to access services.
Qualitative data came from the survey, specifically questions in the Residence, Insurance
Coverage, Travel, and ISE scale sections. The ISE scale may give some insight into levels of selfefficacy for accessing infertility services being different for people in different geographic
locations, and with different travel requirements. A
R3: What influence does living in a state with mandated insurance have on access to infertility
services?
Attempts to answer this question in the current literature are based on quantitative methods
(Boulet et al., 2019; Schmidt, 2007). The issue this poses is that there are no qualitative contexts
regarding the extent of insurance coverage people had on the services they accessed. The research
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question posed here adds missing context surrounding the actual utility of the infertility insurance
mandates by inquiring into the experiences of people living in states with and without those
mandates. This question was answered using both qualitative and quantitative data. Qualitative
methods using informal interviews asked questions about insurance coverage, payment for
services, influence of the existing mandates for their situation, and dealings with employers in
gaining coverage. Quantitative data came from the survey, specifically in the Insurance block,
which inquired about the person’s insurance coverage, use of mandates, and extend of use of
mandates (covered nothing, covered some, covered everything).
R4: What are the roles of specialized infertility specific insurance or other financial aid
organizations in increasing access to infertility services in the United State?
Missing in the discourse surrounding insurance for infertility services are the organizations
that are essentially filling in accessibility gaps by providing grants, loans, payment programs,
reduced rate programs, or specialized infertility insurance directly to employers to offer to their
employees. These organizations can add important missing context into the use of infertility
services by observing how these organizations functioned as facilitators in the access to infertility
services in the United States. Data to answer this question came from the expert interviews.
However, data from this question may also be used to add context to the answers provided in the
informal interviews, due to some of the informal interview participants using services from some
of the participating “expert” organizations.
R5: What is the spatial relationship between fertility of women between the years of 2013-2017
based on age, education, ethnicity, nativity, and income?
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There are two primary reasons why this research does not observe the spatial distribution
of diagnosed infertility or use of infertility-specific medical procedures such as in vitro fertilization
(IVF): 1) The absence of geospatial fertility research, and 2) Cost and access restriction on datasets.
Of primary importance here is the lack of geospatial fertility research by which to compare
spatial analyses of infertility. Johnson et al (2018) discussed the different trajectories of fertility
and infertility research, observing that fertility research historically focused more on demographic
trends, applying theory and economics, observing trends over time, while infertility research has
focused more on medicine, looking into the genetics of infertility, psychological distress
management, levels of diagnosis for males and females, and some social and clinical research
observing disparities in access to infertility services. They propose observation of the “dynamically
interrelated” relationship between fertility and infertility through observing these data in tandem,
inclusively (Johnson et al., 2018, pg 25). By observing fertility at the census tract level, future
spatial analyses of infertility can be interpreted with more meaning due to having a distributional
norm to measure it against to answer questions such as: Do spatial trends of infertility follow the
same trends as fertility? Do spatial trends of diagnosed infertility follow similar spatial trends of
fertility, and are there demographic differences? Analysis of fertility at the census tract level will
provide that foundational perspective, and a method of analysis from which to build.
R6: What is the spatial relationship between fertility of women between the years of 2013-2017 in
states with or without infertility insurance mandates?
The rationale for observing fertility by states with and without insurance mandates is based
on two reasons: 1) projected fertility decline in the United States, which could be due to changing
socio-cultural preferences for when and how to start a family; and 2) lack of research that observes
fertility in states with and without an infertility insurance mandate.
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Fertility Decline. Population projections from the Census Bureau indicate that between the
years of 2016-2060, the United States population will grow slower and that the growth will not be
due to fertility rates, but rather due to internal migration (Vespa et al., 2020). This is attributed to
the increased aging population in the United States, predicting that persons age 65 and older will
increase by 93.8% from 44 million in 2016 to 95 million in 2060 (Vespa et al., 2020). Research
by Tannus & Dahan (2019) observe that while diagnosed infertility may not be increasing, the act
of delaying childbearing has increased due to a variety of reasons, including career development
prior to family development. The authors suggest a reason why state-based infertility insurance
mandates should be common practice, being the fact that delaying childbirth leads to increased
chances of natural infertility due to increased age (Tannus & Dahan, 2019). A continuous
observation of spatial fertility trends by state could inform policy makers of a need for increased
access to these services to stabilize a falling fertility rate due to social factors- rather than purely
physiological factors.
Research gap. There is some research that statistically shows uses of infertility services in
mandated vs non-mandated states. Boulet et al. (2019) observed the difference of payment for
infertility services between claims filed in states with and without an infertility insurance mandate,
and Schmidt (2007) found infertility insurance mandates do increase accessibility of infertility
services, but only for those women who are white, older, and highly educated. There are no
analyses of fertility rates in states with and without an infertility insurance mandate. It would be
informative to observe the fertility of women with those same demographics of women accessing
infertility services with the most frequency, to see if the sociodemographic disparities regarding
births from infertility services are also disparities that exist in the fertility of women in states with
and without an infertility insurance mandate.
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R7: What is the spatial relationship between fertility of women age 15-50 and the spatial
distribution of SART reporting clinics between the years of 2013-2017?
The purpose of this question is not to estimate or predict the number of live births from
assisted reproduction, but rather to spatially observe the density of births and total population in
relation to fertility clinics. Based on the Preliminary 2018 CDC Fertility Clinic Success Rates
Report, there were 73,831 live births from 456 reporting clinics (Centers for Disease Control and
Prevention [CDC], 2020), compared to the CDC projection of total births in the United States of
3,791,712 (National Center for Health Statistics, 2020). This means that births from ARTs in
2018 accounted for approximately 2% of all births in the United States. This research question
includes birth density, where

"𝐴𝑙𝑙 𝑤𝑜𝑚𝑒𝑛 𝑤𝑖𝑡ℎ 𝑏𝑖𝑟𝑡ℎ𝑠
𝑐𝑒𝑛𝑠𝑢𝑠 𝑡𝑟𝑎𝑐𝑡 𝑚𝑖 2

, and population density, where

𝑇𝑜𝑡𝑎𝑙 𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
𝑐𝑒𝑛𝑠𝑢𝑠 𝑡𝑟𝑎𝑐𝑡 𝑚𝑖 2

.

It was assumed that 1) clinics will be located in census tracts with high birth density and high
population density; and 2) there will be a spatial disparity in the distribution of the clinics, but that
could be informed by the qualitative interviews.

Part 1: Online Survey and Interviews
This research utilizes SCT to guide the development of interview and survey questions and
analysis of both the qualitative interview and quantitative survey data. SCT considers the very
prominent psychological aspects of human infertility and behaviors of use of infertility services
and positions those cognitive processes in the context for which behaviors developed. This stem
from observation of, retention of, reproduction of, and motivation to act on influences from the
social environment. The construct of self-efficacy is key to this research because of the number of
potential obstacles that exist when attempting to access infertility services.
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Part 1a: Quantitative Survey Instrument: Context of Infertility Service Use. Part of
the quantitative research component is the development of a survey instrument that can be
distributed online. The survey is titled “Access to Infertility Services in the United States”. When
reviewing the different surveys available that include questions related to the use of infertility
services, such as SART and the NSFG, not only were the datasets very expensive and difficult to
access (due to needing the geographic variables), they did not include questions that would
provide insight into aspects of place assumed to be influential, such as employment status (part
time, full time) and whether people travel for services, including distance and time.
Clinic-based surveys, such as from SART, are also not able to obtain responses from
people who have not yet been able to access infertility services because clinic-based data come
from the reporting clinics – people included are already accessing those services. The rationale for
the survey instrument is that there are information gaps which can be addressed with the right
questions, and there is an exclusion of people who are looking for information regarding infertility
services but who may not have yet accessed them. Questions about place, not just the state in which
people live, could be informative to learn when linked to answers about the state people live in,
employment, knowledge of mandates, fertility education, type of insurance, travel for services,
and how these aspects affect the perceived self-efficacy in accessing infertility services.
Survey development. There are three main stages of infertility service use reported in this
research: looking for information (Prospective), using the infertility services (Active) ,and no
longer using (Past). The rationale for seeking these three stages is due to the nature of the current
literature only observing people who are currently using infertility services. The perspectives of
people who are in the beginning stages of looking for options and people who have accessed
infertility services already and had either successful or unsuccessful pregnancies are perspectives
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that could reveal important contextual information about how insurance applicability affects
people’s decisions at different stages of infertility service use. The entire survey is located in
Appendix B. The online survey was developed using Qualtrics (Qualtrics, 2005).
The first part of the survey includes 18 demographic questions regarding the stage of use.
Table 3.1 lists the demographic variables chosen for the survey and their source from the literature.
Skip logic was employed in this survey to direct people in different stages to the questions
applicable to them. For example, if a person indicated they had “not yet used infertility services
but are looking into it”, the next question asked, “What is the reason you are seeking infertility
services?”. In the same way, if a person indicated they “used infertility services in the past”, the
next question they were asked was “What was the reason you sought infertility services?”, to
ensure the proper tense of the questions asked. The survey was broken into seven sections:
demographics, health education, health insurance coverage, residence, online communities, travel
for services, and the ISE scale.
Health education. This section has two questions of primary education regarding ever
receiving health education related to infertility at various stages, and personal opinions for the
education level when children should learn about the risk of infertility. Education on fertility
decline in school is referenced in some literature as lacking (Kudesia et al., 2017), so inquiring
about when people learned (or if they learned) about fertility decline could reveal an educational
gap that needs to be addressed.
Health insurance coverage. This section has nine questions regarding types of insurance
the person has, and if the insurance covers infertility services. Regarding types of health insurance,
it is important to link this question with sociodemographic data and type of employment to
understand if the types of insurance influences the accessibility of infertility services. Also
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important to be determined is if that effect is different in states with or without mandated infertility
insurance. This section also inquired into the person’s knowledge of an infertility mandate in their
state, and if one is present, if they could apply it to their situation. Knowledge of infertility service
mandates in the respondent’s state of residence is important because knowledge of insurance
availability could increase perceived self-efficacy in accessing those services. Employment is also
a component in this section. This is important to address because of how influential employers
are in making these services visible and available for their employees (Nathenson, 2020;
Worthington et al., 2020). It is assumed that employment will be a determining factor for infertility
service access and self-efficacy.
Residence. There are three questions about the person’s residence. One of the goals of this
research is to determine the effect of where people live on their access to infertility services. Since
the present infertility insurance mandates are state-specific, it is assumed that residence will affect
the accessibly of infertility services. Questions about residence include the person’s state of
residence, state they accessed infertility services, and if their state of residence is the same state as
the one where they used infertility services.
Online communities. It is referenced in literature that people living with infertility prefer
to discuss their experience using infertility services with people online rather than in person (Craig,
2020; Gazit & Amichai-Hamburger, 2020; Sormunen et al., 2020). There are three survey
questions related to the use of online communities to express experience using infertility services.
The questions inquire about using online support communities for help in decision making for
what types of services to use, preference for discussing infertility with people online more than in
person, and use of online support prior to having discussions with physicians about infertility
services.
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Travel for services. There are seven questions related to travel for infertility services.
Observing types of domestic or international travel are important because some literature suggests
people will travel out of their state of residence or even to a different country to access more
affordable infertility services (Simopoulou et al., 2019). Data to observe from the answers will be
the travel tendencies from non-mandated states to mandated states, which is a behavior research
on infertility health insurance has not reported.
Infertility Self-Efficacy Scale (ISE). The Infertility Self-Efficacy Scale (ISE) was
developed by Cousineau et al. (2006), and since then appears in many qualitative and quantitative
research designs related to infertility (Table 3.2). Most of the research is focused on psychosocial
issues in dealing with infertility within a pronatalist society (Altiparmak & Aksoy Derya, 2018;
Cox et al., 2006), however it will be useful to measure self-efficacy in continuing to seek infertility
services. The ISE is a validated Likert scale that consists of 16 statements that refer to the
experience of living with infertility that literature shows affects individual levels of self-efficacy
to continue using infertility services (Cousineau et al., 2006). The responses range from 1-9, where
1 is “Not at all Confident” and 9 is “Extremely Confident”. Respondents are asked to rate their
degree of confidence in embodying the statements posed to them in the survey, with the prompt:
“I feel confident that I can…”.
Internal consistency of this scale reached 0.94, where the items ranged from 0.59 to 0.89,
and the authors make note that “none of the items improved the scale’s Cronbach’s a estimate if
deleted” (Cousineau et al., 2006, pg 1691). Test-retest reliability from the two analysts was
correlated at 0.91 (P=<.01), meaning the scale measured the same construct – self-efficacy. This
survey instrument does not require permission for use. This scale is used in other research, mainly
psychosocial (Altiparmak & Aksoy Derya, 2018; Cousineau et al., 2006), and it is important to
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use it in this research due to its ability to link the ISE results to demographics and responses to
health education. It is assumed those factors will influence a person’s self-efficacy in accessing
infertility services.
Eligibility. Eligibility criteria included: persons age 18-65, must be a United States citizen
or permanent resident, and must be in one of the three stages of using infertility services:
(Prospective) looking for information on using infertility services, (Active) using any type of
infertility services, and (Past) no longer using infertility services. Excluded from this research are
people who do not use and do not intend to use infertility services to become pregnant or start a
family.
Recruitment. Due to the need for diverse stages of infertility service use, the researcher
accessed recruitment sources that would include persons in any one of those stages. Recruitment
included online support forums for infertility services, advocacy organizations, and word of mouth.
Participants provided their interest in an interview at the end of the voluntary online survey
“Access to Infertility Services in the United States”, where they could indicate their interest and
provide an e-mail at which to be contacted.
Recruitment style for this research is defined as passive recruitment (Estabrooks et al.,
2017), meaning the researcher does not approach patients directly in person, will not recruit from
inside a clinic area, and will not utilize patient records in any way. Recruitment materials included
a survey link and QR code located on a survey flier (Figure 3.1). This research received
Institutional Review Board (IRB) approval with an “Exempt” status on 8/26/2019 (Pro00041799)
(Appendix E), and again on 12/10/2019 (STUDY000110) (Appendix F) after a revision to the
research protocol, discussed further in the informal interview section.
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The survey link was located on an IRB approved research flyer that was distributed on
online forums specific to infertility and assisted reproduction. The recruitment sources are
described in more detail in the Informal Interview section because of an IRB change to facilitate
greater reach. Recruitment for the survey and informal survey are the same because interest in
participating in an interview was the last question in the survey.
Survey data analysis. The survey analysis helped answer research questions 1, 2, 3, and 4
(Appendix A). Frequency statistics, including means and standard deviations, were generated
using SAS statistical software (SAS Institute Inc, 2019). There were a total of 161 surveys initiated
during the recruitment period between September 2019 – January 2020. Of those surveys, 134
were included in any analyses. Of the 27 survey responses excluded from the research, 22 were
surveys that were less than 100% complete based on the variable “Finished”, which was a variable
automatically generated by Qualtrics, and 5 were excluded due to being test surveys conducted to
evaluate the survey and increase reliability that the questions asked are appropriate for the target
audience and aim.
Analysis of the ISE Scale includes mean and standard deviation for each of the 16 items in
the scale. A power analysis for ANOVA fixed effects model using the GPower software revealed
that, with a sample size of 134, where f=0.40 (large effect size), the survey is powered to detected
differences with a 7.6% chance of both Type I (α) and Type II (β) errors, Power (1-β err prob)
=0.932 (Figure 3.2). In literature, sample sizes using the ISE Scale range from between 45 to 250
(Altiparmak & Aksoy Derya, 2018; Kovářová et al., 2010; Turner et al., 2013). The sample size
in this research is situated in the middle of that distribution.
Using SAS 9.4 statistical software (SAS Institute Inc, 2019), analyses of the survey data
included analysis of variance (ANOVA) to compare the total mean scores for the ISE scale to
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observe differences in ISE mean scores based on stage of use, demographics including age, sexual
orientation, education, ethnicity, religion, and state of residence as well as questions from the
online communities, health insurance, and health education sections of the survey. Analysis of
variance was computed using the GLM procedure and post hoc Tukey-Kramer studentized range
test for multiple comparisons. Selection of the PROC GLM procedure over PROC ANOVA was
due to unequal cell values in the data. The Tukey-Kramer studentized range test is suited for
pairwise comparison, and calculates the minimum significant difference (MSD) for each pair of
means in the sample population (McDonald, 2014b). The Tukey test is also capable of detecting
significant mean differences when the ANOVA was not significant, so it may reveal mean
differences between variables. Some literature suggested using a Games-Howell test when the
mean variance are unequal (Day & Quinn, 1989; McDonald, 2014a), which in this case they are,
however SAS does not have a function for the Games-Howell post hoc test, and the Tukey-Kramer
test is similar to the Games-Howell so it was used instead.
Reliability and content validity. Reliability and content validity of the survey were based
on pre-testing the survey with a group of moderators from the r/infertility Reddit group before
posting the survey on the r/infertility subreddit, which is where the majority of the survey and
interview data came from. The moderators were able to provide critique that assisted with clarity
of questions regarding infertility diagnoses, gender identity, insurance types, and questions asking
about parity. The recommendations were made to the survey before posting the survey online for
data collection. It should be noted that two moderators thanked the researcher for including
questions regarding health education, travel, and knowledge of infertility insurance mandates,
because those topics are rarely asked to people accessing infertility services.
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Part 1b: Qualitative Inquiry: Informal and Expert Interviews. Informal interviews.
Informal interviews consisted of one- on- one interviews with individuals who encountered an
issue with procreation and who intend to pursue, are currently using, or used in the past, some
form of infertility service to procreate.
Eligibility. Eligibility criteria included: persons age 18-65, must be a United States citizen
or permanent resident, and must be in one of the three stages of using infertility services:
(Prospective) looking for information on using infertility services, (Active) using any type of
infertility services, and (Past) no longer using infertility services. Excluded from this research were
people who do not use and do not intend to use infertility services to become pregnant or start a
family.
Recruitment. Recruitment for the survey and informal interviews are the same due to the
interview request being the final question of the survey.
The informal interview recruitment began in August 2019. This research first utilized
networking and two different infertility advocacy groups as sources for informal interview
participants. The advocacy groups included RESOLVE: The National Infertility Association, and
the Family Equality Council. Networking consisted of a co-worker offering to post recruitment
materials on personal Facebook and Twitter pages.
Networking. One networking source offered to post recruitment materials on the person’s
personal Twitter feed, as well as Facebook pages for the College of Nursing at USF, Black Nurses
Rock, and Sigma Theta Tau – The International Honor Society of Nursing. These postings
occurred in January 2020.
RESOLVE: The National Infertility Association. RESOLVE is possibly the most active
and well-known infertility advocacy organization in the United States. It was founded in 1974 and
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is a 501(c)3 national patient advocacy organization (RESOLVE: The National Infertility
Association, 2019a). Members of the organization actively advocate in Washington D.C., such as
the most recent in-person Advocacy Day in Washington D.C. May 15, 2019 (RESOLVE: The
National Infertility Association, 2019b). RESOLVE members and advocates, along with the same
from the ASRM, were involved in the First Virtual Federal Advocacy Day on May 20, 2020, due
to the Covid-19 cautions for large gatherings (ASRM: The American Society for Reproductive
Medicine, 2020). After contacting the Chief Engagement Officer at RESOLVE and completing a
research proposal application approved by their department, recruitment materials were placed on
the online support forum Inspire, specifically on the “What’s Happening at RESOLVE?” page.
The Family Equality Council. The Family Equality Council (FEC) is an advocacy
organization founded in 1979 at the National March on Washington for Lesbian and Gay Rights.
They embody the mission of advancing legal and lived equality for same-sex couples who want to
start a family, and one of their methods is to initiate policy change (Family Equality Council,
2019). Because of the lack of attention to same-sex couples in infertility services research,
inclusion of the FEC will encourage more perspectives of LGBTQ couples and individuals to be
integrated into the discourse on how to reduce the disparities in accessing infertility services. After
contacting the Chief Program Officer at the FEC via email, the researcher was able to set up a time
to discuss the research. After the discussion, the organization agreed to help distribute recruitment
materials through their email listserv.
Due to a low number of responses from these two sources, there was a need to diversify
recruitment reach. Between September-October 2019, a total of 23 organizations providing
infertility services, ranging from clinical services to patient advocacy, were invited to participate
in the research by disseminating recruitment materials. From those, 4 (17.4%) responded, and only
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one, The Oncofertility Consortium at Northwestern University, agreed to collaborate. The
recruitment materials were placed on their Facebook page by one of their staff.
Recruitment revision. By the beginning of December 2019, the current recruitment efforts
yielded two informal interviews and four surveys. In an effort to increase participation, the
methods were amended (STUDY000110) to include a $30 Amazon Gift Card for completing an
interview (Coopersmith et al., 2016; Morgan et al., 2017), as well as the addition of two other
sources for recruitment: Reddit and Craigslist.
Craigslist. Although not used often in research, Craigslist has served as a platform for
research recruitment for clinical trials (Antoun et al., 2016), reaching rural populations (Warren et
al., 2015), and reaching stigmatized groups for different genres (Worthen, 2014). Strategies for
using Craigslist are often centered around posting in main sections for major cities, and then in
smaller sections of major cities if rural populations are a target (Worthen, 2014). For this research,
the perspective of rural populations would be informative in terms of observing the role of
residence in accessing infertility services, which is one of the main reasons Craigslist was chosen
as a recruitment site.
Geographic selection for the Craigslist posting started with selecting five random states to
test the use. States randomly selected were Montana, Oregon, New Mexico, Nevada, and Georgia.
Initial post attempts started in January 2020, with five postings. The primary topic area for each
post was in the “Community” section, and the secondary topic area, if applicable, was the
“Volunteers” section. However, none of the posts lasted online for longer than 48 hours before
being flagged and removed by online moderators. Flagging of research posts on Craigslist is a
common occurrence, and can at times be mediated by adding a note that the research is approved
and based from a university or hospital (Worthen, 2014). However, attempts to use that method in
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this research were fruitless. Attempts to post research recruitment on any Craigslist page ended in
January 2020.
reddit Inc. Reddit is an online social platform where people can post information,
suggestions, videos, photographs, and have discussions on any type of topic, and those topics are
sectioned into subreddits – indicated by “r/” prefix. Reddit is referenced in the literature as a
reliable and potentially rich source for qualitative and survey recruitment when the correct
subreddit forums are selected (Amaya et al., 2019; Shatz, 2017).
A search on the Reddit homepage for “infertility” revealed 125 subreddits that were
specific to human infertility. The larger subreddits were more general to infertility issues, and other
smaller subreddits were specific to aspects of the infertility experience, such as being male, having
cancer, experiencing loss of pregnancy, adoption, and some specific to procedures like in vitro
fertilization (IVF) and intrauterine insemination (IUI). Recruitment for this research was based in
the subreddit r/infertility, which is the largest infertility specific subreddit with approximately
18,000 members from multiple countries. English is the primary language spoken on this
subreddit.
Each subreddit has a single moderator or group of moderators who monitor the discussions
and postings on the forum. The moderators are the gatekeepers for removing unapproved postings
on the subreddit, so in order to post something on the subreddit page it must follow certain
guidelines. The moderators for the r/infertility subreddit had an organized list of criteria for posting
on the forum, as well as a note for researchers to contact the moderators directly before posting
research recruitment materials. The r/infertility subreddit moderators were contacted in January
2020, and after discussing the project and sharing the IRB approval letter, permission was given
to post the recruitment material on the r/infertility public forum.
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Recruitment on the r/infertility subreddit began on 2/3/2020. Within four hours of posting,
the interview request number increased to 30. Within eight hours of posting, the interview request
number reached 77. After 12 hours from the initial post, there were a total of 105 requests to do an
interview, at which point the post was taken down due to reaching nearly 4x the initial recruitment
goal of 30. All requests were from people who qualified as eligible for the research. Each request
was individually followed up by an email to the address provided by the participant.
Between September 2019 and February 2020, 66 people (62.9%) who responded to do an
interview completed an interview. Of the total 105 persons who requested to be contacted for an
interview, 38 (36.2%) did not respond to the follow-up email, 3 (2.7%) who scheduled an interview
did not answer the phone on the interview date, and 1 (0.95%) declined to do an interview.
Informal interview procedures. After indicating interest in doing an informal interview via
the survey, participants were contacted via email to set up a time for an interview. Interviews were
conducted over the phone between September 2019 – February 2020. Consent to participate in the
research was confirmed verbally by participants as allowed by the IRB. All interviewees had the
option to not have the conversation audio-recorded, however all participants allowed the
conversation to be recorded. Interviews were recorded using an Olympus WS-821 voice recorder.
Social Cognitive Theory and the Glass and McAtee model of risk regulators informed the
construction of the interview guide for the informal interviews (Appendix C). The interview guide
included demographic questions, and questions in the following domains: reason for
accessing/wanting to access infertility services, travel associated with accessing infertility
services, health insurance, and out-of-pocket expenses related to infertility services.
These questions reflect the assumption that a person’s state of residence and
presence/absence and type of health insurance will affect decisions made regarding the timing,
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location(s), and magnitude of financing people will undergo when accessing infertility services.
The intent was to be able to identify facilitators and barriers to infertility service use, to see if those
facilitators and barriers were present at different stages of infertility service use and observe how
they were associated with the constructs of SCT.
Expert interviews. This research also utilizes expert interviews with members of a
specialized insurance companies and non-profit organizations that specifically offer insurance,
financing, or other types of funding specifically for infertility services. This research uses the
sociological interpretation of “expert knowledge,” meaning those chosen for interviews maintain
levels of knowledge that have not been reconstructed empirically- rather they have knowledge they
are aware of and embody – also referred to as discursive consciousness (Giddens, 1984; Meuser
& Nagel, 2009). Expert interviews are used in an increasing number of qualitative social science
research projects, as well as in political research (Bogner et al., 2016). This research utilized the
exploratory and explanatory expert interview types, as defined by Bogner, Littig, and Menz (2016).
These are positions that views the expert as a topic orienting actor used to generate knowledge
through subjective experience – as such it falls on the researcher to consider the expert advice in
the context of the research. One could argue that people who use infertility services are also
experts, however the utilization of the expert in this research is specific to understanding the
function of for-profit and non-profit philanthropy for infertility-specific medical procedures to
individuals and infertility-specific insurance to employers. Appendix G contains the expert
interview guide.
Eligibility. In order to be eligible to be an expert interview participant, the contact had to
offer some type of financial assistance for paying for infertility services. There are multiple types
of companies that offer services like this, such as Progyny that offers employer options for health
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insurance specific to infertility services, and non-profit organizations such as the Baby Quest
Foundation, which offers grants to a limited number of applicants per year to help pay for services.
Selected organizations were contacted by email, and the contact was described online as
the “media contact”. If no media contact was listed, an e-mail was sent to the generic email for the
organization. Exclusion criteria for expert interviews were that they did not represent a company
that offers insurance, specialized financing, or grants or scholarships for infertility services in the
United States. Financing organizations that were specific to an individual clinic system or
individual clinic were not included in this research.
Recruitment. The recruitment style for this research is defined as passive recruitment
(Estabrooks et al., 2017), meaning the researcher did not approach participants directly in person,
did not recruit from inside a clinic area, and did not utilize patient records in any way. Recruitment
materials included an IRB Informed A consent letter was sent through email. Interested
interviewees were directed to reply via email. Although informal interviewees received a $30
Amazon gift card, the expert interviewees were not compensated for their participation based on
their role as employees for an organization from which information is being requested. Expert
interview participants did not complete the survey because it was not applicable to them.
To identify potential organizations, this research first utilized a Google search for
“infertility+financial+support”. The search revealed multiple advocacy websites that listed sources
of funding for infertility services, ranging from loans to grants to types of private insurance. Also
utilized were lists of organizations disclosed on websites from RESOLVE, NeedyMeds.org,
Alliance for Fertility Preservation, CadeFoundation, Growing Family Benefits, FutureFamily,
CapexMD, Maven, and WinFertility. Many of the organizations were replicated on other websites.
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A total of 30 organizations were contacted up to two times between January 2020 and
February 2020. Of those 30 organizations, 11 responded (36.7%), and 19 (56.7%) did not respond
to any emails. Of the 11 organizations that responded, 8 (26.7%) completed an interview, 2 (6.7%)
declined to do an interview, and 1 (3.3%) was lost to follow-up. Reasons for declining an interview
were that the organization representative did not feel their organization was within the inclusion
criteria because they offer refunds or discounts to patients who use physicians within their
network; and/or the representative was also the founder of the organization and did not feel he or
she had the time to dedicate to the interview due their work responsibilities.
Expert interview procedures. Interviews were conducted over the phone between January
and February 2020. The consent to participate in the research was confirmed verbally by
participants and the verbal consent process. All interviewees had the option to not have the
conversation audio-recorded, however all participants allowed the conversation to be recorded.
Interviews were recorded using an Olympus WS-821 voice recorder. Interview questions were
informed by the previously described informal interviews, as well as inquiry into the nature of the
organization’s development, the types of services they offer, and to whom those services are
available.
Within Bandura’s triadic model of causation, the expert interview organizations function
within the ‘environmental’ domain due to their ability to facilitate increased financial access to
infertility services, and the concept that the applicability of their services will affect decisions on
types and extent of infertility services on which an individual or couple decide. As such, the
questions asked during the expert interviews inquired into the services offered, who they were
offered to, and how they (as a representative of the organization) perceived the facilitative function

81

of state-mandated health insurance for infertility services. The researcher thought these
organizations would be in favor of state-mandated health insurance for infertility services.
Interview data analysis. This research utilized a constant comparison method of qualitative
data analysis to code for themes related to constructions with SCT. Transcript coding was done by
two doctoral candidates from the USF College of Public Health trained in qualitative data analysis.
The software utilized was MaxQDA 2020.
Codebook development. This research utilizes a theory-driven coding methodology, using
Social Cognitive Theory (SCT) constructs and themes within the survey instrument as parent codes
(Appendix D). Simons-Morton et al. (2012) and the Office of Behavioral and Social Sciences
Research, (2018) provide definitions for the SCT constructs used in this research. In the
construction of theory-driven codes, there are three necessary steps (DeCuir-Gunby et al., 2011).
These are: 1) obtain the theory for which the codes will be based on, using the definitions of the
theory constructs as definitions for the codes; 2) review and revise the code definitions within the
context of the data (transcripts), which entailed rewording the constructs to be specific to observing
the behavior of accessing infertility services; and 3) establish reliability, which in this research
involved review of the codebook by the qualitative coders to ensure validity of the coding scheme
and clarity of the code definitions.
The codebook was revised four times due to some constructs needing clearer definitions,
and the addition of emergent codes. The final codebook listed the code name, code abbreviation,
a section for what the code is, and a section for what the code is not. The coders were instructed
to use the memos in MaxQDA to account for any potential uncertainty in the codes used, which
reduced bias during the constant comparison of coding among the transcripts (Given, 2012). The
memos were reviewed along with the coding discussions. After the fourth revision, the coders
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agreed to remove “Self-Control” because it was difficult to discern it from “Behavioral
Capability,” and to remove “Reinforcements” as it was difficult to discern a negative
reinforcement from a barrier and a positive reinforcement from a facilitator. The final SCT
constructs that remained as codes were: Environment (Office of Behavioral and Social Sciences
Research, 2018; Simons-Morton et al., 2012a), Self-Efficacy (Office of Behavioral and Social
Sciences Research, 2018; Simons-Morton et al., 2012a), Behavioral Capability (Simons-Morton
et al., 2012a), Expectations and associated Outcomes (Simons-Morton et al., 2012a), and
Observational Learning (Office of Behavioral and Social Sciences Research, 2018; SimonsMorton et al., 2012a). There were also codes for barriers and facilitators, and although these are
often coded along with environment (addressing environmental facilitators and barriers), this
research observes them as separate codes in order to observe their co-occurrence with
environmental variables (Glanz et al., 2015). Definitions of these constructs are located in the
codebook (Appendix D).
There are seven SCT construct codes, and a total of five literature-informed codes specific
to insurance for infertility services. One emergent code developed – Infertility Story – as a result
of wanting to capture the interviewee’s process of obtaining an infertility diagnosis because at
times the story was not captured with any of the pre-defined codes.
The purpose of the six literature-informed codes was to observe their occurrence in
conjunction with the SCT constructs. Survey-informed codes include: Insurance, Finances, Travel,
Employer, Legal, and Health Education. Rationale for these topics are disclosed in the methods
section for the survey development. To observe the interplay between aspects of insurance or
finances in one’s decision-making process, it is important to be able to observe his or her cooccurrence within the discourse.
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Qualitative data visualization. MaxQDA 2020 graphics tools were utilized to observe the
relationships between qualitative codes includes Code Maps of the relationship between SCTbased and survey-based codes, and a development of Code Relations tables that showed the
frequency of times a code occurs along with another code. The function of the Code Map is to see
a visual representation of how close qualitative codes appear in proximity to others. The logic is
that, the closer the codes are in the map, the more similar they are in terms of their application to
the content of the data. The larger the code name, the more frequently it appears in the corpus of
interviews. If a codes are not connected by lines, it means they do not appear in the same segment
of coded text as other codes (MAXQDA, 2020a). The Code Relations tables show the actual
frequencies of co-occurrence of the selected codes (MAXQDA, 2020b).
Use of expert interviews. This research does not assume the sample of organizations
included reflect the entire population of organizations offering types of financial or advocacy
assistance specific for infertility services in the United States. However, the opinions reflected by
the organizations included in this research are perspectives that exist among that population of
organizations, and thus do have merit.
The codebook for the expert interviews was based on interview-guide based thematic
codes. The structure of the conversation was to obtain knowledge of the organization, and the
questions posed were related to the following five themes: types of services offered (Services
offered), who the services were available to (Eligibility), how the services are advertised
(Advertisement), the source of the funding (Source of Funding), and the perspective of the
organization representative on the role of state-mandated health insurance for infertility services
(Perspective). The domains served as the thematic codes: Services offered, Eligibility,
Advertisement, Source of Funding, and Perspective (Appendix G).
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This research utilizes expert interviews in exploratory and explanatory functions, as
defined by Bogner, Littig, and Menz (2016), utilizing the expert as a topic orienting actor to
generate knowledge through subjective experience, and

confirming knowledge through

triangulation of data sources (Muskat et al., 2012). The overall objective of this research is to add
context to the use of infertility services. The organizations that exist to facilitate greater access to
infertility services – whether financially, through advocacy, or through dissemination of
information – are important actors in the discourse surrounding the medical legitimacy of human
infertility to be covered by health insurance because they are in a sense on the frontlines of both
the politics and the practice of infertility services. The founders and members of these
organizations know how people access infertility services, they know reasons why people are
denied coverage, and some, like Progyny, have the perspective of the employer when it comes to
infertility services because they provide insurance options directly to employers.
The expert interviews included in this research provide important contextual information
regarding the inconsistency of how existing state-based infertility health insurance mandates are
applied to individual experiences, how employers can act as facilitators in increasing financial
accessibility to infertility services (regardless of a state mandate), and the perspectives of the
business of medicine. The non-profit organizations and advocacy groups exist due to a nationwide problem of unequal access to infertility-related medical care.
Trustworthiness. The absence of bias is not possible in qualitative research, but it can be
reduced by engaging in and reporting on certain measures enacted at all stages of the research
process (Miles et al., 2014). Measures used to reduce bias in this research included reliability and
credibility.
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Reliability. Reliability refers to the research process stability over time, where research
questions and methods are disclosed a priori and adhered to throughout the research process (Miles
et al., 2014). An aspect relating to reliability of the qualitative data and analysis in this research
comes from the consistent use of SCT in the creation of research questions, interview guides,
codebooks, and data observations, specifically observing self-efficacy both in the informal
interviews and the online survey. A theory-based link was established between the qualitative and
quantitative data through the observation of SCT constructs and literature-derived themes related
to place as a risk regulator (health education, health insurance, residence, employer, travel for
services) during the conceptualization of this research and throughout the data collection and
analysis phases.
Another aspect of reliability comes from the use of two graduate level trained qualitative
analysts to code the interviews. Before the two coders began the coding for reliability testing, the
researcher used a random number generator to select seven transcripts, 10% of the 66 transcripts
(n=7). In this research, the coders used segmentation to standardize the amount of text included
for each code, where each segment was a unit of text used to answer the question posed to the
interviewee (O’Connor & Joffe, 2020). The researcher segmented the seven transcripts based on
the question asked to the interviewee. Inter-coder reliability was based on Cohen’s kappa statistic,
where Pr(a) represents the actual observed agreement, and Pr(e) represents chance agreement. The
coding file was exported from MaxQDA as an excel file. Kappa calculations were conducted in
MS Excel using the coding file exported from MaxQDA. The Kappa statistic is a squared
correlation coefficient, called the coefficient of determination, which can be interpreted as a
statistic to represent agreement between two coders – albeit with an acknowledged degree of error
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(Cohen, 1960; McHugh, 2012). A value between .80-.90 is agreed to be a strong level of
agreement, with greater than .90 being near perfect agreement.
Coders for this research reached an overall kappa of 0.91 (range: 0.88-1.0) for all codes
after one round of coding, meaning there was approximately a 4% chance the agreements are
erroneous. Standard, unweighted error is reported at SE=0.0031 (CI: 95%, lower: 0.9596, upper:
0.9716). Standard error was calculated using VassarStats (http://vassarstats.net/kappa.html),
which calculates error based on unweighted, linear weighting, and quadratic weighting.
Interestingly, none of the error estimate types were different. Establishing interrater reliability
increases the trustworthiness of the data (O’Connor & Joffe, 2020), and a kappa score of 0.91
represented strong agreement in the SCT constructs and literature derived codes.
Credibility. The concept of credibility is closely related to establishing the trustworthiness
of the conclusions made by the researcher (Korstjens & Moser, 2018; Mills et al., 2010).
Establishing trustworthiness of qualitative research can be established through credibility and
reliability of both the source of the data, and the analytical methods used. In this research,
credibility of the results and suppositions came from a rich source of interview and survey data,
being the subreddit r/infertility that is specific to the topic of this research. Members of the
subreddit r/infertility provided unsolicited confirmation that the topic of health insurance for
infertility services is an important topic for those experiencing infertility – a sentiment also
expressed in expert interviews. The inclusion of expert interviews allowed for confirmation on
topics expressed during the informal interviews, which increased credibility in the qualitative
results of this research.
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Part 2: Spatial Analyses.
Part 2a: Spatial Analysis of Fertility in the United States. Data collection. Boundary
lines for states and census tracts comes from the 2017 TIGER/Line geodatabase for National
Substate Geography (US Census Bureau, 2017). The American Community Survey 2013-2017
5yr dataset is the source of data for both fertility (S1301) and total population (B01003). The
American Community Survey in this research includes 50 states plus Washington D.C., and their
associated census tracts. The data are specifically related to fertility of women age 15-50, with
various demographic characteristics related to age, ethnicity, poverty status, marriage status, and
nativity. Between the years of 2013-2017, there were a total of 3,994,223 +/- 20,838 women who
had a birth in the United States, which is a rate of 52 +/- 1 births per 1,000 women (Table 3.3).
Number estimates from the American Community Survey are based on sample data and thus are
subject to some degree of sampling variability, which is accounted for in the 90% margin of
error. The 90% margin of error allows this data to be interpreted to mean that there is a 90%
probability that the defined intervals plus and minus the margin of error contains the true value.
There are two primary reasons why this research does not observe the spatial distribution
of diagnosed infertility or use of infertility-specific medical procedures such as in vitro fertilization
(IVF). These are 1) Cost and access restriction on datasets, and 2) the absence of geospatial
fertility research.
Cost and access restriction. Datasets specific to the use of ARTs that are linked with
geospatial reference data to the state and county levels are expensive, costing upwards of of $3,000
depending on dataset, and difficult to access taking and up to five months for project approval,
depending on the dataset (CDC, 2017; National Center for Health Statistics, 2020). There are
legitimate privacy reasons for the restricted access to this data, such as those required under Public
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Health Act Section 308(d) in the protection of private medical information (CDC, 2017), but it
does pose a limitation on its analysis. Although this research includes geocoded fertility clinics
that have frequency statistics for certain infertility services and procedures conducted, the analysis
of the geocoded clinic data did not observe the frequency data for infertility services, as those
analyses were outside the objectives of this dissertation. There is an intention for future geospatial
analyses on the geocoded clinic data.
Geospatial analysis of fertility. The current literature on infertility services does not analyze
fertility data along with it, outside of observing rates of national fertility over time. Some
researchers are researching the relevance of observing both fertility and infertility with the same
type of analytical approach. This includes Johnson et al (2018) who bring up the different research
trajectories of fertility and infertility research. They observe that fertility research historically
focused more on demographic trends, applying theory and economics, observing trends over time,
and infertility research has focused more on medicine, researching

the genetics of infertility,

psychological distress management, and levels of diagnosis for males and females, and some social
and clinical research observed disparities in access to infertility services (Johnson et al., 2018).
One of the authors’ main propositions is that understanding the “dynamically interrelated”
relationship between fertility and infertility through research that observes them both could give
meaningful insight into the perceived and lived experiences of both conditions (Johnson et al.,
2018, pg 25). In this research, geospatial observation through a mixed method research design will
to give insight into the utility of observing place with both fertility and infertility related data.
The geospatial observations of fertility and infertility below the county level, using
geostatistical software and statistics suited to account for geographic place, are largely absent from
the literature. Although some research tangentially refers to a decrease in fertility in the United
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States (Simoni et al., 2017; Vander Borght & Wyns, 2018), there are no analyses that observe
recent fertility trends relating to the demographics of people who use infertility services (white,
highly educated, household income over $90,000). Observing the geospatial patterns of fertility in
the United States can give insight into future geospatial analyses of infertility, creating the ability
to compare linear and geostatistical trends.
Data preparation. This research utilized the software ArcPro 2.4 (ESRI, 2018) for data
preparation, creation of shapefiles, spatial analyses, and visualizations including maps. Statistical
analyses were also conducted using SAS/software, Version 9.6 of the SAS System for Windows
Copyright © 2019 SAS Institute Inc (SAS Institute Inc, 2019). Figure 3.3 shows a diagram of the
geoprocessing preparation for the census data.
Spatial joins. Data from the American Community Survey came in an MS Excel format
that contained geographic variables that can be used to join the excel table to polygon shapefiles
of the same variables that define geographic extent. After downloading the American Community
Survey Fertility (S1301) data at the census tract level, the second row of description variables are
deleted so that the data values started in row 2. The column identified as “GEOID” is then
converted to a text format to it can be recognized by the ArcMap software. (Figure 3.3)
Using ArcPro, the US census tracts shapefile was imported to the map document. The
“GEOID” column in this shapefile was then converted to a “Double” integer type in order for it
to be joined to the American Community Survey fertility excel file. This process involves the
creation of a new attribute field called “ID2” and used the Field Calculator to copy the content of
the “GEOID” field to the new “ID2” field. Once finished, the American Community Survey
fertility excel file is imported into the map document. The two files (census tracts and excel file)
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are then spatially joined together using the “Join” function in ArcPro, based on the field called
“ID2”.
Addressing spatial dependence. Due to the dependence these analyses have on spatial
location, there are some census tracts that need to be removed from the contiguous United States
before data analysis. Some census tracts in the United States do not represent locations where
people live, such as census tracts over the great lakes and around coastal areas that define the extent
of a state’s geopolitical boundary. Alaska and Hawaii were also separated from the contiguous
United States so that the distance of these two states were not included in the spatial analyses that
considered nearest neighbor (in this case, nearest census tract). By separating these two states and
analyzing them individually, the accuracy of the observed spatial relationships was maintained.
The total number of features included in the analysis of the contiguous United States was 72,483
census tracts. The total number of census tracts for analysis in Hawaii was 337, and for Alaska
was 167.
Data analysis. Count variable models. Linear regression statistics were applied to the
American Community Survey Fertility data in order to observe any linear relationships between
the variables, which in this case referred to count values that reflect women with births based on
sociodemographics said to be associated with disparities. Linear tests applied here were a
Poissonian distribution, followed by a Negative Binomial distribution, quantitated using SAS 9.4.
Statistical significance in the Poisson regression was determined by a 95% confidence
level, which was used to ascertain whether the proportions of women with births differed by
sampled location (census tract). Poisson regression can be used for prediction, including
forecasting of inference, hypothesis testing, and modeling of causal relationships (Haight, 1967).
The regression analyses assumed independent counts (i.e., ni), taken at locations i = 1 2... n, where
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each of the estimated count values, was from a Poisson distribution. These counts were described
by a set of explanatory variables denoted by matrix Xi, a 1×p vector of covariate estimates for each
census tract i. The expected value of these data was given by:

where β

was the vector of non-redundant parameters and the Poisson rates parameter was given by:

The rates parameter λi (Xi) were both the mean and the variance of the Poisson distribution
for a estimated number of “All women with births” (fertility) within a census tract i. The dependent
variable was the total count of All women with births” (fertility). All of the estimates for the models
were tested for multicollinearity using partial F test in SAS, and no problematic correlations were
found. In statistics, multicollinearity (also collinearity) is a phenomenon in which one predictor
variable in a multiple regression model can be linearly predicted from the others with a substantial
degree of accuracy. In this situation, the coefficient estimates of the multiple regression may
change erratically in response to small changes in the model or the data. Multicollinearity does not
reduce the predictive power or reliability of the model as a whole, at least within the sample data
set. It only affects calculations regarding the individual predictor (Belsley, 1991).
Extra-Poisson variation was detected in the residual variance estimates of the fertility
model. Extra-Poisson variation occurs when discrete data comes in the form of counts or
proportions that display greater variability than would be predicted when fitting a model (Haight,
1967). When sampled data are overdispersed, the square root and logarithmic transformations may
be less effective at making the mean and variance independent (Hosmer & Lemeshow, 2000).
Overdispersed Poisson processes can be modeled in many alternative ways. The most
common approaches used for count data include quasi‐likelihood‐based Poisson models
(Wedderburn, 1974), random‐effects models (Bolker, 2008), and negative binomial models
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(McCullagh & Nelder, 1989), all extensively used in the literature and readily available in
statistical software packages. In quasi‐Poisson methods the amount of overdispersion is estimated
under the assumption that the variance is proportional to the mean, after which, e.g., standard errors
are corrected for the estimated overdispersion. On the other hand, mixed‐effects Poisson models
and typical negative binomial models assume that the extra‐Poisson variance is a quadratic
function of the mean. The statistics literature also proposes other types of overdispersed
generalized Poisson models (Famoye, 1993) and zero‐inflated variants of the Poisson and negative
binomial models (Lambert, 1992).
Ver Hoef & Boveng (2007) made a comparison between quasi‐Poisson and negative
binomial regressions as two contrasting approaches for dealing with overdispersed count data. The
authors showed that the choice of approach can affect the outcome of the analysis. The authors
recommended sound scientific reasoning and graphical investigation of the data as the basis for
model choice. Different processes underlying overdispersion in spatially dependent data may
result in various mean–variance relationships (Griffith, 2003).
For this research, a negative binomial regression with a gamma distributed nonhomogenous mean was constructed in PROC GENMOD to account for the overdispersion in the
fertility model. The negative binomial distribution arises as a continuous mixture of Poisson
distributions in a model where the mixing distribution of the Poisson rate is a gamma distribution
(Hilbe, 2011). A specific parameterization of the negative binomial distribution can be used to
approximate overdispersed Poisson processes with a wide range of mean–variance relationships
(Haight, 1967). The negative binomial model is a quadratic function of the mean and the variance
which commonly affect the weights in the iteratively weighted least-squares algorithm for fitting
sampled data (Cameron & Trivedi, 1998). In probability theory and statistics, the negative
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binomial distribution is a discrete probability distribution that models the number of failures in a
sequence of independent and identically distributed Bernoulli trials before a specified (nonrandom) number of successes (denoted r) occurs (Lambert, 1992). A Bernoulli trial (or binomial
trial) is a random experiment with exactly two possible outcomes, success and failure, in which
the probability of success is the same every time the experiment is conducted (Papoulis, 1984).
Employed here is the negative binomial regression model with a non-homogenous gamma
distributed mean to linearly adjust the sampled extra-Poissonian variation in the fertility data. An
analytical solution to this integral exists when

is assumed to follow a gamma distribution. This

solution is the negative binomial distribution. When the model contains a constant term, it is
necessary to assume that

, in order to identify the mean of the distribution

(Haight, 1967). Thus, it is assumed that follows a gamma(

:

where

and is a positive fertility-related parameter. Then, the density of

Making the substitution

rewritten as

(

) distribution with

and

was the gamma function
given

was derived as

), the negative binomial fertility distribution was then

In so doing, the

negative binomial distribution was derived as a gamma mixture of Poisson random variables.
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For this research, the assumption about equality of mean and variance (i.e., Poisson
distribution property) is relaxed. In our fertility model the variance of negative binomial was equal
to µ + k µ 2, when k ≥ 0 was a dispersion parameter. The key criterion for using a Poisson model
is after accounting for the effect of predictors, the mean must equal the variance (Haight, 1967).
The maximum likelihood estimation method was used to estimate k as well as the parameters of
the regression models for log(µ). Since the Poisson regression model can be generalized by
introducing an unobserved heterogeneity term for observation i (McCullagh & Nelder, 1989),
individual sampled estimate of “All Women with Births” were assumed to differ randomly in a
manner that was not fully accounted for by the Poissonian values.
In this research the unobserved heterogeneity term was independent. Overdispersion
results from neglected unobserved heterogeneity (Cameron & Trivedi, 1986). The Poisson
regression model was generalized by introducing an unobserved heterogeneity term for the fertility
classified observation . This was formulated as
heterogeneity term

was independent of the vector of regressors

the distribution of conditional on and

variance

:

in the model. In so doing,

was Poissonian with conditional mean and conditional

in the fertility model output letting

probability density function of . Then, the distribution
obtained by integrating

where the unobserved

with respect to :

be the

(no longer conditional on ) was
(see Haight,

1967).
Because the Poisson distribution is a special case of the negative binomial distribution,
coefficients estimated using Poisson regression will not differ significantly from coefficients
estimated using negative binomial regression, although the standard errors estimated by the
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negative binomial regression may not be as efficient (Haight, 1967). As a result, this research
offers the caveat that some factors identified as significant, using Poisson regression, may or may
not become insignificant when using negative binomial regression.
The fertility model output suggests the negative binomial may be used for handling
overdispersion in fertility data. Negative binomial regression models can estimate a dispersion
parameter that can remove the effects of overdispersion from a model (Neter et al., 1993). When
the negative binomialized fertility data were fitted by the maximum likelihood method, the model
outputs were considered to be convenient and practical. They handled the overdispersion and
allowed the likelihood ratio and other standard maximum likelihood tests to be implemented with
robust properties. Inappropriate imposition of the Poisson in fertility data may underestimate the
standard errors and overstate the significance of the regression parameters, and consequently,
giving misleading inference about the regression parameters.
Spatial autocorrelation. The prior analyses observed the interaction between overall
fertility and fertility based on predefined sociodemographics identified in the literature. Spatial
autocorrelation in this research includes statistical analysis of autocorrelation using PROC
VARIOGRAM in SAS (Moran’s I) and using the Optimized Hotspot Analysis (Getis-Ord Gi*)
function in ArcPro. All spatial analyses using latitude and longitude coordinates were computed
in the Lambert Conformal Conic geographic projection, which is appropriate for the analysis of
Getis Ord Gi* in ArcPro when the span of analysis exceeds 30° - otherwise calculations will
automatically use Chordal distance, which is not as accurate beyond 30° (ESRI, 2020a).
Moran’s I statistic. Spatial autocorrelation will observe the interaction of these variables
while also taking into account the geographic location of each census tract, based on latitude and
longitude coordinates. An autoregressive model was employed that used a sampled Y value [i.e.,
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an autoregressive response (AR) or spatial linear (SL) specification] and/or the residuals of Y as a
function of nearby Y residuals [i.e., an AR or SE specification]. Sampled spatialized fertility
variables were defined in terms of an n-by-n geographic weights matrix, C, whose c ij values will
be 1 if the sampled covariate and coefficient values i and j respectively, are located adjacent in
geographic regression space and 0 otherwise. Alaska and Hawaii were separated from the
contiguous United States so that the distance of these two states were not included in the spatial
analyses that take into account nearest neighbor (in this case, centroid from the coordinate data).
The formulation for the Moran's index of spatial autocorrelation used in this research was
as follows: where with i ≠ j as in Jacob, et al, (2013). Moran’s I is a product moments correlation
coefficient that can detect latent positive/negative autocorrelation (i..e, similar /dissimilar
aggregation of attributes in geographic space) Spatial autocorrelation is the correlation among
values of a single variable strictly attributable to their relatively close locational positions on a
two-dimensional surface, introducing a deviation from the independent observations assumption
of classical statistics (Griffith, 2004).
Spatial analysis frequently employs model-based statistical inference, the dependability of
which is based upon the correctness of posited assumptions about a model's error term. One
principal assumption in the fertility model construction was that that individual error terms came
from a population whose entries were thoroughly mixed through randomness. Moreover, the
probability of a sampled parameter estimator value in a autocorrelation paradigm taken on by one
of a fertility model's error term entries may not affect the probability of a value taken on by any of
the remaining error term entries (i.e., the violation of independent observations assumed in
classical statistics). Non-zero spatial autocorrelation would violate this assumption (see Jacob et
al., 2009). Without detecting autocorrelation in a fertility time series national dataset, few
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variables would exhibit a geographic expression when mapped. Most variables would exhibit some
type of spatial organization across space. Zero spatial autocorrelation means geographically
random phenomena and chaotic landscapes (Griffith, 2003).
Dd the directional distribution of the fertility-related variables in order to observe raw
spatial trends based on the count data alone and 1 standard deviation from the mean center.
The standard deviational ellipse is given as:

where

. In this equation, x and y refer to latitude
and longitude coordinates of the feature i, {x̄, ȳ} are the Mean Center for the features, which can
be specified by a variable in the dataset, and n is the total number of features. In this research, the
overall trend of “All Women with Births” is compared to the distributions of the each of the other
fertility variables based on sociodemographics (specified in the Case Field option). The covariate
matrix is represented by eigenvalues and eigenvectors, where the standard deviations for these are

computed using:

,
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which includes scaling of variance using an adjustment factor so the ellipse includes an accurate
representation of datapoints (ESRI, 2020b).
Observing the raw values of the fertility data based on socio-demographics allowed some
visual spatial trends of the data, but the directional ellipse makes those spatial relationships more
clear because it calculates the x and y directions separately – defining the axis of the ellipse based
on standard deviations of the x- and y-coordinates (Chew, 1966). Should the autocorrelation reveal
statistical significance, a directional distribution can give insight into a directional significance
based on standard deviations of the raw values from the mean center of each feature (Fisher et al.,
1987).
Getis-Ord Gi* statistic. Statistical significance of maternal fertility demographics in this
research was observed both linearly, with the aforementioned Poissonian and Negative Binomial
distributions, and spatially with the Moran’s I statistic. Although the Moran’s I statistic calculated
in SAS can indicate significance between variables using coordinate data, it does not provide the
ability to observe the spatial boundaries the data represent, such as , census tracts in the United
States. The difference between these two spatially-based statistics is that the Moran’s I is a global
statistic observes the overall trend in the data, which works best when the data are consistent over
space (Goodchild, 1986; Griffith, 1987). The Getis Ord Gi* statistic is a local statistic that observes
the relationships of neighboring features, comparing the local to the global (Arthur Getis & Ord,
1992).
Within ArcPro 2.4, the Getis Ord Gi* statistic is calculated using an Optimized Hot Spot
Analysis which observes the count values of features and compares them to the values of
neighboring

features

in

the

dataset.

The

Getis-Ord

Gi*

statistic

is

given

as:
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where xj is the attribute value for the feature (j), wi, j is the
spatial weight between features i and j, n is equal to the total number of features, and X̄ and S are

respectively:

,

. Statistical significance is based on

z-scores, where positive z-scores indicate high clustering of high values (hot spots), and negative
z-scores indicate high clustering of low values (cold spot).
The variable observed is the total number of women with births within the last 12 months
(coded: AllBirths). Analysis of this variable alone was done to observe the overall spatial trend of
births in the United States in order to have a reference for analysis of women with births based on
certain sociodemographics. Also this was to done to have a reference for a national spatial analysis
of infertility or use of infertility services. Future analysis might consider Optimized Hot Spot
analyses for the fertility variables based on sociodemographics.
Part 2b: Spatial Analysis of CDC-Reporting Fertility Clinics in the United States.
Collection of ART clinic data in the United States began in 1986, shortly after the establishment
of the SART in the early 1980s. In 1992, the Federal Trade Commission condemned fertility
clinics of false advertisement of success rates which resulted in the passing of the Fertility Clinic
Success Rate and Certification Act of 1992 (FCSRCA), Section 2(a) of P.L. 102–493 (42 U.S.C.
263a-1(a)). This Act required clinics to report yearly to the CDC their information about ART
cycles performed at their clinic. In 1997, the first ART Success Rates Report was published from
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data in 1995. Clinic reports are available online through the CDC from 1995-2017. As of June
2020, the 2018 data are available as summaries, but is not available for download (CDC, 2019b).
This research utilized ART Success Rate clinic data from 2017, since that is the cut-off
date for the American Community Survey Fertility data (representing 2013-2017). Although the
clinic data from 2013, 2014, 2015, and 2016 were also downloaded, it was found that the number
of clinics did not vary greatly, so only 2017 – being the year with the most clinics – was used for
this research.
Data collection. Clinic data were obtained through the CDC website, in the NASS archived
reports (https://www.cdc.gov/art/reports/archive.html). Data were downloaded in MS Excel
format and converted to shapefiles through the geocoding process.
Data preparation. Addresses and geolocated clinics were not available through the CDC’s
archived clinic tables. In order to obtain the geographic locations of each clinic, the clinic name
was searched in Google and matched with the state and city disclosed on the CDC website. To
triangulate the accuracy of the address of each clinic, the website FertilityIQ was referenced to
check the status of the clinic and the address. Status was important as some clinics closed or
reorganized since the previous year, so they may no longer be in service, or have a new name. If a
clinic changed or was reorganized, it was identified in the Excel file downloaded by the CDC. This
process was conducted for all clinics between the years of 2013-2017, as disclosed by the CDC.
Earlier years had more instances of closed clinics and more incidences of reorganized clinics. The
2017 dataset had the least of both at 0.
Once the addresses were obtained, the data were georeferenced in ArcPro 2.4. The initial
results were 444 matched (99.11%), 1 unmatched (0.22%), and 3 tied (0.67%). All unmatched and
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tied results were reconciled by reviewing them individually and placing them in the correct
locations or confirming they were in the correct locations.
Data analysis. For this research, observation of the spatial locations of the clinics was used
to answer the research questions relating to the spatial relationship between reporting fertility
clinics, population density, and birth density. There were variables relating to success rates, types
of services offered, and accreditation and memberships of the clinics, but these were not observed
in the analyses.
Select by location. With over 72,000 census tracts and less than 450 ART clinics, it was
presumed that the majority of census tracts would not have a clinic, a census tract would have no
more than one clinic if there was one, and that the clinics would be located in areas of high
population density. To test this concept, the Select by Location tool was utilized so that census
tracts that had a clinic could be selected. A new shapefile and excel file were created for the census
tracts that had at least one clinic. In this way, the data from all census tracts with clinics could be
compared to all census tracts without clinics.
Kernel density. Observation of spatial density was conducted using the Kernel Density tool
in ArcPro, which is a predicted measurement of the magnitude-per-unit area from a point. The
measurement uses a kernel function to create a smoothed raster surface to observe spatial clustering
with a gradient image. Calculation of density is based on the following formula:

, where i=1,….,n are input points, pop
is an optional parameter for a population field, and disti is the distance between point i and (x,y)
location (Silverman, 1986). Within ArcPro 2.4, this analysis used the Planar method of analysis
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with square meters since the data in ArcPro 2.4 and from the Census are automatically in meters.
Also

the

default

search

radius

is

calculated

using

, where Dm is the weighted median
distance from the mean center, n is the number of points, and SD is the standard distance. The
default search radius was 412,323.06 meters (256.21 miles).
Getis-Ord Gi* statistic. The Optimized Hotspot analysis was also utilized with the fertility
clinic data points. This analysis required the creation of a grid, or fishnet, to have a spatial boundary
from which to determine spatial density. More points within a grid cell indicated higher density.
The grid cell size was automatically calculated in ArcPro 2.4 at 43,289 meters (26.9 miles).
Statistical significance was based on z-scores, where positive z-scores indicate high clustering of
high values (hot spots), and negative z-scores indicate high clustering of low values (cold spot)
(ESRI, 2020a; Getis, 2001). Parameters of the Getis-Ord Gi* statistic used here is the same as
described earlier, with the exception that the spatial parameters are the grid cells rather than census
tracts.
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Chapter Three Tables
Table 3.1 Sociodemographics chosen to observe with qualitative and quantitative data
Independent Variables References to Support Inclusion
Geographic
State
(King & Meyer, 1997; National Conference of State Legislateres,
2017)
Census Tract
(Dragićević, 2004; Dustin T. Duncan et al., 2018)
Sociodemographics
Ethnicity
(M. P. Bitler & Schmidt, 2012; M. Bitler & Schmidt, 2006; Dieke
et al., 2017; Kissil & Davey, 2012; Seifer et al., 2010)
Sexual Orientation
(Bergmann, 2011; Greenfeld & Seli, 2016; Jin & Dasgupta, 2016;
The Ethics Committee of the American Society for Reproductive
Medicine, 2013; Wu et al., 2017)
Age
(Albertini et al., 2017; Chandra et al., 2013; Lemoine & Ravitsky,
2015)
Income
(Jacqueline R. Ho et al., 2017; Mehta et al., 2016; Seifer et al.,
2010; The Ethics Committee of the American Society for
Reproductive Medicine, 2015)
Religion
(Greil et al., 2011; Kee et al., 2000; Klitzman, 2018)
Education
(Jacqueline R. Ho et al., 2017; Kunicki et al., 2018; The Ethics
Committee of the American Society for Reproductive Medicine,
2015)
Employment
(Langher et al., 2019; Nicolette, 2016; Simoni et al., 2017)
Nativity
(Kronenfeld, 2017; Luke et al., 2016)
Insurance
Private insurance
(Dieke et al., 2017; Mutcherson, 2017)
Public insurance
(Adashi & Dean, 2016; Kulkarni et al., 2017; Mutcherson, 2017)
Presence of infertility (Bitler & Schmidt, 2012; Bitler & Schmidt, 2006; Boulet et al.,
insurance mandate
2019; Schmidt, 2007)
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Table 3.2 Infertility Self-Efficacy (ISE) Scale

*adapted from (Cousineau et al., 2006)
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Table 3.3 American Community Survey 2013-2017: Fertility (S1301)
United States
Total
Women with births in the past 12 months
Number
Percent Distribution

Women 15 to 50 years
15 to 19 years
20 to 34 years
35 to 50 years
RACE AND HISPANIC OR
LATINO ORIGIN
One race
White
Black or African American
American Indian and Alaska
Native
Asian
Native Hawaiian and Other
Pacific Islander
Some other race
Two or more races
Hispanic or Latino origin (of
any race)
White alone, not Hispanic or
Latino

Estimate

Margin of Estimate
Error

Margin of Estimate
Error

76,416,928
10,359,412
32,739,120
33,318,396

+/-12,601
+/-5,575
+/-5,658
+/-9,542

3,994,223
157,388
2,979,339
857,496

+/-20,838
+/-2,685
+/-16,878
+/-8,559

(X)
3.9%
74.6%
21.5%

Rate per 1,000
women
Margin of Estimate
Margin
Error
of
Error
(X)
52
+/-1
+/-0.1
15
+/-1
+/-0.2
91
+/-1
+/-0.2
26
+/-1

74,075,571
53,241,216
10,778,133
666,447

+/-30,513
+/-19,470
+/-11,790
+/-5,081

3,871,392
2,728,858
579,871
41,764

+/-19,302
+/-15,855
+/-6,335
+/-1,311

96.9%
68.3%
14.5%
1.0%

+/-0.1
+/-0.2
+/-0.1
+/-0.1

52
51
54
63

+/-1
+/-1
+/-1
+/-2

4,942,390
158,031

+/-7,117
+/-1,887

258,381
10,011

+/-3,533
+/-757

6.5%
0.3%

+/-0.1
+/-0.1

52
63

+/-1
+/-5

4,289,354
2,341,357

+/-24,402
+/-23,741

252,507
122,831

+/-3,773
+/-3,274

6.3%
3.1%

+/-0.1
+/-0.1

59
52

+/-1
+/-1

14,938,405 +/-4,877

889,228

+/-7,740

22.3%

+/-0.2

60

+/-1

43,509,770 +/-8,118

2,146,670

+/-13,573

53.7%

+/-0.2

49

+/-1
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Table 3.3 (continued)
United States

Total
Estimate

NATIVITY
Native
Foreign born
EDUCATIONAL
ATTAINMENT
Less than high school graduate
High school graduate (includes
equivalency)
Some college or associate's
degree
Bachelor's degree
Graduate or professional
degree
POVERTY STATUS IN THE
PAST 12 MONTHS
Below 100 percent of poverty
level
100 to 199 percent of poverty
level
200 percent or more above
poverty level

Margin of
Error

Women with births in the past 12 months
Number
Estimate Margin of
Error

Estimate

Margin
of
Error

63,572,289 +/-36,161
12,844,639 +/-40,383

3,204,452
789,771

+/-18,611
+/-7,294

80.2%
19.8%

+/-0.2
+/-0.2

50
61

+/-1
+/-1

13,105,452 +/-44,727
16,069,512 +/-76,049

516,785
920,398

+/-6,231
+/-8,708

12.9%
23.0%

+/-0.2
+/-0.2

39
57

+/-1
+/-1

24,932,063 +/-33,883

1,258,848

+/-8,881

31.5%

+/-0.2

50

+/-1

14,765,055 +/-69,703
7,544,846 +/-63,402

811,834
486,358

+/-10,902
+/-8,445

20.3%
12.2%

+/-0.2
+/-0.2

55
64

+/-1
+/-1

11,484,450 73,281

883,722

+/-14,932

22.4

+/-0.3

77

+/-1

13,176,393 77,293

797,006

+/-15,777

20.2

+/-0.4

60

+/-1

48,041,799 +/117,261

2,147,404

+/-21,015

53.9%

+/-0.3

45

+/-1
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Chapter Three Figures

Figure 3.1. Survey and interview recruitment flyer
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Input:

Effect size f
=
β/α ratio
=
Total sample size =
Numerator df
=
Number of groups =
Output: Noncentrality parameter λ=
Critical F
=
Denominator df
=
α err prob
=
β err prob
=
Power (1-β err prob)=

0.40
1
134
10
3
21.4400000
1.7487775
131
0.0764412
0.0764412
0.9235588

Figure 3.2. Power analysis for Infertility Self-Efficacy Scale

National ACS
Fertility: S1301
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Spatial Join:
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National census
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Statistical Functions
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Spatial Autocorrelation
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Figure 3.3. Geoprocessing of census data
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CHAPTER FOUR:
RESULTS

This chapter provides the results of both the qualitative and quantitative data analyses for
this research Descriptive results are presented first, followed by results based on each of the seven
research questions. By organizing the results by research question, all data sources (qualitative and
quantitative) used to answer each research question can be observed simultaneously, either
triangulating results or adding contextual information to further explain the results of one source.
This follows the guidelines for a multiphase mixed method research design (Creswell & PlanoClark, 2011). Some of the results of this dissertation have been published in conference abstracts
from the 2020 American Society for Reproductive Medicine Scientific Congress and Expo
(Stanley, 2020; Stanley & Foti, 2020). Use of the previously published material is allowed due to
the user agreement of the journal Fertility and Sterility (Appendices H and I).

Descriptive Statistics

Qualitative Interviews
Informal interviews. Demographics. Table 4.1 lists the informal interview
demographics. Bring next sentence forward for this paragraph. There were a total of 66
interviews completed between September 2019 – February 2020. The length of the interviews
ranged from 9-28 min, with a total of 1,023 min (17.05 hours) of recorded interview time.
Regarding state representation, 51.5% of participants lived in a state with an infertility health
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insurance mandate, and 48.5% lived in a state without an infertility health insurance mandate.
There were 16 states without a mandate, and 11 states with a mandate – representing 61% of the
18 states with an infertility health insurance mandate. States with mandates included California
(3), Colorado (3), Illinois (5), Louisiana (1), Maryland (3), Massachusetts (3), New Jersey (3),
New York (9), Rhode Island (1), Texas (4), and West Virginia (2). The states identified as
having a mandate only reflect the mandated states as of January 2020.
Regarding the stages of infertility service use (Prospective, Active, Past), 51.5% were
currently using infertility services (Active), 43.9% had previously used infertility services and
either had successful pregnancies or were seeking other options (Past), and 4.6% were not yet
accessing services but seeking information about infertility services in anticipation of using them
(Prospective). The majority was female (92.4%), however there were also three men and two
individuals identifying as non-binary or gender queer. Age ranges were between 21-43, with a
mean of 32.7 (4.09). Estimated household income was self-reported, ranging between $30,000 $700,000 with a mean of $155,107.69. Of the reported income, 86.4% was joint income between
married or cohabitating partners. The majority of participants was married (92.4%), heterosexual
(83.3%), identified with no religion (54.6%), were Caucasian (86.4%), and employed full time
(72.7%).
There were 16 different employment industries identified by interviewees. The three most
common were healthcare (21.1%), higher education/adult education (16.7%), and non-profit sector
(10.6%). The majority of participants had a master degree (42.4%), followed by bachelor degree
(30.3%), and the next most common was the PhD (16.8%). PhD and professional doctorates (MD,
DVM, PharmD, etc.) were identified separately. Regarding health insurance, 87.9% of participants
reported having private health insurance through their employer or individually.
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Expert interviews. Demographics. A total of eight organizations participated in an
expert interview. Regarding the type of financial or other assistance provided by the
organizations, five organizations specifically offered one or more grants to help with infertility
services, ranging in amounts from $500-$10,000. The other three were particular to the
organization. One was described as offering insurance benefits, one described a shared risk and
medical savings management program, and one was described as offering insurance and case
management. The types of organizations were also variable, where four were certified 501c3
non-profits, and the other four had their own descriptions (Table 4.2).
All but two of the organizations had residency requirements for persons seeking their
assistance. Residency restrictions included U.S. resident or naturalized citizen (n=4), both U.S.
resident and resident of Philadelphia, PA (n=1), and one that specified that the employer must be
based in the United States (n=1). Of the eight organizations included, six offered services directly
to individuals or couples, one offered services to individuals, couples, and clinics, and one offered
to only employers as an insurance benefits package.
Baby Quest Foundation. The Baby Quest Foundation is a 501c3 non-profit that offers
grants to two applicants per year to cover up to $500 of associated costs for infertility services.
Their main restriction is based on age, where persons over the age of 55 are not eligible for the
grant, based on guidelines from medical professionals of the patient and those on the selection
board. As of April 2020, the Baby Question Foundation has been able to fund 117 families in 29
states – 10 of which are states that have an infertility insurance mandate (Baby Quest Foundation,
2020).
The Tiniana Q. CADE Foundation. Founded in 2005 by a couple with personal experience
using infertility services, The CADE Foundation is a 501c3 non-profit that offers two $10,000
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grants per year for people with diagnosed infertility. There are three grants they offer. These
include 1) the Dr. Stephen Greenhouse Grant, founded in 2018 by physicians and staff of Shady
Grove Fertility in memory of Shady Grove Fertility physician and reproductive health leader
Stephen Greenhouse, MD; 2) the Family Building Grant, funded in part by donations from EMD
Serono for medical infertility treatment and child adoption; and 3) the Savannah Grant, which is
specifically for Shady Grove Fertility patients and was made in honor of a baby born at a Shady
Grove who died in 2010 (Tiniana Q. CADE Foundation, 2020). Although people who require
infertility services for reasons other than diagnosed infertility do not qualify for this grant, the
foundation has raffle prizes for certain services or some money provided through various events
that are open for anyone to receive. As of April 2020, the foundation has been able to provide
funding for 12 families.
The Hope for Fertility Foundation. This 510c3 non-profit organization was founded in
2016 by a couple who went through the process of using infertility services and wanted to provide
more funding “hope” for other couples who need infertility services to start a family. The
foundation provides one grant between $250-$5,000, and since 2016 they have awarded 31 grants
totaling $122,650, resulting in three current pregnancies and 13 babies born or adopted (The Hope
for Fertility Foundation, 2020).
Progyny. Progyny is described as a “fertility benefits administrator” that directs their
fertility benefits to employers who self-insure their employees, utilizing a network of reproductive
endocrinologists throughout the country (Progyny Representative, 2020). The benefits provided
through Progyny are standalone or secondary insurance if the person either already has insurance
or is on his or her partner’s insurance. By focusing on self-insured employers, Progyny is not
affected by the state-based infertility insurance mandates. However, they adhere to the fertility
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benefits included in the respective state mandates. “Progyny itself, the company, is not subject [to
the state-based infertility mandate]. But, let’s say we were a self-funded employer and the mandate
in New York State is three IVF cycles for infertility – even though Progyny wouldn’t have to
adhere to it [the state-based infertility mandate], we do.” (Progyny Representative, 2020). The
benefits they provide affect employers the same way as other types of insurance. “They’re [selfinsure employers] paying deductible co-insurance and co-pay. But, there’s no added fee for them
[employers] to access Progyny.” (Progyny Representative, 2020).
The Jewish Family and Children’s Service (JFCS) Fund. The Jewish Family and
Children’s Service was first founded as an orphanage in 1855. Then in 1941 the orphanage in
conjunction with the Association for Jewish Children (ACJC) and the Jewish Family Service
(JFS), merged to become the Jewish Family and Children’s Service (JFCS, 2020). The
organization created a grant program, called The Fertility Fund: A Gift from the Heart, for persons
of Jewish ancestry living in the Philadelphia region needing infertility services. Applications for
the grant are assessed by an external panel of physicians and funders of the grant, which is funded
through donation from individuals and couples. The foundation also has partnering physicians who
assist their members with navigating the fertility treatment process and pay clinics directly after
verifying treatment recommendations from physicians.
Parental Hope. Parental Hope is a 510c3 non-profit organization founded in 2016 by a
couple who used infertility services to start their family. After experiencing the high financial costs
directly, they decided to create this organization that includes an online support group community,
and two grants to support funding for infertility services. These are the Parental Family Hope
Grant, which covers costs related to in vitro fertilization (IVF) or one frozen embryo transfer
(FET); and the Embryo Adoption Grant, which offers a one-time award of $5,000 to a couple who
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qualifies for embryo adoption with the National Embryo Donation Center (Parental Hope, 2020).
Since 2016, Parental Hope awarded 41 grants totaling $370,900, resulting in 18 babies born and 4
on the way as of August 2020 (Parental Hope, 2020).
ART Risk Solutions. ART Risk agency was founded 15 years ago by a woman with personal
experience navigating the use of surrogacy services in the United States. As she became very
knowledgeable on the topic she began to identify trends in insurance coverage there surrogacy
ends up not being covered, and from that created ART Risk Solutions that functions to either
provide or direct clients to the sources of insurance or other financing they would need for
surrogacy services (ART Risk Solutions Representative, 2020). ART Risk Solutions is described
as a financial insurance solutions company that provides financial case management to individuals
and couples using infertility services related to surrogacy. They also provide insurance groups
available to individuals, gestational carriers, clinic offices, and employers (ART Risk Solutions,
2020). The agency is based in California, but they have an approximately 50% international client
base (ART Risk Solutions Representative, 2020).
IntegraMed Fertility. IntegraMed Fertility is a division of IntegraMed America that
functions as a medical savings account (MSA) crisis management association that provides
discounted fertility services at their clinic partners throughout the United States and Canada. The
company does not provide loans, but acts as a third party between self-pay patients and the clinics
to process payment for services in a type of shared risk program (IntegraMed Representative,
2020). Self-pay patients are those who may have health insurance, but it does not cover infertility
services beyond diagnostics. They offer “bundles” of fertility services and provide refunds up to
100% of costs if the cycles do not result in a baby, based on the type bundle program. The entity
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that processes the payments between patients and clinics is a subsidiary of IntegraMed Fertility
called Attain Fertility.

Survey Instrument
Demographics. There were a total of 134 survey responses included in this research,
collected between September 2019 – January 2020. The majority of survey respondents heard
about the research through Reddit (89.6%), and the next highest was through a friend (6.7%).
Regarding the stages of use, there were 12 Prospective (9%), 71 Active (53%), and 51 Past
(38.1%). Table 4.3 shows the demographics for the survey responses. All of the interviewees also
completed a survey, and their data were also reflected in these results.
The majority of respondents was female (95.5%), between the age of 31-35 (47.8%), and
married (90.3%) with annual household incomes above $100,000 (70.1%). The majority were also
heterosexual (82.1%) and Caucasian (88.1%), identifying with no religion (51.5%), and employed
full time (83.1%). There were, however, a variety of employment levels. Some had only parttime jobs (2.9%), multiple jobs (1.5%), were unemployed but had a partner who was working
(8.2%), were a student (1.5%), or were self-employed (3.7%).
Due to the supposition that employers might play a role in facilitating access to infertility
services, this research also included information about the employment industry to show the
variety of places that have employees who utilize infertility services. There were 16 different
industries identified by survey respondents. The three most common industries were Healthcare
(26.9%), Higher Education/Adult Education (10.5%), and K-12 education (8.2%). The majority of
participants had a Masters degree (35.8%), followed closely by Bachelors degree (34.3%). The
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next most common degree was the Doctorate (13.4%). The doctorate includes PhD, SciD, DrPH,
EdD, DDiv, etc., but not professional degrees such as MD, DVM, DDM, PharmD, etc.
The following are descriptive statistics based on the following sections in the survey:
Health Education, Online Communities, and the Infertility Self-Efficacy Scale.
Health education. There were two questions about health education related to human
infertility. Tables 9 and 10 show the responses for these questions. When asked about the grade in
which they received information about the risks of fertility decreasing with age, the majority of
respondents responded that they never received that information in any level of school (56%), and
20.6% did not remember if they received that information in any level of school (Table 4.4). No
one reported hearing this information in elementary school, 1 remembered hearing about it in
middle school (0.8%), followed by high school (3.8%), and 12 heard about those risks in college
or university (8.7%) (Table 4.4).
When asked about their opinion on the earliest grade at which people should learn about
the risks of fertility decreasing with age, 24.8% did not think it was a topic to provide in any level
of school, however the majority thought that high school (45.1%) was the best time to introduce
this type of health education (Table 4.5).
Online communities. In an effort to gauge the use and perception of online support
communities, the survey contained three questions related to the use of these online spaces, and
types of information shared. These questions are based on Likert-type scales ranging from 1
(Strongly Agree) to 5 (Strongly Disagree) (Table 4.6). When asked to respond with their level of
agreement to the prompt “I use online ART/infertility support forums to help me make decisions
about what infertility services to use”, 41.8% responded “Agree”, followed by “Strongly Agree”
at 31.3%. When asked to respond with their level of agreement to the prompt “I talk about my
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experience with using infertility services more online than I do with people in person”, 44%
respond with “Strongly Agree”, however the responses for Agree, Neutral, and Disagree were
close at 19.4%, 8%, and 15% respectively. When asked to respond with their level of agreement
to the prompt “I prefer to access online support forums for ART/infertility before talking to a
physician”, 32.8% responded “Neutral”, followed by “Agree” at 28.4%, and “Disagree” at 22.4%.
Future analyses could determine if there are demographic differences among the
respondents to these survey questions, based on characteristics such as age, ethnicity, education,
and income.
Infertility Self-Efficacy Scale. The mean scores for each item of the ISE scale are located
in Table 4.7. Using a GML model, comparisons in mean ISE score were measured against
residence in a state with or without an infertility insurance mandate, stage of use, age, ethnicity,
and responses to questions about infertility health education and the use of online infertility support
communities. There were no differences between ISE mean score and residence in a state with or
without an infertility insurance mandate, stage of use, age, online community use about making
decisions, or preference to talk to people in online community forums before speaking to a
physician about infertility services (Prospective, Active, Past) (Table 4.8). There were significant
differences in ISE mean scores between ethnicities (F=3.19, Pr>F=0.009), responses to health
education (F=2.53, Pr>F=0.032), and preferences for discussing infertility related issues in online
forums (F=5.01, Pr>F=0.0009). Post-hoc analysis using the Tukey’s test to control for Type 1
experiment wise error rate found statistically significant differences in ISE mean scores at 95%
confidence between Asian and Caucasian groups (Table 4.9), as well as the mean ISE scores
between those who responded “Strongly Agree” compared to “Disagree” or “Strongly Disagree”
to the prompt “I talk about my experience with using infertility services more online than I do with
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people in person” (Table 4.10). Significant difference in ISE mean scores with the the health
education responses were not significant after the post hoc analysis.

American Community Survey: Fertility of Women Age 15-50, Census Tract
National fertility statistics between the years of 2013-2017 show that there were estimated
to be 76,416,928 (+/- 12,601) women between the age of 15-50, of which 3,994,223 (+/-20,838)
gave birth, at a rate of 52 (+/- 1) per 1,000 women (Table 3.3). Among the age ranges, women age
20-34 had the highest number of women with births (n=32,793,120), highest fertility rate (91 +/1 per 1,000 women), and the highest percent distribution of women with births among all the age
ranges (74.6%). For race/ethnicity, Caucasian women with (n=53,241,216, 68.3%) and without
(n=43,509,770, 53.7%) Hispanic/Latin ancestry reported giving birth the most and had the highest
percent distribution. However, those two groups had the lowest fertility rate per 1,000 women,
where Caucasian women with Hispanic/Latin ancestry had a rate of 51 +/- 1 per 1,000 , and
Caucasian women without Hispanic/Latin ancestry had a fertility rate of 49 +/- 1 per 1,000. The
highest fertility rates were among racial groups with the lowest estimates of women with births,
which were Native Hawaiian and Other Pacific Islander (63 per 1,000 +/- 5) and American Indian
and Alaska Native (63 +/- 2 per 1,000 ). Foreign born women had higher fertility rates than native
born women, at 61 +/- 1 and 50 +/- 1, respectively. Women with a graduate or professional degree
had the lowest estimated pregnancies that led to live birth (n=7,544,846), but they had the highest
fertility rate (64 +/- 1 per 1,000) compared to the rest of the education variables. Among the
poverty variables, women who were below 100% of the poverty level had the highest fertility rate
per 1,000 women with births at 77 +/. The comparison was women with births who were 100%-
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199% of the poverty level and women who were 200% above the poverty level. These groups had
the fewest number of women with births at 11,484,450 (Table 3.3).
The spatial scale the data were obtained is at census tract level, and there are 72,483 census
tracts included in this research. Interestingly, the mean number of women who had a birth between
states with and without an infertility insurance mandate were very close, where states without a
mandate had a mean of 53.71 women with births (n=2,137,744) and states with a mandate had a
mean of 55.9 (n=1,856,479) (Table 4.11). The number of census tracts between states with/without
an infertility insurance mandate was also close, where states without a mandate had 39,798 census
tracts and states with a mandate had 33,198. Examining the population density between these
groups gives context to that close difference, where states without an infertility insurance mandate
have a lower population density of 2,669.1 per mi2 compared to states with a mandate where
population density is 9,152.2 per mi2. Since the fertility data reflects the years 2013-2017, these
analyses are based on the 16 states that had infertility insurance mandates during those years.
Before calculating spatial autocorrelation, the first step in the analysis was to determine
the relationships between the variables based on linear regression using the Poissonian distribution
(Table 4.12), which showed some overdispersion. To account for the overdispersion, a negative
binomial regression was utilized to account for unequal mean and variance (Table 4.13), as
recommended by Haight (1967). The negative binomial reduced the Akaike information criterion
(AIC) from 1,640,741.0079 to 645,221.8708, effecting a 60.7% reduction in prediction error. A
reduction in the AIC indicates a reduction in the out-of-sample prediction error (Hurvich et al.,
1998), so this negative binomial distribution shows a more accurate description of the relationship
between these variables. The negative binomial removed statistical significance from five

120

variables: African American, American Indian/Alaska Native, Asian, Two or more ethnicities, and
Hispanic.
The spatial autocorrelation utilized the significant variables from the Poissonian and also
for significant variables from the negative binomial to show their effect on the spatial
autocorrelation output. This experiment is encouraged due to the high degree of overdispersion,
where a reduction in the number of variables should affect the output due to the iterative analysis
included in autocorrelation (Griffith, 1987).

CDC-Reporting Fertility Clinics
There was a total of 448 fertility clinics reporting information to the CDC in 2017 (Table
4.14). The majority of the clinics provided all services described in the report from the CDC, which
includes: use of donor eggs (89.1%), donor embryos (62.3%), embryo cryopreservation (100%),
egg cryopreservation (98%), see single women (99.1%), and use gestational carriers (88%). Every
state but Alaska and including the territory of Puerto Rico, had at least one ART clinic. Of those
448 clinics, 82% were SART member clinics, and 92% were accredited labs through one of three
organizations: (1) the College of American Pathologists/American Society for Reproductive
Medicine (CAP/ASRM), (2) the Joint Commission on Accreditation of Healthcare Organizations
(JACHO), or (3) the New York State Tissue Bank certification for ART laboratories (NYSTB)
(CDC, 2019a) (Table 4.15)
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Place as a Risk Regulator for Infertility Service Use

Research Question 1: Reasons for accessing infertility services
R1: Why do people access infertility services in the United States?
Survey. At the time of the survey, the majority of respondents were not currently parenting
(76.7%), and those who had children (n=31) had between 1 (n=19) and 3 (n=1) (Table 4.3). Only
people who used infertility service in the past reported having children as a result of using assisted
reproduction (n=25). Many of the participants had more than one reason for needing infertility
services. The most common reason for people prospectively seeking infertility services was
unexplained infertility (n=5). For those actively seeking infertility services, the most common
reasons were unexplained infertility (n=35) and female factor (n=25). For those who sought
infertility services in the past, reasons were for female factor infertility (n=16) and dual
male/female factor (n=10) (Table 4.3). Overall, the most common reported reasons for seeking
infertility services were split between unexplained (26.7%) and female factor for infertility
(26.7%).
Informal interviews. At the time of the interviews, the majority of participants were not
pregnant (89.4%) and had no children (80.3%). Of those who were pregnant, four were due to IVF
(6.1%), one from IUI and one from using egg retrieval. There was one instance of twins from using
IVF, and one instance of adoption (Table 4.2). There were 11 (16.7%) interviewees who reported
having children from using assisted reproductive technology. Many of the participants had more
than one reason for seeking infertility services, especially those who had some form of diagnosed
or unexplained infertility. Primary reasons for those actively seeking infertility services were
unexplained infertility (27.3%) and female factor (25.8%), and the secondary reasons for seeking
services were reversed, with female factor at 6.1% and unexplained infertility at 3%. There were
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also other non-infertility related reasons, such as being in a same-sex relationship (10.6%),
infertility due to cancer (4.6%), and avoidance of transgenerational inheritance of recessive genes
(1.5%).

Research Question 2: Aspects of travel
R2: What influence does geographic location have on access to infertility services?
Survey. There are seven survey questions related to travel for infertility services. These
questions inquire about instances of, or intentions to, travel either domestically or internationally
to access infertility services. The questions also inquire into reasons for and where persons want
to travel to seek services.
When asked about inter-state travel, the majority of respondents indicated they have not
and do not intend to move out of state to access infertility services (90.3%), while nine (6.7%)
indicated they are considering moving out of state, 3 (2.2%) indicated actually moving out of state,
and 1 (0.75%) indicated traveling out of state for services, but did not move residence (Table 4.16).
When asked about potential reasons for traveling out of state to access infertility services to access
better services, 94% indicated having not and not intending to move out of state to access a better
physician or fertility clinic, while three respondents (2.2%) moved out of state to access better
services, and four respondents (3%) are considering moving out of state to access better services
(Table 4.17).
When asked about instances or intentions to travel internationally for infertility services,
83% indicated they have not and do not intend to travel internationally to access infertility services,
while 20 respondents (15%) reported considering traveling internationally, two respondents
(1.5%) traveled internationally to access infertility services, and one respondent intends to travel
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internationally (Table 4.18). For those who travelled internationally to access infertility services,
reasons were because of lower cost of services. For the person who intended to travel
internationally, the reason was specifically because of a greater availability of egg and embryo
donors, compared to the United States. The two countries identified as having been visited
specifically to use infertility services were the Republic of Georgia and Czech Republic. The
countries people indicated considering travelling to were: Republic of Georgia, Czech Republic,
Barbados, Croatia, Canada, Greece, Israel, Tunisia, Finland, Mexico, Cayman Islands, and some
were undecided.
Informal interviews. When observing the relationships between the code “Travel” and the
SCT construct codes, the code that intersects most frequently with “Travel” is “Facilitator” (Figure
4.1). This suggests that, when discussing aspects of travel, most interviewees tended to discuss
travel as a facilitating aspect of accessing infertility services. Within the discourse related to
“Travel”, two main themes developed: distances people travel to access infertility services; and
making clinic decisions based on travel, cost, quality of services, and restrictions based on
insurance and provider networks. In the following quotes, state’s that are bold represent states
with an infertility insurance mandate.
Distances. Distances traveled to clinics were not explicitly asked of the interviewees, but
22 (33%) reported distances traveled in minutes, one way. Distances ranged from 5 minutes to 240
minutes, and modes of transportation reported by interviewees included travel by foot, motor
vehicle, train, boat, and airplane. There were responses from persons in both state’s with and
without infertility insurance mandates that clinics were within an appropriate proximity of where
someone lives.
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“…it’s [the clinic] actually like eight blocks away or something. It’s very
convenient.” (Interview 006, Female, Caucasian, Pennsylvania)
“…it’s really only six miles, although in south Florida, that’s about 30
minutes, depending on traffic” (Interview 026, Female, Caucasian,
Florida)
“ Our office that we utilize is within our same city. It’s actually very close
to our house. We don’t drive very far” (Interview 048, Female, Louisiana)
“We’re very lucky because we live in southern California, so there’s many
clinics in our immediate area. We actually ended up going to three
different ones because we weren’t happy with the first two. So, we had a
lot of options. They were all in our same county” (Interview 052, Female,
Caucasian, California)
There were instances where distance was described as the proximity of the fertility clinic to the
person’s place of employment, rather that the proximity of the clinic to the person’s residence.
“Oh, it [clinic] was really close. It was less than five minutes from work.”
(Interview 001, Female, Caucasian, New Jersey)
“Actually, the clinic is a mile from my job. It’s just one of two in the area.”
(Interview 043, Female, Caucasian, Wisconsin)
“It’s [the clinic] actually really close by, the same campus where I work,
so a 10-minute walk from my office” (Interview 057, Caucasian, Georgia)
Clinic decisions. The rationale for selecting a clinic varied and was never just one reason.
Proximity to home and work were main drivers for clinic selection, as well as recommendations
from primary physicians or OBGYNs, and some decisions included cost of services and reputation
of the clinic or attending physician. When travel was discussed along with clinic selection, the
choice of clinic was marginally based on proximity.
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“It’s quite close. It’s a 15-minute drive. It is the only one in the city”
(Interview 024, Female, Caucasian, Virginia)
“We have a local clinic here…This is within the same city, but if I wanted
to go to any other one, I would have to leave the city roughly two hours
away” (Interview 015, Non-binary, Multiracial, Minnesota)
There were sentiments relating to the lack of other closeby clinic options that provided the full
range of services people required, and the majority of those responses was from people living in
non-mandated states.
“So, it’s in state. So, the clinic I use has a satellite office about 20 minutes
from me, but the main office where they do their more extensive
procedures is an hour away from me…So, even though there’s a location
I can drive to 20 minutes away, it’s nowhere near as well-equipped as the
main one. So, I think options are a bit limited. Of course, for people who
live closer to the metro ***** area, there’s tons of options to choose from.
But in this area, you either have to be willing to spend a lot of time in the
car or maybe opt for a clinic that’s a little less than desirable. So, that’s
been interesting” (Interview 012, Female, Caucasian, Michigan)
“We drove to ****, so there’s the University of **** has a women’s health
group, they’ve got a reproductive medicine office that does IUI, IVF, egg
and sperm freezing. So, we drove about two hours to get to those services.
And it would have been a two- or three-hour drive anywhere we needed
to go or to get to that service” (Interview 029, Female, Caucasian, Kansas)
Others reported network-imposed restrictions forcing them to use clinics within the network of the
person’s insurance provider in order to have any type of insurance coverage for infertility services.
“I live in **** and there are three clinics in the city…I have to go to the
clinic that’s affiliated with the network that I work for. It’s in the same
city but it is like an hour away. It’s not necessarily close. It was a
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significant burden to have to go there. Especially every other day for
monitoring during the IVF process…I actually ended up traveling to Texas
**** in **** and sought care from their clinic. My insurance actually did
pay for it there because they’re in network, apparently” (Interview 039,
Female, Caucasia, Pennsylvania)
“We started off at **** Fertility Clinic because I worked for ****. So,
that’s the only clinic that they [insurance] would cover, but they don’t
cover IVF. So, when we reached that point in our path and I switched onto
my husband’s insurance, we went to a private clinic that was in network
for his insurance, but also nearby, so super lucky" (Interview 016, Female,
Caucasian, North Carolina)
It is important to note that although the “Travel” code was found along with facilitating
factors more than barriers, there were instances of travel that still involved moving out of state,
traveling out of state, or traveling out of the country to access infertility services. Travel was a
facilitating factor, but only when there were financial benefits to traveling. There were three
instances where people traveled from a mandated to another mandated state; two instances of
people traveling from a mandated state to a non-mandated state; and one instance of someone
traveling from non-mandated state to non-mandated state,
“We actually do travel. We're located in Virginia, but we travel to New
York for our IVF clinic…because of the cost.” (Interview 019, Female,
Caucasian, Virginia)
“So, I found an amazing clinic up in – I was living in Florida at the time –
up in Michigan and this clinic had an amazing success rate and it happened
to be located right next to my aunt's house…So, we ended up going with
that clinic based on its success rate and the fact that I could stay at my
aunt's house next to it” (Interview 037, Female, Caucasian, Florida)
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It is also important to note that some people who lived in a mandated state still required travel to
another state to access infertility services.
“So, I was originally in Massachusetts – living in Massachusetts – and
working in Massachusetts. And that is where I started fertility treatment
and I did one. I did one embryo transfer before going to law school in
Illinois, but all my embryos were in Massachusetts and it’s kind of like
expensive to start with a new doctor and to transfer them over. So, I kept
flying back to Massachusetts” (Interview 007, Female, African American,
Illinois)
“Initially, I went in-state with the IUIs and they could not figure out what
was wrong. They did not consider me a candidate for IVF. At that point, I
moved to out-of-state services and so I traveled to Maryland, which is four
hours from my home…I did because they have a money-back guarantee,
the ‘shared risk’ program” (Interview 051, Female, Caucasian, West
Virginia)
In instances of surrogacy, travel was required if the individual or couple had residence in
a state where surrogacy was not legal, such as in New York prior to April 2020 when the couple
below were using surrogacy services,
“Yeah, I did have to go out of state. It’s [surrogacy] not legal in New York
City yet…I mean every time you have – I mean the agency can do
everything online or over the phone, Skype. For the clinic, obviously, you
have to go [out of state], yes. And since she [surrogate] was in Connecticut
not too far, I also went to meet her in person three or four times…I mean
some people they have a surrogate in Ohio or I actually was offered a
surrogate in Ohio, another one in North Carolina. So, yeah, you have to be
prepared for travel – either you or the surrogate – to the clinic, you know?”
(Interview 004, Male, Middle Eastern, New York)
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In the two instances of international travel, one of the couples lived in a state with an
infertility insurance mandate and the other lived in a non-mandated state, however their reasons
for seeking services internationally were the same: to reduce the cost. Even though health
insurance was not an issue, international travel was perceived as more cost effective,
“For the workup, like diagnostic testing, it was in the same state. So, I do
have insurance coverage for – I mean not complete coverage, but pretty
good coverage for the diagnostic tests. And my policy also covers up to
six IUIs per attempt at pregnancy. So, a lot of that was covered. But I don’t
have any coverage for IVF so we decided to travel abroad to do IVF. We
ended up flying to the Czech Republic. That’s where we did IVF”
(Interview 049, Female, Caucasian, Minnesota)
“So, I guess it wasn't strictly necessary, but I've been going to Tbilisi,
Georgia; Republic of Georgia. And part of that is the cost factor because
we're trying to keep everything under the $20,000 reimbursement… I
guess I would say the care is different in Georgia. It's a little bit more
consumer-focused, we could just pay for whatever we want. Where in the
U.S., most of the – actually we spoke to a doctor in Canada too, they really
wanna push you into one type of treatment, or they kind of have a timeline
of how you do things” (Interview 035, Female, Caucasian, California)
There were also responses from people in both mandated and non-mandated states about
considering traveling abroad to access services, including receiving medications, although those
individuals had not traveled at this point in time.
“I have looked at some of the other states. I’ve also looked at some other
countries. So, I’ve just kind of gotten a gauge for the pricing and the
success rates and stuff in different places, but no official decisions have
been made about if we’ll do any of that” (Interview 010, Male, Caucasian,
Texas)
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“I have looked into a lot of ways to pay for it. We looked into going abroad
to Greece or Prague because it’s a lot cheaper there to do IVF. But, it is a
time investment from work by taking off a lot of time. You’re kind of
putting all of your eggs in one sort of IVF basket. We have looked into a
lot of things like that and ultimately decided our local ones – although
they’re more expensive – would just be easier” (Interview 024, Female,
Caucasian, Virginia)
“I sometimes talk about going down to Mexico to get IVF, but I don't think
I’m really serious about it. But sometimes I think about it”(Interview 013,
Female, Caucasian, Arizona)
“I think if we wound up having to do this again though, we might look
into purchasing drugs internationally. Because we did some calculations
and it looks like it’s actually way cheaper to go to Mexico, like, including
the flight there to go spend a weekend to Mexico City and get medications
within Mexico and then fly back with them, and save a few thousand
dollars actually on the medication, which is wild” (Interview 057, Female,
Caucasian, Georgia)
“I'm from [North Africa], so I'm thinking about going there because it
would be cheaper and I'll have the support at home” (Interview 020,
Female, Middle Eastern, Massachusetts)
Although traveling out of state or internationally were not common occurrences, there were
responses about knowing that extensive travel was often part of people’s experiences, empathizing
with those and being thankful they were not in the same situation,
“I know plenty of people who had to do crazy amounts of travel and I was
very thankful that I was not one of those” (Interview 001, Female,
Caucasian, New Jersey)
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“So, travel, I mean we had to travel across the city, but we were not
traveling out of state like other people have. But I feel like we’re pretty
lucky because I do know that people do travel out of state to come to this
doctor” (Interview 003, Female, Caucasian, Colorado)
“I think that it is becoming a larger trend for people to travel for IVF
because of different costs, which is really unfortunate because it's
becoming more common” (Interview 019, Female, Caucasian, Virginia)
Expert interviews. The knowledge of travel being a requirement for some people who are
seeking infertility services was also mentioned in the expert interviews, where some
representatives gave examples of patients they came across where some went to the extent of
changing residences or jobs in order to get better access to infertility services,
“And there are patients that will literally leave their state, or leave their
job, or go wherever they have to go to either get a job that offers access
care or to go to a state that will give them access to care” (IntegraMed,
MSA crisis management company)
Based on the responses from the survey, informal interviews, and expert interviews, the
influence of travel on infertility services can be described as a facilitative nuisance. Few people
reported wanting to travel, or thinking about travel for infertility services, however qualitative
responses express travel is a common requirement for people using these services – even if it was
not experienced by them. Interestingly, “Travel” was never coded along with “Expectations” or
any associated outcomes, as evidenced by the lack of lines connecting “Travel” to “Expectations”
or “Outcomes” in the Code Map (Figure 4.1). Travel was, however, distantly linked with “Selfefficacy” and “Behavioral Capability”, suggesting that when participants discussed self-efficacy
or exhibited behavioral capability to access infertility services, it was rarely related to travel
associated with infertility services.
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The decision to travel for infertility services can be forced due to environmental
restrictions, such as when the required services are either not offered in the area, illegal in the state,
or there are not any fertility clinics nearby that are in network. Also, it can be voluntary, albeit
based on the desire to reduce the high financial burden and have behavioral capability to identify
methods to circumvent high costs.

Research Question 3: Influence of residence
R3: What influence does living in a state with mandated insurance have on access to
infertility services?
Survey. There were two questions related to residence in this survey (Appendix B). There
are 32 states represented in this research. Of those 32, 13 (40.1%) have an infertility insurance
mandate (Table 4.19). When asked if their state of residence is the same state in which they access
infertility services, 88.3% responded “Yes”, and 11.7% (n=15) responded “No” (Table 4.20).
There were 12 states identified by those who responded “No”, and 8 of those 13 (67%) were states
that have an infertility insurance mandate – meaning 67% of the people who accessed infertility
services in a state other than their state of residence did so in a state that had an infertility insurance
mandate (Table 4.21).
Health insurance coverage. There were seven questions related to health insurance and the
knowledge of an infertility insurance mandate in the respondent’s state of residence (Appendix B).
When asked whether their state of residence had in infertility insurance mandate, 48.5% responded
“No”, 38.1% responded “Yes”, and 13.4% reported being unsure (Table 4.22). Of those who
responded “Yes”, 47% were not able to apply the state-mandated infertility insurance to their
situation, 20.4% were able to apply the mandate and have 100% of infertility-related expenses
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covered, and 32.6% were able to have partial coverage from the mandate (Table 4.23). This means
that 47% of people who accessed infertility services in a state with an infertility insurance mandate
were disqualified from accessing that mandate for one reason or another.
When asked about their health insurance status, 86% reported being covered by private
insurance (without Medigap) either individually or through their employer (Table 4.24). When
asked about the presence of private health insurance specifically for infertility services, 41.8% said
“Yes”, and 41.8% said “No”, while 10 responded “Not Sure” and 12 indicated that while they do
not have that coverage on their health insurance, their partner’s insurance does have that coverage
(6%) (Table 4.25). When asked about the presence of employer coverage for infertility services,
50% responded “Yes” 40% responded “No”, and 6% indicated that while their employer does not,
their partner’s employer does (Table 4.26). When asked about the presence of any health insurance
that specifically covers infertility services, 52.2% responded “Yes” s (Table 4.27). There were 17
different providers who provided infertility insurance coverage, but the most frequent were
BlueCross/BlueShield (n=14), Aetna (n=13), and United Healthcare (n=10). There were also three
entities that were insurance or loan companies that offered financial options specifically for
infertility coverage: Progyny (n=5), WINFertility (n=1) and Freedom Fertility (n=1) (Table 4.28).
Informal interviews. The overarching narrative surrounding the use of infertility
insurance mandates is that if you live in a state with an infertility insurance mandate, you will have
greater access to coverage. However, this research found such an assumption to be false. Data from
these interviews suggest that living in a state with an infertility insurance mandate will only benefit
you if you meet certain requirements. There were two major themes that developed based on the
influence of residence on access to infertility services: role of the employer, highlighting instances
where it was the employer that influenced the approval or denial of infertility services and
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applicability of the state’s infertility insurance mandate; and perception of the mandate, which
were unsolicited reflections about the infertility insurance mandates. Based on review of the
frequency of the coded segments in each document using the Code Relations Browser in
MaxQDA, both the employer and infertility insurance mandates are described as barriers more
often than facilitators (Figure 4.2).
Role of the employer. Employers were discussed as both facilitators and barriers in
accessing infertility services, and that pattern existed in states both with and without infertility
insurance mandates. The code map showing the relationship between the codes employer,
mandate, and the SCT constructs in Figure 4.3 shows that employers are described more as barriers
than facilitators, and that the infertility insurance mandates are discussed more along with barriers
and also with employers. The most striking barrier had to do with both the employer and the
infertility insurance mandate, where either residents in mandated states would be disqualified from
accessing their state’s mandate because their employers’ headquarters is based in a non-mandated
state, or people in non-mandated states would still be disqualified from accessing the mandate
coverage in the state of their employer’s headquarters,
“So, we live in Massachusetts where there is a mandate, however, I work
in New Hampshire, and my husband works in Massachusetts for an
employer that is self-insured. So, from May of 2018 when we got our –
when we got the azoospermia diagnosis up until January 1, 2020, we were
entirely out-of-pocket. New Hampshire passed their fertility mandate that
went into effect on January 1st of this year and my employer was subject
to the mandate, so they are now offering coverage.” (059, Female,
Caucasian, Massachusetts)
“I guess Texas has one of the lower types of mandates as far as fees go.
They just say that they have to offer infertility coverage on insurance
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plans. My company is based in California, so they don’t have to obey that
law. They are also self-insured, which is a way that they don’t have to
offer it. My husband works for a religious employer, so I think they choose
not to offer it” (063, Female, Caucasia, Texas)
“The company that my husband works for is actually based out of New
York, but they are independently insured, so they don't have to follow the
state mandate” (019, Female, Caucasian, Virginia)
However, the same type of residence loopholes that disqualified some people, also qualified others.
“When we originally started pursuing this we were living in Washington,
D.C. We’ve since moved to Maryland but it’s still in the Washington
metropolitan area. It’s [husband’s employer] actually a really small
company. And I think that we’re in a little bit of a loophole because his
company is based in Massachusetts. They have a satellite office here in
D.C. And I think because it’s based in Massachusetts, that’s why we have
the mandated infertility coverage” (050, Female, Caucasian, Maryland)
“So, we dropped my employer coverage and I got on my husband’s
employer coverage because his company is based in California and
therefore IUI coverage is required by law” (031, Female, Caucasian,
Florida)
In yet another example, a couple living in New York was getting insurance from the employer
based in New Jersey, but when the company changed, their insurance fell under the New York
mandate – which did not offer as much coverage as the New Jersey mandate,
“So, we briefly went to another clinic because we had this New Jersey
insurance that a lot of New York clinics didn’t take, and we found one that
did. We did one IUI there and it was unsuccessful. Then, our insurance
changed so we unfortunately found out that we no longer had any
coverage. Because when it was a New Jersey insurance, New Jersey is a
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mandated state. They covered up to four rounds of IVF. We lost that when
our insurance switched to New York insurance. And then even though
New York is now a mandated state, we work for companies that don’t
qualify for the mandate because they are less than 100 employees for New
York state” (038, Female, Caucasian, New York)
There were also barriers related to the type of insurer the employer had due to being selfinsured and small companies under 100-500 employees (depending on the state) being exempt
from the majority of the infertility insurance mandates.
“I live in New Jersey – which is a state mandated state – but there’s the
loopholes. So, my employer who provides my insurance is a self-insurer
and is therefore exempt from having to cover infertility treatments.
(Interview 001, Female, Caucasian, New Jersey)
“The company that my husband works for is actually based out of New
York, but they are independently insured, so they don't have to follow the
state mandate” (019, Female, Caucasian, Virginia)
“It’s out of New York. But unfortunately, it’s a very small company so all
of the mandates that were recently introduced in terms of fertility and
coverage do not apply to my company because it’s such a small
organization” (042, Female, Caucasian, New Jersey)
“And then even though New York is now a mandated state, we work for
companies that don’t qualify for the mandate because they are less than
100 employees for New York state” (Int 038, Female, Caucasia, New
York)
“We work for a pretty small company. They are I feel like our insurance
plan is pretty barebones. Our plan’s kind of vague. It says, “Oh, some
infertility benefits are covered.” But then when you go and actually talk to
them or you know get more in detail about it, you find that most of the
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things after diagnostics are not covered at all. Some of the diagnostics stuff
is also not covered, so pretty limited in scope” (010, Male, Caucasian,
Texas)
“Originally, how we had New Jersey state insurance even though we lived
in New York and then losing that was a pretty unique experience. Going
into this process thinking ‘We were gonna have four rounds covered’, and
then because of job change or a company being spun off basically losing
that coverage. Then having the hope that we were gonna be able to qualify
for the New York mandate and then finding out that the mandate doesn’t
apply to us because we work for small companies and our company
doesn’t have to opt into the mandate. So, that was kind of painful” (038,
Female, Caucasian, New York)
Decisions made by employers were among the barriers to accessing infertility services.
There was one instance where an interviewee explained a situation where both her and her
husband’s employers had the opportunity to apply a new infertility insurance mandate in New
York, but they opted not to based on the self-insure opt out – even though the husband’s employer
was in the medical field. In this case, the decision to not add infertility services is based on a
financial barrier perceived by the employer.
“So, we’re in New York state…And we were waiting to see if either of
our companies, because they are both headquartered in New York, would
adhere to the law, but because they are self-insured companies, they didn’t
choose to add that fertility coverage…we were working with a rewards
reinvention program for my work with our benefits team, and I did find
out that in order for my company to add the IVF coverage, it would have
been a total of $1,500.00 for each in the organization. But I think there
was just a fear of – what I was told, which is kind of disheartening to hear,
is that they would have to then pay for more people. If they paid for the
IVF coverage, then more people would be getting pregnant, and then
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they’d end up having to pay for more maternity leave and more services
like that. And even my husband’s – he works for a health system here.
And the president is a reproductive endocrinologist, but they decided not
to opt in this year, either” (017, Female, Caucasian, New York)
And in another situation, the employer decision was to remove infertility coverage while a couple
was still using them, which cost them financially,
“I don't know exactly how this works. But he [employer] decided that
infertility no longer count towards out of pocket maximum. So, we had hit
our out of pocket maximum, and that should have meant that the second
cycle was essentially covered 100%, but because my husband’s company
just decided, and with no warming, we no longer could count towards out
of pocket max. And so, we were suddenly stuck once again paying 50%.
So, that decision cost us personally at least $10,000.00” (028, Female,
Caucasian, California)
In the instances where employer-based insurance policies included infertility services, the
knowledge that infertility benefits existed through the place of employment was at times not
known – and almost missed out on.
“We weren't aware that there's a separate infertility group. So, on my plan,
it says like you have a $100,000 maximum for fertility benefits. And it
was like "Oh, cool. That's really amazing and really good." But I didn't
realize there was a separate group within the insurance that you had to
contact first. And so, the short version is it was almost not covered, but
they let me slide because I didn't know” (018, Female, Caucasian, Illinois)
“The big thing for me in all of this was that I found it very frustrating to
know that my insurance changed in I want to say June of 2018. And we
were told at the time that there were no major changes to it. I want to say
it was like three or four months later, I happen to call my insurance about
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something else and the customer service rep was the one to tell me that I
had practically full benefits. And so, I guess it was a little – on one hand
I'm grateful that I do have this coverage from my employer, but I really
think that the employer did not do a good job in rolling out. And obviously
when you're older, time is of the essence” (054, Female, Caucasian, New
Jersey)
“My husband’s company originally did not offer insurance at all – fertility
coverage. They were exempt from the mandate because they had an office
of less than 50 people. The office grew within two years to about I guess
75 and so they were then required to offer it” (007, Female, African
American, Illinois)
Besides the presence or absence of an infertility insurance mandate, employer flexibility
was a facilitative factor for some people because of the need to go to frequent appointments
required for some services that also follow strict scheduling and cannot be missed, and at times
need to be scheduled with short notice.
“I have a very flexible work schedule, so if I have to go in an hour late, I
just stay an hour late and it's not a big deal. So, I still get paid. I just kind
of shuffle my work hours around accordingly” (021, Female, Caucasian,
Colorado)
“I have a lot of flexibility with my job. I’m able to be honest with my boss
and tell her I’m gonna be a little late because I have an appointment. When
I have to go into the clinic for monitoring and stuff, which is two times a
cycle, their hours for monitoring are 7:00 a.m. to 8:30 a.m. It makes for a
long day. But, I’m able to go and still get to work on time. (027, Female,
Caucasian, New York)
“The biggest problem is that you usually don’t know until last minute
when they’re gonna be. So, it’s hard to plan around. But I’m fortunate in
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that my company is pretty understanding. I’ve worked there for almost
five years” (042, Female, Caucasian, New Jersey)
“Well, my dad is my boss. I’m his only employee. He’s pretty forgiving
about when I need to go places. He understands that I’ve gotta do what
I’ve gotta do. I have a pretty unique situation” (062, Female, Caucasian,
Iowa)
There was an instance where it was the type of work and associated early schedule that would
make going to appointments difficult at times.
“Because I work within the hospital system, I have very early hours as
well. So, even like a 7:00 a.m. appointment means going in late to work.
So, that makes it a lot harder” (032, Female, Asia, New York)
There were some instances where people described examples of trying to work with
employers to cover infertility services. In some cases, the advocacy for those services worked, but
in other instances they were not successful.
“My husband started this job at this small company and their insurance
was really bad at first. And so, he tried to work with his boss to get better
insurance going on. And it’s this weird thing…you usually offer a couple
plan options to your employees, and if you offer one plan with infertility,
then all the other plans have to have infertility coverage. And it does bump
up the cost of the plan significantly. And so, it’s this weird thing of my
husband couldn’t ask for a plan that we might have been able to utilize
because it would have forced everyone else to pay $100.00 more a month
so that he could have the option” (028, Female, Caucasian, California)
“I did send an email to my HR department saying that I thought they
should cover it you know kind of laying out some heuristic arguments,
policy arguments, and they did not change their policy” (033, Female,
Caucasian, Michigan)
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“At my new job, it's just something that they, unfortunately there is kind
of some loopholes that they can say that infertility treatment doesn't, they
are allowed to find a loophole to get out of FMLA or any kind of medical
leave that you would need to take. So, it was discussed, and ultimately, I
think was up to the company, and they were able to find a way to make
me use my own personal time” (019, Female, Caucasian, Virginia)
“And all through 2019 anytime my company had – I work for a health care
company – anytime they had any surveys asking how they were doing; I
would use a little bit of a template and then my own research from the
RESOLVE webpage advocating that they cover it. And they did up their
coverage” (053, Female, Caucasian, Minnesota)
One person described an instance where her employer was about to remove infertility benefits, but
since she knew people in her company’s HR department, she was able to get them to keep the
benefits before they completely removed them.
“The funny part was I'm actually close with a few people are in our HR
department. And I let them know that I discovered this [full infertility
coverage] and that they hadn't rolled it out properly. They were in the
midst of trying to remove that benefit – because they had thought that no
one had caught on. And so, when they were told that I had done a round
of IVF by that point, they decided to keep it as part of our benefits for this
year 2019. And so, when they had the open enrollment session and they
were announcing the benefits and the changes since like from last time,
they had to underscore not only the fact that we had full fertility coverage,
but also they had to talk about the mandate the New York state mandate
from I guess this year. So, they did eventually come around to announcing
it properly but something like someone made a mistake. I don't know if it
was intentional or if it was like truly an oversight, but it was not handled
properly” (054, Female, Caucasian, New Jersey)
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For people who worked in the federal government or military, fertility benefits were
variable but mainly consisted of diagnostic coverage and initial IUIs, but nothing beyond those
services – which were often the most expensive.
“I work for the federal government, so I have insurance through my
employer. That covers 50% of diagnostic for infertility and then it covers
50% of IUIs and then my Tricare insurance they cover 100% of diagnostic,
but they don’t cover any infertility services. If they’re treating the
infertility, then it’s no” (008, Female, African American, Maryland)
“I wish I had known a little bit better when I was picking coverage and
plans because you get a pretty wide variety of plans to choose from with
the federal government when we had open season. When we had open
season, I was at the point where I thought I wanted to try to find a plan
that has some kind of better fertility coverage. Looking back, I think I
would consider changing plans the next open season because of it being
pretty limited. It would definitely make a difference” (023, Female,
Caucasian, Texas)
“I’m dual insured. My primary insurance does not cover anything
infertility related. My secondary insurance is Tricare. They cover
diagnostics. The clinic that we’re going to now is in-network with Tricare
for diagnostic. That was enough of a reason for us to go with them. Tricare
is not covering the IUI now, but they did cover everything up until this
point. (062, Female, Caucasian, Iowa)
Perception of the infertility insurance mandates. The most prominent aspect about
sentiments regarding the infertility insurance mandates were the differences in expressed selfefficacy and behavioral capability related to the use of these mandates between people living in
mandated vs non-mandated states. There were some instances where people had to argue with
clinics and insurance companies to apply the mandated coverage to their situation, where
142

sometimes it was due to the experimental nature of some procedures. Other times it was an issue
of the organization not being up to date on the current infertility insurance mandates they need
abide by. In these instances, the individuals displayed a high degree of self-efficacy and behavioral
capability to preserve through the red tape. To observe the relationship between mentions of the
infertility insurance mandate and expressions of self-efficacy and behavioral capability, code maps
were created for people living in mandated (Figure 4.4) and non-mandated states (Figure 4.5).
Both of these code maps show the relationship between the codes “Mandate”, “SelfEfficacy”, and “Behavioral Capability” but their co-occurrence in the interview between people in
mandated and non-mandated states show they are not discussed in the same ways. In mandated
states, talk related to the infertility insurance mandates co-occur along with statements coded as
self-efficacy and behavioral capability (Figure 4.4). However, in non-mandated states there are
fewer mentions of the mandate and none of those mentions co-occur with self-efficacy or
behavioral capability (Figure 4.5). This shows that the mandates that exist are not cut-and-dry
applications to every situation. There are times where people must fight for their coverage, even
when it is being mandated to be covered or offered.
This example shows how doctors’ offices are not always up to date on what infertility
services will and will not be covered. It is then left to the patient to go through their often-vague
insurance policy and then follow up with the insurance company before going through certain
procedures due to the high cost and necessity of coverage.
“We a couple times have had to even some tests done and we were told by
our doctor, ‘Hey, yeah, it looks like you’re covered’ and then we get a bill
for it later and we’re like, ‘Uh, I thought this was covered’ and they’re like,
‘Oh, actually sorry, no. It wasn’t.’ I’ve had to kind of go into the insurance
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plans and try to read as much fine print and then – when it’s not listed or
not clear – I’ll call and ask before we do any of that” (010, Male,
Caucasian, Texas)
In a similar example, a woman working for the federal government and living in a
mandated state needed to have preimplantation genetic testing for Sickle Cell, and although the
information on the lab’s website said that procedure was covered, she kept being denied. Through
her own education in law, she was able to get the procedure covered.
“The weirdest thing about going through this entire process was that – at
some point – it seemed that the insurance companies were less aware of
the requirements of the mandates than I was and that happened fairly often.
I actually had to report the lab testing company that did my PGT testing
to the Board of Massachusetts Health Insurance because they just refused
to bill my insurance or go through them, even though they had a contract
with each other. I eventually got the PGT testing covered, but it took a
year and a half and it actually only got covered because I went to law
school and I found out who I needed to contact in order to get it through”
(007, Female, African American, Illinois)
The infertility insurance mandates often disqualified people from accessing services.
Disqualifications often centered around the need for a diagnosis of infertility, which at times
disqualified people who were single and those in same sex relationships when there was not an
infertility related issue, or required them to use more services than are needed in order to qualify
for their state’s insurance coverage,
“So, for 2014 and I want to say 2017, it did say that there was an infertility
mandate if I'm not mistaken. However, because the caveat to that was, I
needed to have some something wrong with me and I needed to be female.
I needed to have problems carrying a child holding a child or conceiving
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a child. Unfortunately, with two men, that doesn't, you know, there are no
problems unless there's something wrong with the sperm” (044, Male,
Hispanic, New York)
“Yeah, so, Colorado’s talking about a law that would mandate infertility
coverage and one of the questions I have about it is ‘Is this gonna cover
queer people?’ Because one of the things that happens is that a lot of times
there will be a requirement that you have to try for a year or six months or
whatever it is, depending on your age. And so, typically for straight people
you go in and say, ‘I’ve been trying’ And often for a same-sex couple
they’ll end up requiring medicated IUIs monitored by a doctor. Which
basically means your spending $12,000.00 in the first year trying to get
pregnant, possibly more if you’re buying sperm. So, you’re spending
$12,000.00 on medical intervention before you’re even eligible for IVF or
for the fertility coverage that you’re supposed to get” (061, Female,
Caucasia, Colorado)
Some instances were not necessarily disqualifications, but rather limited coverage, vague verbiage
in the insurance policies and descriptions of the mandates, or a lack of insurance companies and
clinic personnel updating their policies as the new infertility mandates are passed.
“When we were first starting, I just started googling, just to see what, as a
state – to see if there were any mandates or any – I don’t know – and then
I also looked at my actual insurance policy to see what was covered, what
was excluded. Louisiana is one of the mandated states. However, it doesn’t
mandate coverage of treatment. It only states that a person cannot be
denied coverage, I guess, as a pre-existing condition. That was not easy to
see online because Louisiana is in the list of pretty much every website
that lists mandated fertility coverage for states, but it actually does not
cover very much at all. I don’t think it’s very specific to our unique case,
where we’re not actually a mandated state for treatment coverage. That is
difficult, I think, if someone was just starting out and they were looking
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they would, maybe, misinterpret that information to mean that they would
have the coverage in this state and that’s just not the case” (48, Female,
Caucasian, Louisiana)
“So, it [New York mandate] changed in 2018, but insurance didn’t actually
update their policy online or anywhere. So, even though it was supposed
to be covered it took me talking to my infertility services nurse trying to
figure out what the hell I could do to try to cobble together some coverage
because I knew was running out of time and I needed to access services
that I didn’t have $3,000 to pay out of pocket for each round, and it took
three rounds of IVF to get any viable embryos. She literally found a piece
of paper that had the updated 2018 policy. This was just a piece of paper,
a single piece of paper that had this policy change on it and that wasn’t
updated anywhere internally. That was in, I think, like April of that year.
So, we had gone four months of having this coverage with insurance just
whoopsie forgetting to update it everywhere. Like they didn’t update it
online, they didn’t update it in their own system. You cannot make this
shit up” (011, Female, Caucasian, New York)
Residence continued to be an issue, where people living in mandated states were not able
to access the fertility benefits of that state’s mandate because their employer was located in a
different state or territory,
“Yeah. I find it really frustrating that I pay taxes in Maryland and I don’t
get the benefit of Maryland’s infertility mandate. It’s very frustrating that
my life is being dictated by insurance companies. And, I’m trying to figure
out if my work will let me become a remote employee from Maryland, and
whether or not I can scam some coverage that way. But, it’s fairly crazy
making” (056, Female, Caucasian, Maryland)
“I am pretty well-informed person on these kinds of things, but I just
assumed if there was a mandate that we have coverage because my
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husband worked in Massachusetts. I didn’t know how many loopholes
there were and that was probably the most frustrating thing for us related
to it” (059, Female, Caucasian, Massachusetts)
There were, however, some instances where people were able to apply the mandate of their state
to their situation after deductibles were met, or assumed that they would be able to have services
covered after their deductible was met based on conversations with financial counselors or by
reading their respective policies.
“We live in Massachusetts, which is one of the mandated states. So, we're
lucky for that, as well as coverage infertility diagnosis and services, and
treatment. We have a $1000 deductible, so for now, we've been paying
towards that. But after, it's gonna cover everything” (020, Female, Middle
Eastern, Massachusetts)
“My company was one of the companies that meets the criteria, that they
have to have the coverage. I work in benefits administration for the HMO
that I have. I kind of have a little more knowledge of exactly what’s
covered and why and things like that. Illinois essentially covers for women
who meet the criteria for infertility for egg retrievals or the policy in the
life science. We were very lucky to have that. We still had deductibles and
things like that. But, the IVF and all that were covered” (025, Female,
Caucasian, Illinois)
“I’m not sure if IVF will be covered. It seems the way the law is written
that it should be. Yeah, that’s one of those things that I figured I’ll ask
once we get there. I know last year that it would’ve been covered up to
$10,000 for IVF. And, anything else would’ve been out-of-pocket for us.
When I first read into our insurance, I didn’t realize that [insurance treats
IUI differently than IVF]. I was really nervous. But we sat down with the
financial coordinator. They told us that the IUI is completely covered by
our insurance. There aren’t caps on how many IUIs we can have. We don’t
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have to have an IUI before going to IVF” (027, Female, Caucasian, New
York)
Some perceptions of the mandates took the form of frustration with the unequal attention
that infertility receives when politicians discuss healthcare coverage for reproductive health, often
focusing on contraception and abortion – methods to circumvent having children – while infertility
services are rarely discussed.
“I work in politics and I’m excited to hear about how everyone’s going to
fix health care. But it’s been frustrating to not hear anyone talk about this
at all, like this isn’t healthcare. And, folks keep calling it “elective,” as if
this is something I chose for myself, which has been infuriating. Everyone
talks about one side of choice, but there’s a whole other side of, “I would
very much like to start a family,” and I cannot. I have no choice right now”
(056, Female, Caucasian, Maryland)
“Well and the sad thing is, too, actually, when they were first devising the
Affordable Care Act, that my understanding was that they were intending
to have in there more fertility benefits. But that got was one of the things
that got on the chopping block” (053, Female, Caucasian, Minnesota)
Expert interviews. There were confirmations from four of the expert interviews regarding
the applicability of a state-based infertility insurance mandate being denied based on a person’s
employer headquarters or main office being located in a non-mandated state. In two of those
instances, the scenario was posed to them and they responded in affirmation that they experienced
that type of situation with some patients, and the other two brought it up organically as they were
explaining the services their organization provides.
“I think that at some point legislation will change, and maybe it'll become
more specific to where the patient lives. But at this point, it's depending
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on where the business is at” (IntegraMed, MSA crisis management
company)
“Correct. Correct. What we run into is the fact that some insurances won't
cross state lines…when the employer base is in New York, but the baby's
going to be born in, you know, Texas. But the baby would have no
coverage in Texas, and that's, you know, a hard concept for people to
understand” (ART Risk Solutions, Financial insurance solutions
company)
In response to the research question “What influence does living in a state with mandated
insurance have on access to infertility services?”, the main synopsis is that personal residence is
often negligible, and in fact what is most influential are two aspects about one’s employer: 1)
employer headquarter residence, and 2) decisions the employer makes about what types of health
insurance are available. This conclusion is based on the evidence from both informal and expert
interviews that the way insurance companies interpret “residence” is not necessarily the same way
that residence is interpreted in the infertility insurance mandates, and that even in non-mandated
states, if the employer has infertility benefits then the employees can access those infertility
insurance benefits.
There were more examples of how the existing infertility insurance mandates were not able
to be applied to people’s situations than examples of successful use of the infertility insurance
mandates. Even in the presence of accessing those insurance benefits, there were examples of
interstate and international travel specifically to reduce the cost of services. A common theme was
that mandated coverage would only extend to diagnostic services, but when an intervention was
required there was limited to no coverage, requiring people to sacrifice house savings, all savings,
dig into health savings accounts, get creative with credit card balance transfers, or apply for types
of loans they may be eligible for and also have the credit for approval.
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Research Question 4: Role of Organizations
R4: What are the roles of specialized infertility specific insurance or other financial aid
organizations in increasing access to infertility services in the United States?
Survey. Another financial aspect missing from the literature are the uses of the various
grant and scholarship programs to support an individual or couple with their infertility expenses.
To observe the use of those services, there are two questions related to the knowledge and use of
scholarships or grants for infertility services. Two of the organizations who provide these services
are among the “expert interview” sources in this research. When asked if they heard of grants or
scholarships that provide financial assistance for infertility services, 70.1% responded “Yes” they
have heard of them. When asked if they ever applied for and received a grant or scholarship, five
received one (5.3%), 16 applied for but did not receive a grant or scholarship (16.8%), and 77.9%
said they never applied for either a grant or scholarship.
Informal interviews. There were a total of six different fertility specific insurance, grant,
or financing organizations utilized among the interviewees. These included Progyny (n=5),
Freedom Fertility (n=3), Baby Quest Foundation (n=2), Walgreens Specialty Pharmacy (n=1),
ArcFertility (n=1), and Prosper Healthcare Lending (n=1). Two of these organizations are
represented in the expert interviews (Progyny and Baby Quest Foundation). A lexical search in
MaxQDA allowed for these organizations to be searched among the corpus of documents, and then
allows the user to create a de novo code based on those search hits. After reviewing the search hits
for these organization names to confirm their context, the code map was generated with the code
“Organizations”, representing the named insurance, financial, or non-profit organizations used by
the interviewees. Figure 4.6 shows the code map of the frequency of instances these organizations
were discussed and observes them based on their co-occurrence with SCT constructs. Based on
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the code map lines connecting to the code “Organizations”, these organizations are discussed
directly along with (in order of proximity): “Self-Efficacy”, “Facilitator”, “Environmental”,
“Behavioral Capability”, and “Barrier”. The organizations are coded along with “Facilitator” more
than “Barrier,” suggesting that those who had something to say about these organizations
expressed facilitative experiences that helped them access infertility services.
The interactions with these organizations were described as largely facilitative in terms of
how people expressed their ability to access infertility services by these organization. Some of
these organizations were described as facilitative specifically to cover medications, as some of
these them were specialty pharmacies that offer discounts on certain medications, such as the
Compassionate Care Program through Freedom Fertility,
“I applied for the Compassionate Care Program, which gives a discount
on some medications for people who don’t have insurance coverage. So, I
did get a discount on my meds through that. I used it with Freedom
Fertility, which is the name of a pharmacy where you can order the
medications over the phone and they mail them to you” (Interview 012,
Female, Caucasian, Michigan)
The variability of cost for the same medication at different pharmacies of the same company
caused some concern. In one description, there were pharmacy locations of the same company that
had variable prices for the same medication. This was concerning when it was required that
medication be purchased from a particular pharmacy based on one’s insurance.
“So, the other thing that we found out that was surprising that I didn't really
realize was how the cost of medications even if you're paying out-ofpocket how they can vary so much from one pharmacy to another. So, for
example, there's a pharmacy in **** that has those discounted
medications. The Walgreens in **** or **** or any of those nearby cities,
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their prices are higher. So, I didn't realize that prices could vary even
between one location to another, even if it's the same company” (053,
Female, Caucasian, Minnesota)
There was one instance where a person was told it would be four times cheaper to purchase
medications through a specialty pharmacy than through the pharmacy her insurance uses, which
she did. She did not regret the decision due to needing multiple attempts at IVF that included those
medications.
“So, we chose to pay for all the medication out-of-pocket. So, it
technically would have been covered but we were advised that the price
of the medication would have been like four or five times higher than it
would have been out-of-pocket. So, we would have used up our – the
lifetime benefit of the $25,000.00 really quickly, so we chose to pay for
the medication out-of-pocket, which I’m glad we did, because if we only
needed one IVF cycle, it would have been fine, but now that we’re going
into our second cycle now, I’m glad we saved that benefit. I’ve heard that
from other people too, that Aetna would require a CVS Caremark and it’s
just a lot more expensive through CVS than it is through the specialty
pharmacy that we use” (057, Female, Caucasia, Georgia)
GoodRx was brought up once, and it was used to specifically reduce the cost of medications
not covered by health insurance.
“Since insurance did not cover treatment, they wouldn't cover that
medication, so I used a prescription saving program, GoodRx, to help cut
the cost on the prescriptions. I didn't know I could do it for the first round.
So, for the second round I cut the cost about in half for the pills. The
trigger, which is an injection, went to a specific pharmacy that they're excontracted with, so that stayed the same, but the other portion was
significantly lower” (066, Female, Caucasian, Texas)
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The two individuals who received the Baby Quest grant reported still needed to use out of
pocket savings for things such as lawyer fees since they were using surrogates, but the grant
money was able to reduce some of the cost related to clinic fees.
“…through Baby Quest – I had a small grant. Then that helped a little bit.
It was $10,000.00 (Interview 004, Male, Middle Eastern, New York)
“We applied for the Baby Quest Grant and were approved. We got the
grant for like $8,000. And then the rest of the money was out of pocket
savings that we had for the process. The lawyer was partially covered, but
most of it [grant] was just for the clinic” (Interview 044, Male, Hispanic,
New York)
An unanticipated organizational facilitator and barrier that came up in these interviews was
the use of medical coding for medications, surgeries, bloodwork and general doctor visits for
health insurance claims. Sometimes, medical recoding was successful in “tricking” insurance to
approve a medication or doctor visit. In other instances, the recoding was not successful, or the
interviewees were just experiencing the denial of medications, bloodwork, or doctor visits that
were previously covered, but not when they started using IVF.
In the instance of medical coding of doctor visits, it was explained that physicians will
input a Current Procedural Terminology (CPT) code in the patient’s file, and that code is what
insurance companies use to determine if the visit will be covered by the patient’s health insurance.
In this example, the woman had difficulty determining whether to disclose all of her medical
history with her physician, or not mention the use of infertility services as to avoid the physician
coding the visit as a fertility related consultation.
“When I go to see my regular doctor just for regular human stuff, not
reproductive stuff, often the doctors will ask you questions, ‘Oh I see
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you're taking this drug’ for whatever. And then I'm like, ‘Yeah we're doing
fertility stuff’ And then they start asking you questions about it. And then
once they ask you questions about it, then they probably put in their notes,
"Oh, talked to the patent about whatever." And then when it comes to
putting the CPT code, they end up putting something like ‘preconception
counseling’ or ‘fertility counseling’ or something like that. And then a
regular insurance doesn't cover it. And you're just put in this position
where you have to tell the doctor, ‘I don't wanna talk about that with you’
Or something just to make sure my normal office visit is going to be
covered” (035, Female, Caucasian, California)
Medications, surgeries, and bloodwork are similar in that they require physicians to code
them based on the treatment the medication is for, or the reason for the surgery or bloodwork. In
some cases, the infertility=related medication or bloodwork could also be used for other types of
diseases that tend to be covered by most insurance.
“Both **** and my prior clinic will try to code everything they can
differently to try to get it covered. There’s also a tendency to prefer
Letrozole for ovulation induction over Clomid for ovulation induction –
both for medical reasons and because Letrozole is a cancer drug and
therefore is almost always covered” (031, Female, Caucasian, Florida)
“I visit a local clinic, and they’ll do like bloodwork and exams a couple
times a week sometimes. My clinic will code those so that they’re not
related to IVF so that my insurance will then cover them. They code them
as ovarian disfunction which is something that most insurances cover. I’m
not sure if that’s what it’s actually supposed to be coded as but I’ve heard
people talking about asking for it to be coded that way so that their
insurance will cover it” (042, Female, Caucasian, New Jersey)
“My doctor does – I don’t know if it’s creative medical coding but I know
for some of the medications it’s not sent to the pharmacist as infertility. It
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will be sent under endocrine disorder or I forget the other term that he
used, so that insurance would cover it. That has worked for some of the
medications. They understand and I think that they are able to, I guess, get
creative with their medical coding” (048, Female, Caucasian, Louisiana)
“So, our doctor actually was able to code things in certain ways so that it
would be covered. For example, she coded my surgery so that it was for
dysmenorrhea versus female infertility, which then we were able to apply
the cost of that surgery to our deductible” (030, Female, Caucasian,
Florida)
There was one instance where the person mentioned it was the insurance company, not
clinic, that provided the medical recoding because they were knowledgeable of the fact that
Lupron, a medication used for IVF, was also a cancer drug and therefore eligible.
“For example, Lupron is one medication that I’ve had to take that was
covered by our insurance because it could also be used for something else
that was non-IVF related. Like I was basically told it was also a cancer
drug and that’s why that one was covered. But then, for example, GonalF and Menopur and Cetrotide which are very specific to IVF were not
covered. All I was told by the representative from United Healthcare was
that because it can also be, I guess, coded as a cancer drug, they approved
it” (038, Female, Caucasian, New York)
There were also some examples where people were just experiencing denials on
medications or services there were previously covered.
“As far as the doctor’s visits…there was a change in the way that the clinic
did their coding and my insurance has been instructed to deny all claims
regarding that code, even though it was previously covered under a
different code” (015, Nonbinary, Multiracial, Minnesota)
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“So, it includes medications if I am doing IUI. It does not include
medications if I do IVF. So, the exact same Follistim that I used this past
month for $20.00 would then cost me $1,000.00…just because it’s used
for IVF instead of IUI, which is not a covered procedure” (056, Female,
Caucasian, Maryland)
In one of those examples, the expenses paid out of pocket due to insurance claim denials were later
recoded and the person received reimbursement. This example reveals an interesting perception of
infertility by the insurance companies, where things that were covered as diagnostic procedures
were then denied once there was a diagnosis of infertility,
“I have been fighting with our insurance company over a blood panel and
certain medications that used to be covered. But now, because we have
this diagnosis and we have sought out treatment, it won’t cover certain
medications. So, we have to pay for things out of pocket. They said
because of the treatment now. Because I sought out treatment for
infertility, then those were things that were now excluded. I actually just
got a couple of checks in the mail from them because the provider was
able to recode some of it, and then resubmit it, and get them to review it,
and then reapprove it” (043, Female, Caucasian, Wisconsin)
Expert interviews. The roles of these organizations, as described by their representatives,
were similar in that the services they offer to help with the costs associated with infertility services
exist only because of the high cost of infertility services. However the types of financial assistance
are not the same (Table 4.2). There were three themes that developed through analysis of these
expert interviews: Prior insurance, responses about the effect that having health insurance with
some sort of infertility coverage would have on the financial services offered; Personal history
and advocacy, which were sentiments regarding a personal experience with infertility that affected
the creation of the organization or decision to engage in non-profit work related to infertility; and
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Perception of the mandate, which were the representatives’ opinions regarding the current statebased infertility insurance mandates.
Prior insurance. One of the questions asked to each representative was whether the
presence of other health insurance would affect the ability to access the financial assistance their
company provides. The responses to the effect of health insurance largely reflected the notion that
the presence of health insurance was negligible due to the limited amount of coverage that exists
for these types of services.
“It [prior insurance] generally covers testing, sometimes it covers the
bloodwork and the testing up to the diagnosis, and then most of the people
who approach us have a diagnosis of infertility, but no insurance that
covers it” (Baby Quest Foundation, non-profit)
“We do ask about their insurance coverage, and the reason we ask is
because we wanna know about the resources that they have already have
access to. But, if you have someone, for instance, who has insurance
coverage, but they’re out of pocket is $5,000, or let’s just call it an amount
that would make fertility treatment beyond something that they would be
able to cover financially, that person may still qualify. We look at their
taxes and look at their pay stubs, and we look at their financial
background, in addition to what resources they bring to their treatment, or
adoption. We make a decision based on all of that information” (CADE
Foundation, non-profit)
“It may be something that we take into consideration, but it’s not an
eliminating factor. But it could be a deciding factor if it comes down to
decide between two applicants. It also depends. We have seen that most
insurances, if they do offer any sort of infertility coverage, has a lifetime
cap on it. It’s usually around $5,000, $5,000 to $10,000. So, may take that
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into consideration, whether or not they already used that benefit in
previous treatments” (The Hope for Fertility Foundation, non-profit)
“They [recipients of the grant] do [have health insurance], but in
Pennsylvania, it’s not covered. It doesn’t cover IVF. So, they do have
some insurance technically, but infertility is not covered. The treatment
isn’t covered” (The JFCS Fertility Fund, Jewish Human Service Agency)
There was one response from a non-profit organization that health insurance would make someone
ineligible. However, after providing an example from the informal interviews about how some
people with insurance will get coverage for things like diagnostics but not actual procedures
themselves like IVF, it was clarified that insurance coverage for services beyond diagnostics would
make someone ineligible, not the presence of insurance alone,
“So, yeah, that’s a good clarification. So, for example, in Ohio, you can
have coverage – most people have coverage for the diagnosis of infertility.
That is okay. What we do not allow is if there is insurance for the treatment
of infertility. And that would be IVF or embryo transfers, and that kind of
stuff” (Parental Hope, non-profit)
In some instances, such as with surrogacy, the process of how insurance applies becomes more
complicated due to there being a third party who may also have some type of insurance. In the case
explained below, both party’s insurance must be reviewed to determine what resources are
available.
“So, if an individual or couple comes to us and says, you know, ‘We need
to go through surrogacy, what do we do?’ basically it starts with ‘Do you
have a surrogate selected, yes or no? If you have a surrogate selected, what
type of insurance does your surrogate have?’ It's important to note that the
surrogate's insurance would not cover any portion of the IVF because she
is not, by definition, infertile. So, even though her policy may have fertility
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benefits, it doesn't matter because she's never going to need that definition
of infertility. So, then we would start with her insurance. Will it cover a
surrogate pregnancy? Yes or no? If the answer's yes, that's fabulous news
because it saves into the parents' fund. If not, then we start looking for
alternatives for them” (ART Risk Solutions, Financial insurance solutions
company)
In the case of IntegraMed and Progyny, the person seeking help is a “self-insure” client, meaning
they pay all of the treatment for infertility services (not including diagnostics). Progyny is
essentially a type of insurance benefit that can be added on to the company’s insurance plan
through the employer – but it does not cost the employer more to have the Progyny benefits.
“Progyny is a fertility benefits administrator. So, what that means is, we
work with self-insured employers, US only, and for those employers, we
administer the fertility benefits…So, payback to the company, that’s a
really good question. Our members, the employees who access our
services, they pay their premium to their employer, so they pay their
monthly premium, just like anybody would, obviously some of our
employers have $0.00 premiums, but they pay their monthly premium and
then they pay their financial responsibility in the same exact way they
would if they were having ACL surgery. They’re paying deductible coinsurance and co-pay. But, there’s no added fee for them to access
Progyny” (Progyny, fertility benefits administrator)
In the case of IntegraMed, the presence of health insurance would not disqualify someone, but it
might influence the types of services from which they could benefit. That influence will be based
on the insurance offered by the employer, not necessarily the state in which the patient is a resident.
“So, what happens is that typically patients go into a fertility clinic with
medical insurance, regular health insurance, and they bill us for a
consultation as a diagnostic. Typically, most of the insurance companies
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across the nation do cover the initial consultation. Say in Connecticut, [a
mandated state]…they may have the diagnostic coverage, but if it turns
out that the patient needs to do IVF, that's not something that their
insurance would pick up because their employer is 100 employees or less
[in a mandated state]. And so, that would make them a self-pay patient”
(IntegraMed, MSA crisis management company)
Personal history and advocacy. Interestingly, six of the eight representatives, all of whom
hold high administrative roles in their organization, expressed personal experiences using
infertility services. Some described their experience using infertility services to empathize with
people going through the same process and experiencing the same denials of insurance coverage.
“And I speak to this personally because I went through it myself. So, I
lived in Connecticut. I worked for this company based out of New York,
and they didn't have insurance coverage for IVF. They did cover IUI. So,
when I was doing IUI, it was totally fine, and my IUI medication was even
paid for. But the minute I found out I needed IVF, the services were no
longer covered” (IntegraMed, MSA crisis management company)
Representatives from 3 different types of organizations mentioned how theirs or the founder’s
personal experience fueled their passion to create the organization they are representing,
“So, the CADE foundation was founded in 2005 by my husband and
myself. Our vision was to originally provide one family with a grant of
$10,000 for fertility treatment or adoption. That has evolved to the point
where we’ve given out 121 grants to families of up to $10,000 throughout
the country” (CADE Foundation, non-profit)
“So, my wife and I have our own infertility story, I guess you can say. We
now have five-year-old twins, boy/girl twins. However, I had male factor
infertility; my wife had female factor infertility. And we had to go through
IVF in order to conceive our kids…in the beginning, we were very
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concerned about how we were going to pay for it. But luckily for us, my
wife happened to be working for a **** based out of ****. And Illinois,
at the time, was one of eight states that mandated that employers provide
coverage for infertility. And so, her insurance plan allowed us to have up
to four rounds of IVF and retrievals. Once the kids were born, we wanted
to give back to that infertility community, kind of pay forward the blessing
that we had with respect to that insurance” (Parental Hope, non-profit)
“There was a couple in the community who went through this themselves.
And they knew how exorbitant the costs were. And they wanted to help
other couples. So, they donated some money. And then, kind of fund
raised in the community, and then found that there were a lot of other
couples with similar situations. And just kind of fund raised throughout
the past few years” (The JFCS Fertility Fund, Jewish Human Service
Agency)
“So, **** is the owner of Art Risk. She has been in charge for about 25
years at this point. So, she became more of an expert on using major
medical trends for surrogacy and…kind of looking through people's
benefits essentially and seeing what potentially their insurance paper,
either any portion of infertility and then also with the surrogacy fees. So,
that's really how it started, and then it just grew from there. A lot of
teaching engagements kind of helped clarify the law with the attorneys.
Kind of get them to understand what was going on in the insurance world
so that their contracts could mirror that and not be facing some contracts
that insurance could not do” (ART Risk Solutions, financial insurance
solutions company)
One had a personal experience with infertility services in the family that influenced them to pursue
non-profit work rather than strictly political advocacy due to the direct benefit their grant program
has on people who are trying to overcome infertility issues..
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“I made a choice when I started this foundation. This is based on our
daughter going through four IVFs with miscarriages every time, and
eventually, now, having two daughters via surrogacy. We were very
fortunate to be able to financially afford that or help them with it. I made
a choice at that time. I could put my efforts into working towards political
reform, or I could put my efforts into raising money so that people along
the way would get help. I’ve chosen the latter because we funded 117
families now. Those are 117 families representing 85 babies that would
not have been born if I hadn’t chosen this route” (Baby Quest Foundation,
non-profit)
There were both political advocacy efforts and patient advocacy efforts expressed by two
of the representatives. In the case of Progyny, their advocacy was geared towards the patients, to
the extent that their program includes “patient care advocates” (PCAs) who act in a similar fashion
to patient navigators. They assist patients with health education, treatment reminders, and services
as are the patient’s main point of contact throughout the use of their services,
“It’s very similar to a patient navigator service yeah…let’s say in the
example of IVF, a member and their partner are trying to become
pregnant. Their OBGYN tells them that they should really seek fertility
care. They call their HR department and ask about the benefits and they’re
transferred over to Progyny and they’re matched with a one-to-one, we
call them Patient Care Advocates or PCA’s. So, they’re matched with a
dedicated Patient Care Advocate who is their main point of contact and
offers emotional support, logistical support in terms of organizing
appointments, following up on appointments, offers education about what
all the different treatments mean and what all that entails, and how the
medications work and is their main point of contact throughout the
process. In some cases, helping them get second opinions, or if the service
they’re getting at their provider, if they want a different type of service or
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a different type of provider, making sure that they’re getting what they
need throughout their journey” (Progyny, fertility benefits administrator)
It was also brought up by Progyny that PCAs are so intertwined with the infertility journey of the
patient that some advocates have children named after them,
“We have babies named after PCAs. And, obviously, for a lot of people,
it’s a really close relationship that’s formed because members understand
that A.) That they are getting something a lot of people don’t have access
to and they’re grateful and B.) There’s still a stigma that surrounds it
[infertility services] and a woman who’s going through IVF and maybe
recurrent pregnancy loss isn’t necessarily open with her friends or her
family or certainly her colleagues about her experience. And, even when
she is, not everybody understands it because while there is an incidence of
one in eight, not everyone’s gone through it, and even someone who has,
hasn’t had your exact experience. So, having that Patient Care Advocate
who understands what you’re going through and can talk you through it,
and also serves as an expert, you really form close bonds” (Progyny,
fertility benefits administrator)
In the case of IntegraMed, their advocacy was political, where one of the representatives who held
an administrative role in the organization was an advocate with RESOLVE and gave presentations
to some policy leaders that led to some policy changes.
“So, I'm an advocate for RESOLVE. I've been doing it for a few years,
and I've gone to a few of their Advocacy Days. And there have been a
couple of occasions where I've had to present in front of some of the
staffers. And they recently got to some victories [passing new mandates].
New Jersey was one of the more recent ones. I was part of the Connecticut
one. I think Rhode Island is working on one. So, New York recently, too.
I think California” (IntegraMed, MSA crisis management company)
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Perception of mandate. Almost every representative had an opinion of the efficacy of the
current infertility health insurance mandates, and none them were completely positive. While there
were negatives raised, there were also some solutions proposed. Negative opinions of the infertility
insurance mand included the slow process of passing legislation, and the perceived greater positive
effect their grant program had on immediate financial help – albeit for one person per year.
“I know there are people who are doing a great job in the political arena,
and we’re trying to change the laws. But that’s not our focus. My focus is
to get money to help people who need it right now, and who can’t wait till
the laws change…I just know how slowly the wheels of progress move,
and they’re going backwards in insurance in many ways. So, it’s just not,
it doesn’t give the rewards that as immediate as what we’ve seen that we’re
able to help people have babies right away” (Baby Quest Foundation, nonprofit)
Representatives from three different organizations brought up reasons why people get
denied, and much of has to do with the language within the mandates themselves. This includes:1)
some mandates still maintain heteronormative language that exclude same-sex couples,; and2)
there is an unequal perception of “medical need” for infertility services, highlighting the way the
insurance industry perceives infertility as something closer to a cosmetic surgery – wanted but not
medically necessary.
“But I also feel like there should be at least an equal, the way that the
insurance company view infertility, I think, needs to be treated as equal as
any other disease out there. I don’t think that the insurance companies are
doing that” (The Hope for Fertility Foundation, non-profit)
“The problem is, with these plans, is that they tend to be very
heterogeneous. So, even New York that recently passed legislation, was
not bad legislation, they passed it last summer [2018], and it opened up
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the infertility world a bit more. But it still didn't address same-sex couples
– it was a great step forward, it stopped short of really where it should be.
And there's only 16 states that have any type of a mandate. And of those
16, there's really only 3 good ones. So, California loves to say, “We have
a mandate’, but all they really mandate is that you're going to test to see if
you are infertile. And if you are infertile, you're done. There's no coverage
for treatment” (Progyny, fertility benefits administrator)
“But I think that to say then ‘We're [insurance company] not going to
cover this disease’ which truly is a disease – if you're infertile, you are
infertile for a variety of reasons – is, I think, wrong, and wrong on the part
of the insurance companies, and I think there are ways that we can start
limiting the cost” (ART Risk Solutions, financial insurance solutions
company)
The fact that employers must bear an extra cost for adding infertility services, leading to
those services not being offered, was brought up by two different organization representatives.
“When you look at the companies that are voluntarily providing this
coverage, such as Proctor & Gamble, or Fifth Third Bank, or Starbucks,
for example, they are large companies that can afford to take on that
additional cost voluntarily because there’s gonna be a higher percentage
of their employees who are gonna actually access that care” (Parental
Hope, non-profit)
“The cost of IVF is very prohibitive [for employers]. But if there was
insurance coverage for it [infertility services], the price would come down
because you're only going to get reimbursed so much by the insurance
company. I think we'd start seeing equalization of the prices, which then
would make it more affordable, so then the fear on the part of the
employers that it's going to be too expensive would go away. I think it's a
multi-faceted solution” (ART Risk Solutions, financial insurance
solutions company)
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Representatives from the different types of organizations expressed how insurance for
infertility services could be done differently. This is based on their experience working with
patients, couples, clinics, or employers on infertility insurance benefits – such as lowering the costs
of infertility services, rather than create more mandates for insurance companies, or just providing
more coverage for the wide spectrum of services.
“I worry that the more mandates we put on insurance companies just
ultimately causes our insurance rates to go up, making it more difficult for
people to get insurance in the first place. I feel like the solution, well, then
on top of that, the amount that doctors end up charging ends up going up.
So, I feel, if there was a way for treatments to be cheaper to begin with, I
think that would probably be a more effective approach than mandating
insurance on the insurance companies” (The Hope for Fertility
Foundation, non-profit)
“And even in states with really decent mandates like Massachusetts or
Illinois, again, if you're company does not provide benefits, whether it's
because their headquarters are in another state without a mandate, or it's
because they have 100 employees or less, or you're self-employed, you're
a contractor with five people that work for you, you need to go with
somebody like Attain, or you're gonna pay the clinic for each single cycle.
So, patients like this exist. And even though 16 states right now offer some
sort of a mandate, they're not all perfect, and still a really small number”
(IntegraMed, MSA crisis management company)
“If insurance could cover more it would be definitely more beneficial
because people pay so much out of pocket for the cost even prior to doing
the IVF. And there’s no guarantee when people pay for IVF that they’re
gonna have a child” (The JFCS Fertility Fund, Jewish Human Service
Agency)
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“I think actually the state-mandates need to change, because if the state
mandates were to change, which actually we're making progress on,
especially with medically necessary fertility coverage, the state mandates
could get rid of the heterogeneous language, and the insurance companies
would have to follow” (Progyny, fertility benefits administrator)
“But if there was insurance coverage for it, the price would come down
because you're only going to get reimbursed so much by the insurance
company. I think we'd start seeing equalization of the prices, which then
would make it more affordable, so then the fear on the part of the
employers that it's going to be too expensive would go away. I think it's a
multi-faceted solution” (ART Risk Solutions, financial insurance
solutions company)
Some representatives expressed giving much thought into the effect of the mandates and
their role in facilitating increased access, but still feel they cannot tell if the mandates are truly
facilitative. More often than not, respondents felt that the mandates were not effective as they are
now. They identified gaps in coverage after an infertility diagnosis is confirmed, and i the role of
the state in increasing access to infertility services in a more equitable manner,
“I put a lot of thought into it, and I think I’ve bounced back and forth
between my opinion and I’ve sat down with some of our local political
leaders and talked to them about it. To be honest I’m still on the fence a
little bit. It might be that I feel that I’m more surprised at the things that
insurance companies are willing to provide coverage for but tend to ignore
infertility. Most insurance companies will pay to have infertility
diagnosed, but then they won’t pay for any of the treatment” (The Hope
for Fertility Foundation, non-profit)
“I really think that the states have to dictate the coverage and dictate the
language. The insurance companies are not going to do this [offer cheaper
services] voluntarily because they're not going to want to take on the
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risk…I think once the state sets the framework, I think the insurance
companies will step up in a positive way. But they're not going to do it if
it's not mandated” (Progyny, fertility benefits administrator)
All of these organizations exist due to the lack of insurance coverage for infertility services.
Due to this, increased insurance coverage could mean that some of organizations would suffer
through the loss of their own clientele. The representative from IntegraMed reflected specifically
on the longevity of the company’s subsidiary, Attain Fertility, if access to infertility services
increases to the extent that their services are no longer utilized (as much). This highlights the
philosophy under which the organization operates: to help patients.
“Years ago, not all oncology services were covered. A number of years,
most bariatric coverages were not covered. Most of the time, they are now.
I think most employers are going to begin covering fertility treatment. And
that is fantastic for IntegraMed. That is fantastic for patients. That's
fantastic for practices financially. It does really, frankly, hurt Attain, but
that's fine. We're here to help patients. So, if they have coverage, they have
coverage. That's perfectly fine. And we'll continue to be here and help
them – help those that don't have coverage” (IntegraMed, MSA crisis
management company)
The representative from Progyny had a similar philosophy that increased access to infertility
services is good no matter the effect on the company,
“We believe that state mandates are great. Because we are serving the selfinsured groups, and that means that there are a lot of fully insured people
out there and they should have access too. And, we live our vision and
believe our vision for us and our employers, but we believe it for
everybody. So, just because someone doesn’t have access to Progyny
doesn’t mean they shouldn’t have access to benefits. And so, state
mandates are good because it’s improving and increasing access for
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people. I think the New York State one was very good. In some ways,
they’re small amounts. I would love that they cover fertility preservation
more and things of that nature. But, any increase in coverage and increase
of access is always a good thing, whether it directly affects Progyny or
not. We believe across the board that people who want to have a child
should be able to have a child or children if that’s their thing” (Progyny,
fertility benefits administrator)
In sum, the role of organizations on increasing access to infertility services in the United
States is to be advocates for both the patients and the policies meant to help them. This is a type
of collective efficacy to make positive changes in favor of increased access to infertility services,
and to function as a type of safety net for people who cannot achieve insurance coverage for
infertility services. Although most of the survey and interview responses show low usage of these
organizations, those who were able to access them were able to achieve some degree of financial
assistance for infertility services when their insurance would not cover. Many of those expenses
were for medications and actual treatment of infertility beyond IUI or diagnostic services.
The personal histories expressed from these representatives shows that empathy is a
powerful motivation to make change, even in the face of opposition. A type of community
advocacy could also be argued to be present in the support given to fund the different grant
programs. These grants were funded almost 100% on donations from other individuals and
couples who deal or dealt with infertility – who also endured the high cost of infertility services,
but still wanted to give their money to help someone else. Patient advocacy efforts by Progyny
with their PCAs are an example of how informed businesses can provide the full spectrum of
services required, regardless of legislative support.
Political advocacy expressed through these expert interviews shows that these
organizations are not static, but dynamic. They responded to new knowledge (new to legislators
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and insurance companies) that more than heterosexual couples require infertility services; the
definition of infertility within these mandates is disqualifying people, such as surrogates who will
never fall under the designation of “infertile” and be will disqualified from insurance coverage and
that going through these processes is uniquely stressful and expensive. The founders of these
organizations responded to this knowledge by trying to make access to fertility resources to start
a family easier, more affordable, and by influencing policies by advocating that those policies that
exist are not good enough. Also they help by providing guidance on what needs to be done better.

Research Question 5: Spatial dimensions of fertility
R5: What is the spatial relationship between fertility of women between the years of 20132017 based on age, education, ethnicity, nativity, and income?
ACS fertility data. Data used for these analyses are from the American Community
Survey (ACS) 2013-2017 5yr data on Fertility, reflecting an estimated number of women with
births in the past 12 months between the years of 2013-2017 based on census tract level
estimations. Figures 4.7 – 4.26 show the spatial distribution of women with births based on the
selected sociodemographics (Table 3.1). Figure 4.27 represents population density, and Figure
4.28 represents birth density. For the map showing all women with births (Figure 4.7), the lowest
possible number of observations was set to 0 so that they would not be combined with observations
of 1 or more. For the rest of the frequency maps, the lowest possible observation was set
automatically using the Equal Breaks (Jenks) option, which automatically sets the distribution of
values based on the values themselves within the number of levels specified.
Spatial distribution of “All Births” shows some higher birth estimates in large metropolitan
areas. This follows the construction of census tracts, which are based on population numbers
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(Census Bureau History Staff, 2020). The smaller the census tract, the higher the population, and
thus the higher the number of women who could give birth, as seen in their plotted linear
relationship (y = 55.07784 + -0.00936x; R2 = 0.00155973949) (Figure 4.29). The variables with
the most distinct spatial associations that could be observed spatially were the race/ethnicity related
variables. Figure 4.30 shows a dot density map of the fertility data based on census-based racial
groups to observe how there are spatially distinct areas where some racial groups are having births
with greater frequencies than in other areas. As can be seen on the map, there are distinctly higher
and isolated counts of African American women with births along the southeastern United States,
and higher and isolated counts of Hispanic women with births along the southern and western
United States, with some density locations in Florida, New York, and Washington state (Figure
4.30).
Spatial autocorrelation. Spatial autocorrelation of the dependent variable “All Women
with Births” revealed significant spatial autocorrelation (p=<0.0001) for All Women with Births
and population density (Table 4.29), Age (Table 4.30), Ethnicity (Table 4.31), Nativity (Table
4.32), Education (Table 4.33), and Income disparity (Table 4.34). In spatial autocorrelation, the
direction of autocorrelation is also important to observe – whether positive or negative.
Interpretation of Moran’s I is that, for the Moran’s I coefficient, I > E[I] indicates positive
autocorrelation – indicating the neighboring census tracts have similar values. Interpretation of
Gary’s c is that when c < E[c], there is positive autocorrelation (SAS Institute Inc, 2020). Negative
autocorrelation means that the neighboring census tract values are dissimilar (SAS Institute Inc,
2020). All independent variables showed significant positive autocorrelation for Moran’s I and
Gary’s c, except for African American (Table 36) and Graduate and Professional Degree (Table
38) which both exhibited significantly negative spatial autocorrelation for the Gary’s c statistic.
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This may suggest that census tracts containing women with births between the age of 15-50 who
are either African American or who have a graduate or professional degree are located adjacent to
census tracts with few women with births identifying with those sociodemographics. This could
indicate that women with births having those demographics are both fewer and spatially
constrained.
The Moran’s I and Gary’s c statistics did not change when using the significant variables
identified by either of the linear regression statistics (Poissonian and negative binomial), or when
using the Randomized assumption opposed to the default Normalized assumption (Table 4.35).
This occurrence could be due to the highly autocorrelated nature of this data and the fact that it
observes all census tracts within the contiguous United States. Spatial autocorrelation within state
boundaries could give different results.
Optimized hot spot analysis. Previously it was discovered that the fertility variables are all
significantly autocorrelated and that the majority show positive spatial autocorrelation. These
values do not, however, show where spatially these values are autocorrelated. To observe the
clustering of women with births over space, this research utilized the Optimized Hot Spot Analysis
in ArcPro 2.4. Analyses on Hawaii and Alaska were computed separately from the contiguous
United States. The cartographic output of the Optimized Hot Spot Analysis also uses the data
package “U.S. Major Cities” created by ESRI and the U.S. Census Bureau (ESRI & U.S. Census
Bureau, 2020).
The Optimized Hot Spot Analysis revealed the maximum number of women with births
within a census tract to be 1,370 with an average of 54.9 (50.5) women with births. There were
1,287 outliers, which were not included in the optimal fixed distance band used to observe
“neighboring” features. The program did not detect an optimal scale for analysis, so the optimal
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fixed distance band was based on the average distance to 30 nearest neighbors, 17,574m (10.9mi).
The FDR correction detected 27,164 statistically significant census tracts, which included the
corrections for multiple testing and spatial dependence (Figure 4.31). Nearly 14% of features had
less than eight neighbors based on the distance band of 17,547m (10.9mi). Based on observation,
the majority of significantly high or low estimates of women with births were in metropolitan areas
with populations above 250,000 persons.
Directional distribution. To observe the spatial directions in which these data are
distributed, a directional distribution ellipse was calculated for each of the fertility variables. The
ellipses are based on one standard deviation from the mean center of the data observation. Figure
4.32 shows the directional distributions for all of the fertility variables, and Figures 4.34 – 4.38
show the directional distributions based on each demographic domain (age, ethnicity, education,
nativity, income disparity, and densities).
Based on these quantitative spatial analyses, fertility in the United States is highly spatially
autocorrelated. When investigating the directional distributions, the demographic category with
the greatest diversity is Ethnicity, suggesting that some of the spatial autocorrelation may be based
on ethnicity-specific factors.

Research Question 6: Observing fertility in relation to states with/without mandated
infertility insurance coverage
R6: What is the spatial relationship between fertility of women between the years of 20132017 and states with or without infertility insurance mandates?
ACS fertility data. There are now 18 states with infertility insurance mandates, however
this research observes the 16 states that had infertility insurance mandates as of December 2017.
To observe fertility to states with an infertility insurance mandate to those without, a new
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dichotomous variable called “Mandate” was added to the Fertility dataset – where 1 = mandate
present, and 2=mandate absent. When looking at the total number of women with births between
those groups, there is only a difference of 6,600 women with births (Table 4.11). This suggests
that state’s that have mandates are states with higher populations, which also explains the extreme
differences in average population density. States with mandates have an average population
density of 9,152.2 (86,060.04) persons per square mile, whereas states without a mandate have an
average of 2,669.1 (4,185.5) persons per square mile.
After testing for normality, it was discovered these data were positively skewed (Figure
4.39) so traditional two-sample t-test is not appropriate. This analysis used the Wilcoxon rank-sum
test. Results comparing the means of “All Women with Births” between states with and without
an infertility insurance mandate resulted in rejecting the null hypothesis – meaning there is a
significant difference between the mean number of births between states with an infertility
insurance mandate and states without an infertility insurance mandate (Pr > Chi-Square = <0.0001,
df=1). The Poissonian and negative binomial regression also detected significant differences
between “All Women with Births” in states with and without an infertility insurance mandate
(p=<.0001) (Table 4.36).

Research Question 7: Spatial dimensions of CDC-reporting fertility clinics
R7: What is the spatial relationship between fertility of women age 15-50 and the spatial
distribution of SART reporting clinics between the years of 2013-2017?
Informal interviews. There was a total of 22 different clinics identified by the
interviewees – clinics they personally used for some if not all of their services. The names of these
clinics were searched in the clinic data sheet used for this research (accessed from the CDC), and
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(https://nccd.cdc.gov/drh_art/rdPage.aspx?rdReport=DRH_ART.FindAClinic&rdRequestForwar
d=True). Regarding the differences between mandated and non-mandated states, seven people
were living in and using a clinic in a mandated state, 13 people were living in and using a clinic in
a non-mandated state, and 2 people lived in non-mandate states but used a clinic in a mandated
state. Of the 22 clinics identified, four were not found in the database of clinics reporting their data
to the CDC – two clinics in mandated states and two clinics in non-mandated states. One of the
clinics not reporting their data was a military-based medical center, the other three were not
associated with another entity such as military, academic, or within a hospital or university.
Fertility clinics, 2017. Of the 72,987 census tracts included in this research, 0.56% (408)
of those have at least one of the 448 clinics included in this research. When observing fertility in
relation to those clinics, the mean estimates of “All Women with Births” does not vary greatly
between census tracts with clinics (m=53.22 (51.06)) and all census tracts (m=54.73 (50.55),
however the census tracts with fertility clinics represent 0.62% of the total population which could
explain the similarity of the two averages: fertility clinics are located in places of high population
density (Table 4.35).
Spatial distribution of fertility clinics across the United States shows some spatial
restriction, where most clinics tend to cluster around large cities (Figure 4.40). Kernal density
analysis using a defined search radius of 200 miles revealed some high-density clusters of ART
clinics in metropolitan areas, such as San Francisco, Los Angeles, New York, and Chicago (Figure
4.41). Kernal density analysis did not include Hawaii or Alaska due to their distance from the
contiguous United States.

175

An optimized hot spot analysis using polygon cell sizes of 25 miles revealed a similar
pattern of spatial clustering (Figure 4.42). There were 147 (33.41%) fertility clinics within a
significantly closer distance to each other than the others, based on FDR correction and multiple
testing for spatial dependence. Based on the automatic distance band of 54 miles, 4.3% of fertility
clinics had less than eight nearest clinics. There were no cold spots identified, which could suggest
that the clinics not included in the analysis are so spatially distant that they do not have neighboring
features that could be detected by the algorithm.
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Chapter Four Tables
Table 4.1. Informal interview demographics (n=66)
Variable
Stage of Using Infertility Services
Currently using
Previously used
Not using yet
Gender Identity
Female
Male
Nonbinary
Gender Queer
Age
Mean (sd)
Range
Estimated Annual Household Income
Mean (sd)
Range
$30,000 – $84,999
$85,000 – $134,999
$135,000 – $189,999
$190,000 – $299,999
$300,000 – $700,000
Do not know
Joint or Single Income
Joint income
Single income
No answer
Marital Status
Married
Single
In a relationship, living together
Divorced
Sexual Orientation
Heterosexual
Homosexual
Bisexual
Ethnicity (with Hispanic ancestry)
Hispanic or Latin Decent (n=3)
Caucasian
Puerto Rican
Ethnicity (without Hispanic ancestry)
Caucasian
African American
Middle Eastern
Indian

n

Total (%)

34
29
3

51.52%
43.94%
4.55%

61
3
1
1

92.42%
4.55%
1.52%
1.52%

32.7 (4.09)
21-43
$155,107.69 (107,281.77)
$30,000 – $700,000
13
19.70%
25
37.88%
13
19.70%
4
6.06%
10
15.15%
1
1.52%
57
8
1

86.36%
12.12%
1.52%

61
2
2
1

92.42%
3.03%
3.03%
1.52%

55
6
5

83.33%
9.09%
7.58%

2
1

4.55%
3.03%
1.52%

57
2
2
1

86.36%
3.03%
3.03%
1.52%
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Table 4.1 (Continued)
More than one ethnicity
Religion
None
Christian
Catholic
Jewish
Agnostic
Atheist
Buddhist
Muslim
Baháʼí
Hindu
Employment
Full-time
Self-Employed
Multiple jobs
Part-time
Student
Industry
Hospital, Healthcare, Social assistance
College, University, Adult Education
Non-profit
Primary/Secondary Education
Government (locale, state, federal)
Arts, Entertainment, Recreation
Pharmaceuticals
Business (Marketing, Advertising, Consulting,
Manufacturing, Retail/Wholesale, Corporate)
Information Technology (IT)
Real Estate
Science/Engineering
Construction
Travel and Leisure
Legal Services
Insurance
No answer
Education
Associates degree
Bachelors degree
Masters degree
Professional (MD, PharmD)
Doctorate (PhD)
Graduate/Postgraduate Diploma
Currently Pregnant?
No
Yes (IVF)
Yes (IUI)
Yes (Egg retrieval)
Parity

1

1.52%

36
10
6
6
3
1
1
1
1
1

54.55%
15.15%
9.09%
9.09%
4.55%
1.52%
1.52%
1.52%
1.52%
1.52%

48
8
4
3
3

72.73%
12.12%
6.06%
4.65%
4.65%

14
11
7
6
6
3
3
3

21.21%
16.67%
10.61%
9.09%
9.09%
4.55%
4.55%
4.55%

2
2
2
1
1
1
1
3

3.03%
3.03%
3.03%
1.52%
1.52%
1.52%
1.52%
4.55%

3
20
28
2
11
2

4.55%
30.30%
42.42%
3.03%
16.67%
3.03%

59
4
1
1

89.40%
6.06%
1.52%
1.52%
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Table 4.1 (Continued)
0
1
2
3
Losses
Children from ART (n=11)
1
2
3
Primary Reason Seeking Infertility Services
Unexplained
Female factor
Male factor
Dual factor
Same sex
Cancer related
Genetic
Secondary Reason Seeking Infertility Services
Female factor
Unexplained
Dual factor
Genetic
Inconsistent information from doctors
Type of Health Insurance
Private (individually or through employer)
Private with Medigap (individually or through
employer)
Dual (employer + private insurance, spouse
insurance + own insurance)
Tricare/Veterans Affairs
Residence
Living in Mandated State
Living in non-Mandated State

53
9
2
1
1

80.30%
13.64%
3.03%
1.52%
1.52%

9
1
1

81.82%
9.09%
9.09%

18
17
10
10
7
3
1

27.27%
25.75%
15.15%
15.15%
10.60%
4.55%
1.52%

4
2
2
1
1

6.06%
3.03%
3.03%
1.52%
1.52%

58
4

87.88%
6.06%

2

4.55%

1

1.52%

34
32

51.5%
48.5%
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Table 4.2. Expert interview organizational demographics (n=8)
Name
Type of
State
Residence
Assistance
organization
based in
requirement
type
Baby Quest
Foundation
CADE
Foundation
The Hope
for Fertility
Foundation
Progyny

The JFCS
Fertility
Fund
Parental
Hope
ART Risk
Solutions
IntegraMed
Fertility

501c3 nonprofit
501c3 nonprofit
501c3 nonprofit

CA

U.S. resident

Grant ($500)

MD

U.S. resident

UT

U.S. resident

Grant
($10,000)
Grant
(up to $5,000)

Fertility
NY
benefits
administrator
Jewish Human PA
Service Agency

501c3 nonprofit
Financial
insurance
solutions
MSA crisis
management

Individuals
or
Employers?

Cost
to

Individuals/
Couples
Individuals/
Couples
Individuals/
Couples

N/A

Employ
er

N/A
N/A

Insurance
benefits

Employers

None
extra

Grant
(dependent on
services)

Individuals/
Couples

N/A

OH

Must work
for U.S. based
company
U.S. resident
in
Philadelphia,
PA
U.S. resident

Grant ($5,000)

N/A

CA

None

National

None

Insurance and
case
management
Shared risk
programs

Individuals/
Couples
Individuals/
Couples and
clinics
Individuals/
Couples

Table 4.3. Survey demographics (n=134)
Variable/Stage of Use
Prospective
(n= 12, 9%)
n
Gender Identity
Nonbinary
0
Male
1
Female
11
Age
20-25
1
26-30
3
31-35
6
36-40
1
41-45
1
Marital Status
Single
0
Married
10
In a relationship, not living
0
together
In a relationship, living together
2
Divorced
0
No answer
0

N/A

No

Active
(n=71, 53%)
n

Past
(n= 51, 38%)
n

Total (%)

1
2
68

0
2
49

1 (0.8%)
5 (3.7%)
128 (95.5%)

2
19
30
16
4

3
5
28
11
4

6 (4.5%)
27 (20.2%)
64 (47.8%)
28 (20.9%)
9 (6.7%)

1
64
1

0
47
0

1 (0.8%)
121 (90.3%)
1 (0.8%)

5
0
0

1
2
1

8 (5.9%)
2 (1.5%)
1 (0.8%)
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Table 4.3 (Continued)
Sexual Orientation
Heterosexual
Homosexual
Bisexual
Ethnicity (with Hispanic
ancestry)
Hispanic or Latin Decent (n=4)
Caucasian
More than one ethnicity
Puerto Rican
Ethnicity (without Hispanic
ancestry)
Caucasian
African American
Asian
Middle Eastern
More than one
Religion
Christian
Buddhist
Catholic
Jewish
None
Other
Employment
Full-time
Part-time
Multiple jobs
Unemployed, but partner is
working
Student
Self-Employed
Annual Household Income
<= 50,999
51,000 – 65,999
66,000 – 75,999
76,000 – 85,999
86,000 – 99,999
>= 100,000
Education
HS Diploma
AS
Bachelors
Masters
Professional
Doctorate
Where heard about research
RESOLVE
Family Equality Council

9
1
2

59
5
7

42
4
5

110 (82.1%)
10 (7.5%)
14 (10.5%)

0
0
0

0
1
0

1
1
1

4 (2.9%)
1 (0.8%)
2 (1.5%)
1 (0.8%)

9
1
0
1
0

62
1
4
2
1

47
1
0
0
1

118 (88.1%)
3 (2.2%)
4 (2.9%)
3 (2.2%)
2 (1.5%)

2
1
3
0
6
0

15
2
6
6
40
2

14
2
6
5
23
1

31 (23.1%)
5 (3.7%)
15 (11/2%)
11 (8.2%)
69 (51.5%)
3 (2.2%)

9
1
1
1

60
1
1
4

41
2
0
6

110 (83.1%)
4 (2.9%)
2 (1.5%)
11 (8.2%)

0
0

2
3

0
2

2 (1.5%)
5 (3.7%)

1
1
1
1
2
6

3
5
4
2
8
49

1
1
1
1
7
40

5 (3.7%)
7 (5.2%)
6 (4.5%)
4 (2.9%)
17 (12.7%)
95 (70.1%)

0
1
6
2
1
2

1
4
26
26
6
8

2
1
14
20
6
8

3 (2.2%)
6 (4.5%)
46 (34.3%)
48 (35.8%)
13 (9.7%)
18 (13.4%)

0
0

0
0

2
1

2 (1.5%)
1 (0.8%)
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Table 4.3 (Continued)
Friend
Reddit
Facebook
Industry
Hospital, Healthcare, Social
assistance
College, University, Adult
Education
Primary/Secondary Education
Information Technology
Non-Profit
Government (local, state, federal)
Business (Marketing, Advertising,
Consulting, Manufacturing,
Retail/Wholesale, Corporate)
Science/Engineering
Arts, Entertainment, Recreation
Construction
Legal Services
Finance
Pharmaceuticals
Real Estate
Insurance
Hotel and Food Service
Travel and Leisure
No answer
Currently parenting?
Yes
No
Parity
0
1
2
3
Children from ART (n=25)
1
2
3
Reason Seeking Infertility
Services

1
10
1

1
69
1

7
41
0

9 (6.7%)
120 (89.6%)
2 (1.5%)

5

18

13

36 (26.9%)

0

8

6

14 (10.5%)

0
2
1
1
0

6
8
3
6
4

5
0
4
1
3

11 (8.2%)
10 (7.5%)
8 (6%)
8 (6%)
7 (5.2%)

0
0
1
0
0
0
0
1
0
0
1

2
2
3
3
1
1
1
0
1
0
4

3
2
0
1
2
2
1
1
0
1
6

5 (3.7%)
4 (3%)
4 (3%)
4 (3%)
3 (2.2%)
3 (2.2%)
2 (1.5%)
2 (1.5%)
1 (0.75%)
1 (0.75%)
11 (8.2%)

0
12

6
65

25
26

31 (23.1%)
103 (76.7%)

12
0
0
0

65
4
2
0

26
17
6
2

103 (76.7%)
21 (15.7%)
8 (6%)
2 (1.5%)

0
0
0

0
0
0

19
5
1

19 (76%)
5 (20%)
1 (4%)

5
4
4
1
2
0

35
25
19
16
7
3

5
16
8
10
6
1

45 (26.7%)
45 (26.7%)
31 (18.3%)
27 (16%)
15 (8.9%)
4 (2.4%)

(number exceeds total counts of each
group because some people gave
more than one reason)

Unexplained
Female factor
Male factor
Dual factor
Same sex
Cancer related
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Table 4.3 (Continued)
Single person
Advanced age
Type of Health Insurance
Private (individually or through
employer)
Private with Medigap
(individually or through
employer)
Affordable Care Act
(ObamaCare)
Tricare/Veterans Affairs
Single Service Plan
Dual (employer + private
insurance, spouse insurance +
own insurance)
Not covered by any health
insurance
Residence
Living in Mandated State
Living in non-Mandated State

0
0

1
1

0
0

1 (0.6%)
1 (0.6%)

8

60

48

116 (87.9%)

2

3

1

6 (4.5%)

1

0

0

1 (0.8%)

0
1
0

4
0
1

1
1
0

5 (3.8%)
2 (1.5%)
1 (0.8%)

0

1

0

1 (0.8%)

8
4

40
31

27
24

75 (56%)
59 (44%)

Table 4.4. Health education survey responses: Personal experience (n=133)
Q2.1 - I received information about risks of fertility decreasing with age during health education
courses in: (check all that apply)
# Answer
%
Count
1 Elementary school
0%
0
2 Middle school
0.75%
1
3 High school
3.76%
5
4 College/University
8.96%
12
5 I do not remember
21.64%
29
I did not receive this type of information at any level of
6 schooling
55.97%
74
7 More than one grade
9.02%
12
Total (missing 1)
100%
133
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Table 4.5. Health education survey responses: Personal opinion (n=133)
Q2.2 - In your opinion, what is the earliest grade at which to learn about the risks of infertility?
# Answer
%
Count
1 1st - 3rd grade
0%
0
2 4th - 7th grade
15.79%
21
3 High School
45.11%
60
4 College
2.99%
9
5 More than one grade
7.52%
10
6 None
24.81%
33
Total (missing 1)
100%
133
Table 4.6. Survey responses to online communities (n=134)
Prompt: Please select your level of agreement or disagreement with the following statement:
Response
I use online
I talk about my
I prefer to access online support
ART/infertility support
experience with using forums for ART/infertility before
forums to help me make
infertility services
talking to a physician.
decisions about what
more online than I do
infertility services to use. with people in person.
Strongly
Agree
31.34%
42
44.03%
59
9.70%
13
Agree
41.79%
56
19.40%
26
28.36%
38
Neutral
9.70%
13
17.91%
24
32.84%
44
Disagree
12.69%
17
14.93%
20
22.39%
30
Strongly
Disagree
4.48%
6
3.73%
5
6.72%
9
Total
100%
134
100%
134
100%
134
Table 4.7. ISE Score breakdown
Field
Ignore or push away unpleasant thoughts that can upset
me during medical procedures
Keep a sense of humor
Make meaning out of my infertility experience
Handle mood swings caused by hormonal treatments
Keep from getting discouraged when nothing I do seems
to make a difference
Accept that my best efforts may not change my/our
infertility
Control negative feelings about infertility
Cope with pregnant friends and family members
Handle personal feelings of anger or hostility
Keep a positive attitude
Lessen feelings of self-blame, shame, or defectiveness
Stay relaxed while waiting for appointments or test
results

Mean (range 1-9)

Variance

Count

5.19 (2.02)
6.38 (1.95)
4.83 (2.31)
5.35 (2.02)

4.09
3.8
5.35
4.08

133
133
132
133

3.98 (1.99)

3.95

133

5.27 (2.25)
3.76 (1.95)
4.53 (2.31)
5.21 (2.04)
4.83 (2.01)
5.19 (2.18)

5.07
3.81
5.35
4.17
4.05
4.77

133
133
133
133
133
133

4.05 (2.14)

4.6

132
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Table 4.7 (Continued)
Do something to make myself feel better if I am sad or
discouraged
Keep active with my usual life routine
Feel good about my body and myself
Feel like a sexual individual

5.7 (1.78)
6.03 (1.91)
4.83 (2.12)
4.69 (2.22)

3.17
3.65
4.5
4.95

133
133
133
133

Table 4.8. GLM and Tukey’s test: ISE mean total score and stage of infertility service use
Source
DF
Sum of
Mean Square F Value
Squares
Infertility Mandate 1
9.26201
9.26201
0.02
Stage of Use
2
892.34418
446.17209
0.96
Ethnicity
5
6836.20620
1367.24124
3.19
Age
4
1513.52589
378.38147
0.81
Health Education
5
5591.52697
1118.30539
2.53
Online
4
1279.00173
319.75043
0.68
Communities:
decisions
Online
4
8294.16154
2073.54039
5.01
Communities:
discussions
Online
4
524.01567
131.00392
0.28
Communities:
physician

Pr > F
0.8883
0.3851
0.0095
0.5203
0.0320
0.6052

0.0009

0.8929

Table 4.9. ISE mean score and ethnicity – Tukey’s post hoc analysis
Comparisons significant at the 0.05 level
are indicated by ***.
Ethnicity
Comparison

Difference
Between
Means

Simultaneous 95%
Confidence
Limits

Asian – African American

8.333

-37.405

54.072

Asian - Hispanic

14.000

-52.954

80.954

Asian - More than one ethnicity

29.750

-12.595

72.095

Asian - Caucasian

33.983

3.537

64.429

Asian - Middle Eastern

41.333

-4.405

87.072

African American - Asian

-8.333

-54.072

37.405

African American - Hispanic

5.667

-63.483

74.816

African American - More than one ethnicity

21.417

-24.322

67.155

African American - Caucasian

25.650

-9.362

60.661

***
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Table 4.9 (Continued)
African American - Middle Eastern

33.000

-15.896

81.896

Hispanic - Asian

-14.000

-80.954

52.954

Hispanic - African American

-5.667

-74.816

63.483

Hispanic - More than one ethnicity

15.750

-51.204

82.704

Hispanic - Caucasian

19.983

-40.156

80.122

Hispanic - Middle Eastern

27.333

-41.816

96.483

More than one ethnicity - Asian

-29.750

-72.095

12.595

More than one ethnicity - African American

-21.417

-67.155

24.322

More than one ethnicity - Hispanic

-15.750

-82.704

51.204

More than one ethnicity - Caucasian

4.233

-26.213

34.679

More than one ethnicity - Middle Eastern

11.583

-34.155

57.322

Caucasian - Asian

-33.983

-64.429

-3.537

Caucasian - African American

-25.650

-60.661

9.362

Caucasian - Hispanic

-19.983

-80.122

40.156

Caucasian - More than one ethnicity

-4.233

-34.679

26.213

Caucasian -Middle Eastern

7.350

-27.661

42.362

Middle Eastern - Asian

-41.333

-87.072

4.405

Middle Eastern - African American

-33.000

-81.896

15.896

Middle Eastern - Hispanic

-27.333

-96.483

41.816

Middle Eastern - More than one ethnicity

-11.583

-57.322

34.155

Middle Eastern - Caucasian

-7.350

-42.362

27.661

***
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Table 4.10. ISE mean score and online community: discussions – Tukey’s post hoc analysis
Comparisons significant at the 0.05 level
are indicated by ***.
Prompt: “I talk about my experience with using
infertility services more online than I do with people
in person”
Comparison

Difference
Between
Means

Simultaneous 95%
Confidence
Limits

Strongly Disagree - Disagree

8.750

-19.385

36.885

Strongly Disagree - Neutral

15.708

-11.954

43.371

Strongly Disagree - Agree

20.880

-6.687

48.447

Strongly Disagree - Strongly Agree

27.492

1.282

53.701

Disagree - Strongly Disagree

-8.750

-36.885

19.385

Disagree - Neutral

6.958

-10.078

23.995

Disagree - Agree

12.130

-4.751

29.011

Disagree - Strongly Agree

18.742

4.182

33.301

Neutral - Strongly Disagree

-15.708

-43.371

11.954

Neutral - Disagree

-6.958

-23.995

10.078

Neutral - Agree

5.172

-10.909

21.252

Neutral - Strongly Agree

11.783

-1.840

25.407

Agree - Strongly Disagree

-20.880

-48.447

6.687

Agree - Disagree

-12.130

-29.011

4.751

Agree - Neutral

-5.172

-21.252

10.909

Agree - Strongly Agree

6.612

-6.817

20.040

Strongly Agree - Strongly Disagree

-27.492

-53.701

-1.282

***

Strongly Agree - Disagree

-18.742

-33.301

-4.182

***

Strongly Agree - Neutral

-11.783

-25.407

1.840

Strongly Agree - Agree

-6.612

-20.040

6.817

***

***
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Table 4.11. Comparison of births by presence or absence of state-based infertility insurance mandate
Mandate Present
Mandate Absent
Census tracts: 33,198
Census tracts: 39,798
All women with births: 1,856,479
All women with births: 2,137,744
Variable
mean
SD
mean
SD
All Women with Births
55.9
52.3
53.7
49.0
Age 15-19
2.1
7.7
2.2
7.6
Age 20-34
40.5
42.9
41.1
41.1
Age 35-50
13.3
19.4
10.5
17.1
Caucasian (HL)
36.0
40.2
38.5
39.6
African American
7.3
19.5
8.4
22.4
American Indian/Alaska 0.3
2.9
0.8
5.8
Native
Asian
5.1
14.5
2.3
8.6
Native Hawaiian/Pacific 0.2
2.6
0.1
1.8
Islander
Two or more ethnicities 1.8
7.1
1.6
6.2
Hispanic (any)
17.1
32.8
8.0
20.8
Caucasian (only)
25.1
32.5
33.0
36.0
U.S. born
41.7
42.6
45.8
43.2
Foreign born
14.3
25.4
7.9
18.9
Less than High School
7.7
21.8
6.6
15.5
High School Diploma or 12.8
21.8
12.5
20.5
GED
Associate Degree
16.6
24.3
17.8
24.4
Bachelor Degree
11.4
19.2
10.9
18.0
Graduate or Professional 17.7
12.1
16.0
10.9
Degree
100% below poverty
13.6
23.4
13.8
22.7
line
200% above poverty line 30.9
36.9
28.1
33.7
Received public
3.2
9.8
2.7
8.6
assistance income
Population density
9,152.2
86,060.04
2,669.1
4,185.5
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Table 4.12. Poissonian distribution GENMOD procedure
Criteria for Assessing Goodness of Fit
Criterion

DF

Value

Value/DF

Deviance

72E3

1263859.0820

17.4422

Scaled Deviance

72E3

1263859.0820

17.4422

Pearson Chi-Square

72E3

1037929.7930

14.3242

Scaled Pearson X2

72E3

1037929.7930

14.3242

Log Likelihood

12717647.120

Full Log Likelihood

-820347.5039

AIC (smaller is better)

1640741.0079

AICC (smaller is better)

1640741.0231
Analysis of Maximum Likelihood Parameter Estimates

Parameter

DF Estimate Standard Wald 95% Confidence
Error
Limits

Wald
ChiSquare

Pr > ChiS
q

Intercept

1

3.4058

0.0011

3.4036

3.4081

8996605

<.0001

Population
Density

1

0.0000

0.0000

-0.0000

0.0000

1.82

0.1776

Infertility
Insurance
Mandate

Present 1

-0.0055

0.0011

-0.0075

-0.0034 27.14

<.0001

Absent 0

0.0000

0.0000

0.0000

0.0000

.

.

Age 15-19

1

0.0029

0.0001

0.0027

0.0031

623.46

<.0001

Age 20-34

1

-0.0020

0.0001

-0.0022

-0.0018 367.82

<.0001

Age 35-50

1

0.0012

0.0001

0.0010

0.0014

<.0001

White (HL)

1

-0.0017

0.0000

-0.0018

-0.0017 2789.76

<.0001

African
American

1

0.0003

0.0001

0.0002

0.0005

21.75

<.0001

American
Indian/Alaska
Native

1

0.0044

0.0001

0.0043

0.0046

2216.60

<.0001

Asian

1

-0.0006

0.0001

-0.0008

-0.0005 57.94

<.0001

Native Hawaiian/
Pacific Islander

1

0.0014

0.0002

0.0010

0.0017

<.0001

134.69

46.44
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Table 4.12 (Continued)
Two or more
ethnicities

1

0.0010

0.0001

0.0009

0.0012

172.79

<.0001

Hispanic

1

0.0012

0.0001

0.0010

0.0013

287.24

<.0001

White-only

1

0.0033

0.0001

0.0032

0.0035

2175.37

<.0001

Native (U.S.)
born

1

-0.0022

0.0000

-0.0022

-0.0021 9263.15

<.0001

Foreign

0

0.0000

0.0000

0.0000

0.0000

.

.

Less than HS

1

0.0090

0.0001

0.0088

0.0091

18276.5

<.0001

High School
diploma or GED

1

0.0058

0.0001

0.0057

0.0060

8035.53

<.0001

Associates degree

1

0.0093

0.0001

0.0092

0.0094

22107.1

<.0001

Bachelor degree

1

0.0085

0.0001

0.0084

0.0086

18395.9

<.0001

Graduate or
Professional
degree

1

0.0109

0.0001

0.0108

0.0111

25129.5

<.0001

100% below
poverty line

1

0.0037

0.0000

0.0037

0.0038

24585.2

<.0001

200% or above
poverty line

1

-0.0011

0.0000

-0.0011

-0.0011 2502.34

<.0001

Received public
assistance

1

-0.0004

0.0000

-0.0005

-0.0003 109.06

<.0001

Scale

0

1.0000

0.0000

1.0000

1.0000
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Table 4.13. Negative binomial distribution GENMOD procedure
Criteria For Assessing Goodness Of Fit
Criterion

DF

Value

Value/DF

Deviance

72E3

97706.1967

1.3484

Scaled Deviance

72E3

97706.1967

1.3484

Pearson Chi-Square

72E3

41185.3369

0.5684

Scaled Pearson X2

72E3

41185.3369

0.5684

Log Likelihood

13215407.688

Full Log Likelihood

-322586.9354

AIC (smaller is better)

645221.8708

AICC (smaller is better)

645221.8874

BIC (smaller is better)

645442.4574

Analysis of Maximum Likelihood Parameter Estimates
Parameter

DF Estimate Standard Wald 95% Confidence Wald
Error
Limits
ChiSquare

Pr > ChiSq

Intercept

1

2.7299

0.0058

2.7184

2.7413

218693

<.0001

Population
Density

1

0.0000

0.0000

-0.0000

0.0000

0.52

0.4723

Infertility
Insurance
Mandate

Present 1

0.0258

0.0041

0.0177

0.0339

38.73

<.0001

Absent 0

0.0000

0.0000

0.0000

0.0000

.

.

Age 15-19

1

0.0243

0.0007

0.0229

0.0256

1269.74 <.0001

Age 20-34

1

0.0237

0.0006

0.0225

0.0249

1517.94 <.0001

Age 35-50

1

0.0246

0.0006

0.0234

0.0258

1627.04 <.0001

White (HL)

1

-0.0013

0.0002

-0.0017

-0.0009 33.80

<.0001

African
American

1

-0.0008

0.0005

-0.0017

0.0001

3.01

0.0828

American
Indian/Alaska
Native

1

0.0011

0.0006

-0.0001

0.0023

3.25

0.0714

Asian

1

-0.0005

0.0005

-0.0015

0.0005

0.96

0.3261

Native
Hawaiian/

1

-0.0033

0.0012

-0.0057

-0.0009 7.00

0.0082
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Table 4.13 (Continued)
Pacific
Islander
Two or more
ethnicities

1

-0.0003

0.0005

-0.0013

0.0006

0.47

0.4949

Hispanic

1

-0.0002

0.0004

-0.0011

0.0006

0.32

0.5741

White-only

1

0.0021

0.0005

0.0012

0.0030

21.89

<.0001

Native (U.S.)
born

1

0.0005

0.0002

0.0002

0.0008

11.40

0.0007

Foreign

0

0.0000

0.0000

0.0000

0.0000

.

.

Less than HS

1

-0.0061

0.0004

-0.0068

-0.0053 248.93

<.0001

High School
diploma or
GED

1

-0.0058

0.0004

-0.0065

-0.0051 256.55

<.0001

Associates
degree

1

-0.0059

0.0004

-0.0066

-0.0052 278.28

<.0001

Bachelor
degree

1

-0.0058

0.0004

-0.0065

-0.0051 249.97

<.0001

Graduate or
Professional
degree

1

-0.0065

0.0004

-0.0073

-0.0057 257.63

<.0001

100% below
poverty line

1

0.0005

0.0002

0.0002

0.0008

10.56

0.0012

200% or above
poverty line

1

-0.0003

0.0001

-0.0006

0.0000

3.71

0.0541

Received
public
assistance

1

0.0010

0.0002

0.0005

0.0015

15.77

<.0001

Dispersion

1

0.2530

0.0018

0.2495

0.2565

Table 4.14. CDC-reporting fertility clinics in the United States, 2017 (n=448)
Service
Yes
No
Donor Eggs
399
89.06%
49
Donor Embryos
279
62.28%
169
Embryo Cryopreservation
448
100%
0
Egg Cryopreservation
439
97.99%
9
Single Women
444
99.11%
4
Gestational Carrier
394
87.95%
54

10.94%
37.72%
0%
2.01%
0.89%
12.05%
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Table 4.15. CDC-reporting fertility clinic membership and accreditation, 2017 (n=448)
Yes
No
SART Member
367
81.92%
81
18.08%
Lab Accreditation*
410
91.52%
34
7.59%
*Pending accreditation (n=4, 0.9%)

Table 4.16. Survey responses: Inter-state travel (n=134)
Prompt: Which of the statements below most applies to you, regarding inter-state
travel for infertility services?
I moved out of state to access infertility services
I intend to move out of state to access infertility services
I am considering moving out of state to access infertility services
I have not and do not intend to move out of state to access infertility services
I traveled out of state to access infertility services (did not change residence)
Total
Table 4.17. Survey responses: Interstate travel for higher quality services (n=134)
Prompt: Which of the statements below most applies to you, regarding inter-state
travel for higher quality infertility services?
I moved out of state to access a better physician or fertility clinic
I intend to move out of state to access a better physician or fertility clinic
I am considering moving out of state to access a better physician or fertility clinic
I have not and do not intend to move out of state to access a better physician or
fertility clinic
I traveled out of state to access higher quality infertility services (did not change
residence)
Total
Table 4.18. Survey responses: International travel for infertility services (n=133)
Prompt: Which of these statements below most applies to you, regarding
international travel for infertility services?
I traveled internationally to access infertility services
I intend to travel internationally to access infertility services
I am considering traveling internationally to access infertility services
I have not and do not intend to travel internationally to access infertility
services
Total (missing 1)

%
2.24%
0.00%
6.72%
90.30%
0.75%
100%

%
2.24%
0.00%
2.99%

Count
3
0
9
121
1
134

Count
3
0
4

94.03% 126
0.75%
100%

1
134

%
1.50%
0.75%
15.04%

Count
2
1
20

82.71%
100%

110
133
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Table 4.19. Survey responses: States represented in survey responses (n=134)
State
New York*
Illinois*
Florida
Massachusetts*
Texas*
Maryland*
Michigan
Pennsylvania
California*
Minnesota
New Jersey*
Ohio*
Indiana
Missouri
Virginia
Colorado*
North Carolina
Washington
West Virginia*
Arizona
Georgia
Iowa
Louisiana*
Nevada
Tennessee
Connecticut*
Kansas
North Dakota
Oregon
Rhode Island*
South Carolina
Wisconsin
*=state with infertility insurance mandate

%
11.94%
8.96%
6.72%
5.97%
5.97%
4.48%
4.48%
4.48%
3.73%
3.73%
3.73%
3.73%
2.99%
2.99%
2.99%
2.24%
2.24%
2.24%
2.24%
1.49%
1.49%
1.49%
1.49%
1.49%
1.49%
0.75%
0.75%
0.75%
0.75%
0.75%
0.75%
0.75%

n
16
12
9
8
8
6
6
6
5
5
5
5
4
4
4
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1

Table 4.20. Survey response: Residence when accessing infertility services (n=128)
Prompt: Is your current state of residence the same state where you accessed
infertility services?
%
Count
Yes
88.28% 113
No
11.72% 15
Total
100%
128
Total is less than 134 because of skip logic, not all persons had accessed infertility services when
answering this question
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Table 4.21. Survey response: State accessed infertility services if different that current state of residence
(n=16)
Prompt: What was your state of U.S. Territory of residence when you accessed
infertility services?
%
Count
New York*
18.75% 3
Maryland*
12.50% 2
California*
6.25%
1
Connecticut*
6.25%
1
District of Columbia
6.25%
1
Florida
6.25%
1
Hawaii*
6.25%
1
Kentucky
6.25%
1
Massachusetts*
6.25%
1
Minnesota
6.25%
1
Rhode Island*
6.25%
1
Texas*
6.25%
1
Total
100%
16
Total is less than 134 because of skip logic, not all persons had accessed infertility services when
answering this question
Table 4.22. Survey response: Knowledge of state-based infertility insurance mandate (n=134)
Prompt: Does your state of residence have mandated insurance coverage for
infertility services?
%
Count
Yes
38.06% 51
No
48.51% 65
I am not sure
13.43% 18
Total
100%
134
Table 4.23. Survey response: Applicability of state-based infertility insurance mandate (n=49)
Prompt: Were you able to apply the infertility insurance mandate to cover your
expenses?
%
Count
Yes, everything was covered
20.41% 10
No
46.94% 23
Yes, but not everything was covered
32.65% 16
Total (missing 2)
100%
49
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Table 4.24. Survey response: Current health insurance (n=134)
Prompt: What is your current health insurance status?
Currently covered by private health insurance individually or through your
employer, without MediGap*

%
85.93%

Count
116

Currently covered by private health insurance individually or through your
employer, including MediGap*

4.44%

6

Currently covered through the Affordable Care Act (aka. ObamaCare)
Currently covered by Tricare or through Veterans Affairs
Currently covered by a single service plan. (SSP)**
Not covered by any health insurance
Other not listed: (2 student insurance, 2 dual insurance coverage )
Total

0.74%
3.70%
1.48%
0.74%
2.96%
100%

1
5
2
1
4
134

*Medigap is extra health insurance that you buy from a private company to pay health care costs not covered by
Original Medicare, such as co-payments, deductibles, and health care if you travel outside the U.S.
**Single Service Plans are health insurance coverage paid for by an individual or an employer that provides for only
one type of service

Table 4.25. Survey response: Private health insurance specifically for infertility services (n=134)
Prompt: Do you have private health insurance to cover any costs for medical
help to become pregnant?
%
Count
Yes
41.79% 56
No
41.79% 56
Not Sure
7.46%
10
No, but my partner's insurance does
8.96%
12
Total
100%
134
Table 4.26. Survey response: Employer coverage for infertility services (n=134)
Prompt: Does your employer's insurance include coverage for infertility
services?
Yes
Not Sure
No
No, but my partner's insurance does
Total

%
50.00%
4.48%
39.55%
5.97%
100%

Count
67
6
53
8
134

Table 4.27. Survey response: Presence of any insurance specifically for infertility services (n=134)
Prompt: Do you have health insurance that specifically covers infertility
services?
%
Count
Yes
52.24% 70
No
47.76% 64
Total
100%
134
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Table 4.28. Survey response: Respondent-disclosed insurance companies offering their infertility
insurance coverage
Insurance Company
n
Blue Cross / Blue Shield
14
Aetna
13
United Healthcare*
10
Cigna
5
Progyny
5
Harvard Pilgrim
3
Always
1
Fallon
1
HAP
1
Hawaii Medical Service Association
1
HealthPartners
1
Kaiser
1
Medica
1
Tufts Health Plan
1
University of Pittsburgh Medical Center (UPMC)
1
Freedom Fertility
1
Win Fertility
1
*Two of the United Healthcare recipients specified their Fertility Solutions Program

Table 4.29. Spatial autocorrelation of fertility by census tract: All observations and population density
Variable

Assumption

Coefficient

Observed

Expected

Std Dev

Z

Pr > |Z|

All Women
with Births

Normality

Moran's I

0.00862

-0.0000138

0.0000217

398.7+

<.0001

Normality

Geary's c

0.94587

1.0000000

0.0013044

-41.5+

<.0001

Population
Density

Normality

Moran's I

0.00588

-0.0000138

0.0000217

272.1+

<.0001

Normality

Geary's c

0.88240

1.0000000

0.0013044

-90.2+

<.0001

+

*positive autocorrelation = , negative autocorrelation =

-

Table 4.30. Spatial autocorrelation of fertility by census tract: Age
Variable

Assumption

Coefficient

Observed

Expected

Std Dev

Z

Pr > |Z|

Normality

Moran's I

0.00322

-0.0000138

0.0000217

149.1+

<.0001

Normality

Geary's c

0.95767

1.0000000

0.0013044

-32.5+

<.0001

Normality

Moran's I

0.00914

-0.0000138

0.0000217

422.8+

<.0001

Normality

Geary's c

0.94222

1.0000000

0.0013044

-44.3+

<.0001

Normality

Moran's I

0.00812

-0.0000138

0.0000217

375.4+

<.0001

Normality

Geary's c

0.98328

1.0000000

0.0013044

-12.8+

<.0001

Age 15-19

Age 20-34

Age 35-50
+

*positive autocorrelation = , negative autocorrelation =

-
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Table 4.31. Spatial autocorrelation of fertility by census tract: Ethnicity
Variable

Assumption

Coefficient

Observed

Expected

Std Dev

Z

Pr > |Z|

Normality

Moran's I

0.0117

-0.0000138

0.0000217

541.6+

<.0001

Normality

Geary's c

0.9341

1.0000000

0.0013044

-50.6+

<.0001

African
American

Normality

Moran's I

0.0158

-0.0000138

0.0000217

732.2+

<.0001

Normality

Geary's c

1.0416

1.0000000

0.0013044

31.9 -

<.0001

American
Indian or
Alaska Native

Normality

Moran's I

0.0054

-0.0000138

0.0000217

250+

<.0001

Normality

Geary's c

0.7582

1.0000000

0.0013044

-185+

<.0001

Normality

Moran's I

0.0188

-0.0000138

0.0000217

867.3+

<.0001

Normality

Geary's c

0.9490

1.0000000

0.0013044

-39.1+

<.0001

Native
Hawaiian or
Pacific
Islander

Normality

Moran's I

0.00217

-0.0000138

0.0000217

101+

<.0001

Normality

Geary's c

0.80863

1.0000000

0.0013044

-147+

<.0001

Two or more
ethnicities

Normality

Moran's I

0.00258

-0.0000138

0.0000217

119.8+

<.0001

Normality

Geary's c

0.94223

1.0000000

0.0013044

-44.3+

<.0001

Normality

Moran's I

0.0479

-0.0000138

0.0000217

2211+

<.0001

Normality

Geary's c

0.8357

1.0000000

0.0013044

-126+

<.0001

Normality

Moran's I

0.015

-0.0000138

0.0000217

695.5+

<.0001

Normality

Geary's c

0.963

1.0000000

0.0013044

-28.7+

<.0001

White (HL)

Asian

Hispanic (any)

White (only)
+

*positive autocorrelation = , negative autocorrelation =

-

Table 4.32. Spatial autocorrelation of fertility by census tract: Nativity
Variable

Assumption

Coefficient

Observed

Expected

Std Dev

Z

Pr > |Z|

Normality

Moran's I

0.0111

-0.0000138

0.0000217

514.7+

<.0001

Normality

Geary's c

0.9496

1.0000000

0.0013044

-38.6+

<.0001

Normality

Moran's I

0.0258

-0.0000138

0.0000217

1193.0+ <.0001

Normality

Geary's c

0.9496

1.0000000

0.0013044

-38.6+

U.S. Born
Foreign
Born

<.0001

*positive autocorrelation = +, negative autocorrelation = -
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Table 4.33. Spatial autocorrelation of fertility by census tract: Education
Variable

Assumption

Coefficient

Observed

Expected

Std Dev

Z

Pr > |Z|

Less than HS
Education

Normality

Moran's I

0.00628

-0.0000138

0.0000217

290.7+

<.0001

Normality

Geary's c

0.94892

1.0000000

0.0013044

-39.2+

<.0001

HS Diploma
or GED

Normality

Moran's I

0.00495

-0.0000138

0.0000217

229.4+

<.0001

Normality

Geary's c

0.96748

1.0000000

0.0013044

-24.9+

<.0001

Associates
Degree

Normality

Moran's I

0.00867

-0.0000138

0.0000217

400.8+

<.0001

Normality

Geary's c

0.93523

1.0000000

0.0013044

-49.7+

<.0001

Bachelor
Degree

Normality

Moran's I

0.00296

-0.0000138

0.0000217

137.4+

<.0001

Normality

Geary's c

0.97185

1.0000000

0.0013044

-21.6+

<.0001

Graduate or
Professional
Degree

Normality

Moran's I

0.00719

-0.0000138

0.0000217

332.7+

<.0001

Normality

Geary's c

1.01847

1.0000000

0.0013044

14.2 -

<.0001

Pr > |Z|

*positive autocorrelation = +, negative autocorrelation = -

Table 4.34. Spatial autocorrelation of fertility by census tract: Income disparity
Variable

Assumption

Coefficient

Observed

Expected

Std Dev

Z

100% below
poverty line

Normality

Moran's I

0.00613

-0.0000138

0.0000217

283.7+ <.0001

Normality

Geary's c

0.97039

1.0000000

0.0013044

-22.7+

200% above
poverty line

Normality

Moran's I

0.00513

-0.0000138

0.0000217

237.6+ <.0001

Normality

Geary's c

0.95670

1.0000000

0.0013044

-33.2+

Received
Public
Assistance

Normality

Moran's I

0.00353

-0.0000138

0.0000217

163.5+ <.0001

Normality

Geary's c

0.96837

1.0000000

0.0013044

-24.3+

<.0001

<.0001

<.0001

*positive autocorrelation = +, negative autocorrelation = -
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Table 4.35. Spatial autocorrelation: Comparison of presence/absence of Poissonian and negative binomial non-significant variables on Moran’s I
and Gary’s C
All Variables
Poissonian significant
Negative binomial
Assumption:
(normal assumption)
variables
significant variables
Randomization
Moran’s I
Gary’s C
Moran’s I Gary’s C
Moran’s I Gary’s C
Moran’s I
Gary’s C
Variable: Women with Births
All women with births
0.00862
0.94587
0.00862
0.94587
0.00862
0.94587
0.00862
0.94587
Age 15-19
0.00322
0.95767
0.00322
0.95767
0.00322
0.95767
0.00322
0.95767
Age 20-34
0.00914
0.94222
0.00914
0.94222
0.00914
0.94222
0.00914
0.94222
Age 35-50
0.00812
0.98328
0.00812
0.98328
0.00812
0.98328
0.00812
0.98328
Caucasian (Hispanic/Latinx)
0.0117
0.9341
0.0117
0.9341
0.0117
0.9341
0.0117
0.9341
African American
0.0158
1.0416
0.0158
1.0416
0.0158
1.0416
0.0158
1.0416
American Indian or Alaska
0.0054
0.7582
0.0054
0.7582
0.0054
0.7582
Native
Asian
0.0188
0.9490
0.0188
0.9490
0.0188
0.9490
Native Hawaiian or Pacific
0.00217
0.80863
0.00217
0.80863
0.00217
0.80863
0.00217
0.80863
Islander
Two or more ethnicities
0.00258
0.94223
0.00258
0.94223
0.00258
0.94223
Hispanic (any)
0.0479
0.8357
0.0479
0.8357
0.0479
0.8357
Caucasian (non-Hispanic)
0.015
0.963
0.015
0.963
0.015
0.963
0.015
0.963
Native born
0.0111
0.9496
0.0111
0.9496
0.0111
0.9496
0.0111
0.9496
Foreign born
0.0258
0.9496
0.0258
0.9496
Less than High School education 0.00628
0.94892
0.00628
0.94892
0.00628
0.94892
0.00628
0.94892
High School Diploma or GED
0.00495
0.96748
0.00495
0.96748
0.00495
0.96748
0.00495
0.96748
Associates degree
0.00867
0.93523
0.00867
0.93523
0.00867
0.93523
0.00867
0.93523
Bachelors degree
0.00296
0.97185
0.00296
0.97185
0.00296
0.97185
0.00296
0.97185
Graduate or Professional degree 0.00719
1.01847
0.00719
1.01847
0.00719
1.01847
0.00719
1.01847
100% below poverty level
0.00613
0.97039
0.00613
0.97039
0.00613
0.97039
0.00613
0.97039
200% or above poverty level
0.00513
0.95670
0.00513
0.95670
0.00513
0.95670
0.00513
0.95670
Received public assistance
0.00353
0.96837
0.00353
0.96837
0.00353
0.96837
0.00353
0.96837
Population Density
0.00588
0.88240
0.00588
0.88240
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Table 4.36. Poissonian and negative binomial regression: Dependent variable “All Women with Births”
Parameter
DF Estimate
Standard
Wald 95% Confidence Wald
Pr >
Error
Limits
ChiChiSq
Square
Poissonian
Intercept
1
3.3863
0.0011
3.3841
3.3885
876047 <.000
1
1
Mandate
Present
1
-0.0087
0.0010
-0.0108
-0.0067
69.22
<.000
1
Absent
0
0.0000
0.0000
0.0000
0.0000
.
.
Negative Binomial
Intercept
1
2.7242
0.0058
2.7128
2.7357
217006 <.000
1
Mandate
Present
1
0.0229
0.0041
0.0148
0.0311
30.72
<.000
1
Mandate
Absent
0
0.0000
0.0000
0.0000
0.0000
.
.
Table 4.37. Comparison of fertility in census tracts with fertility clinics and all census tracts
Census tracts with fertility clinic (406)
All census tracts (72,987)
Variable
mean SD
min
max
mean
SD
min
max
All Women 53.22 51.06
0
376
54.73
50.55
0
1,370
with Births
Population
8,311 19,366.40 83.37 222,215.64 5,617.12 58,204.47 0
12,516,155.73
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Chapter Four Figures

Figure 4.1. Thematic code map: Travel code and SCT constructs

Figure 4.2. Code Relations Browser: Mentions of employer and infertility mandate as barriers or
facilitators
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Figure 4.3. Thematic code map: Employer code, mandate code, and SCT constructs
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Figure 4.4. Thematic code map: Mandate code, self-efficacy, and behavioral capability in
mandated states

204

Figure 4.5. Thematic code map: Mandate code, self-efficacy, and behavioral capability in nonmandated states
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Figure 4.6. Thematic code map: Financial code, non-profit organizations and SCT constructs

206

Figure 4.7. ACS 2013-2017, Fertility of women age 15-5
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Figure 4.8. ACS 2013-2017, Fertility of women age 15-19
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Figure 4.9. ACS 2013-2017, Fertility of women age 20-34
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Figure 4.10. ACS 2013-2017, Fertility of women age 35-50
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Figure 4.11. ACS 2013-2017, Fertility of women identifying with Hispanic or Latinx ethnicity
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Figure 4.12. ACS 2013-2017, Fertility of women identifying as White/Caucasian and Hispanic/Latinx
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Figure 4.13. ACS 2013-2017, Fertility of women identifying as African American

213

Figure 4.14. ACS 2013-2017, Fertility of women identifying as American Indian or Alaskan Native
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Figure 4.15. ACS 2013-2017, Fertility of women identifying as Asian
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Figure 4.16. ACS 2013-2017, Fertility of women identifying as Native Hawaiian or Pacific Islander
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Figure 4.17. ACS 2013-2017, Fertility of women identifying with 2 or more races/ethnicities
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Figure 4.18. ACS 2013-2017, Fertility of US born women
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Figure 4.19. ACS 2013-2017, Fertility of Foreign-born women
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Figure 4.20. ACS 2013-2017, Fertility of women highest educational attainment: Less than High School
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Figure 4.21. ACS 2013-2017, Fertility of women highest educational attainment: High School graduate, or GED
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Figure 4.22. ACS 2013-2017, Fertility of women highest educational attainment: Associates Degree
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Figure 4.23: ACS 2013-2017, Fertility of women highest educational attainment: Bachelors Degree
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Figure 4.24: ACS 2013-2017, Fertility of women highest educational attainment: Graduate or Professional Degree
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Figure 4.25. ACS 2013-2017, Fertility of women 100% below poverty level
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Figure 4.26. ACS 2013-2017, Fertility of women 200% above poverty level
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Figure 4.27. ACS 2013-2017, Population density by census tract
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Figure 4.28. ACS 2013-2017, Birth density by census tract
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Figure 4.29. Relationship between census tract area (mi2) and all women with births
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Figure 4.30. ACS 2013-2017, Dot density map of women with births based on ethnicity
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Figure 4.31. Optimized hot spot analysis: All women with births, census tract
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Figure 4.32. Directional distribution ellipse: All variables
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Figure 4.33. Directional distribution ellipse: Age
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Figure 4.34. Directional distribution ellipse: Ethnicity
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Figure 4.35. Directional distribution ellipse: Education
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Figure 4.36. Directional distribution ellipse: Nativity
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Figure 4.37. Directional distribution ellipse: Income disparity
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Figure 4.38. Directional distribution ellipse: Population and birth densities
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Figure 4.39. Distribution of “All Women with Births” between states with (1) and without (2) an infertility insurance mandate
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Figure 4.40. Spatial distribution of fertility clinics, 2017
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Figure 4.41. Kernel density of fertility clinics in the United States, 2017
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Figure 4.42. Optimized hot spot analysis: Fertility clinics in the United States, 2017
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CHAPTER 5:
DISCUSSION

Methodological Implications

Spatial Analysis of Fertility to Inform Spatial Analyses of Infertility
A component of this research was to observe spatial and demographic trends of fertility in
the United States at the census-tract level. Results showed that the majority of women who had a
birth between the years of 2013-2017 were Caucasian (68.3%), between the ages of 20-34 (74.6%),
and live 200% or more above the poverty line (53.9%) (Table 3.5). A common trope in academic
literature on the use of infertility services is that there is a disparity in access to those services
based on the observation that there are a high number of people reportedly using these technologies
who are aged <35 (Centers for Disease Control and Prevention [CDC], 2017a), Caucasian (Bitler
& Schmidt, 2012; Bitler & Schmidt, 2006; Dieke et al., 2017; Kissil & Davey, 2012; Seifer et al.,
2010), and have high incomes (Ho et al., 2017; Mehta et al., 2016; Seifer et al., 2010; The Ethics
Committee of the ASRM, 2015). When comparing the demographics between people using
infertility services and demographics of women with births overall, the two reflect similar
demographic trends.
It would be interesting if the demographics of people using infertility services also followed
spatial trends of fertility in the United States, especially knowing there are areas of the United
States where women of certain ethnicities, such as African American, are reproducing significantly
less in some areas than others (Figure 4.34). Do the spatio-demographic patterns of women who
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gave birth through assisted reproduction follow similar spatial patterns as with all women with
births?
This research utilized analytical methods

to observe spatial trends of infertility,

specifically observing these count data with a linear analyses using Poissonian and negative
binomial distributions, and spatial autocorrelation that observes the Moran’s I and Gary’s c
statistics along with directional distributions of the number of women with births based on a variety
of Census derived demographics. However, there are some limitations in the applicability of the
same methods for infertility related data. This research used census tract level data, which is the
lowest scale available for Census based fertility data. Infertility related data may not be readily
accessible at that same spatial scale and was not currently available from the Census. It is possible
that the organizations providing these infertility statistics do not record them at such large scales,
but it is possible to make census-tract level data available through processes of de-identification.
Such processes require a research design with the appropriate statistical tests and software
packages, which this research provided.
For spatial analyses, national-level observations may not be the most efficacious for
infertility related data because of how low the use rates are compared to the whole population of
women of reproductive age. This – could result in a zero-inflated model that cannot account for
so much absence of observations. There are zero-inflated models for the Poissonian distribution
that can account for a high frequency of “0” counts (Lambert, 1992; Ridout et al., 2001;
Waguespack et al., 2020), so investigation of the data to determine the best model fit will be an
important first step. This research does not utilize the zero-inflated model because it was important
to observe the absence of women who gave a birth in the last 12 months.

244

Along the same lines of spatial analysis, it may be more efficacious to observe spatial trends
related to infertility and use of infertility services within state or county boundaries. Results from
spatial autocorrelation showed that each variable contained a p-value of <.0001 (Tables 34-39),
indicating a rejection of the null hypothesis that there is zero spatial autocorrelation present in the
values reflecting demographically categorized counts of women with births. By restricting the
spatial analysis to individual states or counties, a more accurate observation of the spatial
distribution of fertility of a state or county can be determined. This may be more informative for
state-specific policy development related to infertility.
There is, however, a socio-cultural explanation to why such high spatial autocorrelation
exists among this fertility data. This is because the data is related to an aspect of human
reproduction. Would we really expect something like the spatial patterns of human fertility to be
randomly distributed across our legally defined geographic boundaries? Sexual reproduction is not
unique to humans, but humans made fertility into a politicized and socially structured practice
(Basu, 1997). Human reproduction is also not as private or restricted to two individuals as it is
often romanticized to be; in fact human reproduction is “the process in which society itself is
created” (Robertson, 1991, pg 2). Knowing that data related to human fertility will likely be
spatially autocorrelated due to socio-cultural factors that influence the proliferation of human
society across space, future analyses should be interpreted with more attention to where or in what
direction spatial autocorrelation exists. Statistically significant results should be explored further
with visual and statistical methods that examine the direction of spatial autocorrelation.
Taken together, this research that showed the spatial distribution of census-tract level
estimates of human fertility within a five-year span provided more than data related to the spread
of human fertility. It also provides a frame of reference for future analyses related to census data
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and a frame of reference for which to observe spatial distributions related to the use of infertility
services.

Theoretical Implications

The Influence of Place and Policy on Access to Infertility Services
The theoretical implication of observing place and policy in relation to infertility services
is that social constructionism can provide a paradigm in which to observe the complex, bidirectional influence of multi-level systems and individual decisions involved in facilitating
access to infertility services. Referring to the Glass and McAtee model of risk regulators (Figure
2.2), both place and infertility instance mandates (policy) fit within some of the six types of risk
regulators they identified. These are: 1) discriminatory practices, policies, and attitudes, due to
the exclusionary language within the mandates referring to same sex couples, single individuals,
and surrogacy, 2) conditions of work, because of the role of employers facilitating the types of
health insurance plans employees have access to and the size of the company for whom someone
works, and 3) laws, policies and regulations, due to the fact that the infertility insurance mandates
do not cover the more costly procedures and medications. Due to the interrelated nature of place
and policy in this context, both variables could be situated within these three domains.
The Glass and McAtee model of risk regulators (Figure 2.2) fits with the observation that
place and policy are risk regulators in that people in both mandated and non-mandated states
experienced denials accessing infertility services: Living in a state with an infertility insurance
mandated did not mean you will have access to the coverage in that mandate, and if you do get
coverage, you will likely still spend upwards of $5,000 on out of pocket expenses. A person’s
residence, their employer’s residence, and the state of the infertility insurance mandate are all
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regulatory factors that medicate an individual’s access to infertility services. However, an
important prerequisite is that such a perspective requires qualitative inquiry into the individual
situations when people attempt to access infertility services.
Qualitative accounts in this research proved to be invaluable sources of information that
added more context on the extent that the exclusionary language within the infertility insurance
mandates restricts access to infertility services. It is one thing to observe exclusionary language
within health policy text, it is another to observe the extent that such exclusionary language
prohibits people from accessing the health services they require. The facilitative factors increasing
access to infertility services for some people are barriers to others, which would be difficult to
untangle without qualitative inquiry that includes multiple perspectives of different people using
the same types of services for different reasons and in different locations. By also including
organizations who provide for those who fall through the cracks of insurance qualification, the
researcher was able to see how personal struggle can lead to advocacy and creation of
organizations that engage in a collective efficacy to change current policies. This is based on their
own experience overcoming personal, social, and financial barriers accessing insurance coverage
for infertility services.
The method of qualitatively inquiring into the effect of having residence in a state with an
infertility insurance mandate, rather than inquiring into the language of the mandates themselves,
proved to be an effective way to understand how someone can get disqualified from accessing
mandated benefits even when living in a mandated state. There are documented exclusions
included in the text of the mandates, such as the minimum number of employees, but in no mandate
does it mention that it is the residence of the employer that dictates the applicability of the mandate
before the documented disqualifications are even observed. Residence is important, but it is both
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the patient’s residence and the employer headquarter residence that are considered in the
application of these mandates. This phenomenon was identified in both the informal interviews
and the expert interviews. To that end, due to the nature of the state-based insurance mandates,
both place and policy will continue to be intra-active risk regulators that mitigate the access of
infertility services and will be differently experienced at the personal level.
Research on the construction of policy reveals the necessity of observing intra-level
experiences and how they are constructed by macro-level structures, that also function and
influence decisions based on their own historically contingent paradigms (Bernstein & Razon,
2019). A policy review by Keller & Sonfield (2019) theorized that individual needs regarding
reproductive and sexual health cannot be ignored and must be considered within the larger
healthcare economy in the United States. “Patients experience their own health needs as part of an
integrated whole, and the health care system should address them as such” (pg 8). This research
serves as a type of case study in how behavior specific to human reproduction that is in opposition
to the form of reproduction constructed by human society to be normal (heterosexual intercourse)
affects the nature of policies the state develops to protect the public. This research shows how
damaging the assumption of normative behavior imbedded into reproductive health policy can be
for those whose reality contradicts that reality.
Foucault theorizes on the relationship between sex and power, namely the act of repression
on those who engage in sex through avenues the majority judge to be abnormal. This is where the
social majority maintain a type of biopower through the legitimization, institutionalization, and
reproduction of normative sexual acts to repress those whose identities do not conform along with
the social majority (Foucault, 1984b). Institutionalization of normative behaviors become
reinforced through the establishment of law. An example of this is the first iterations of the
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infertility insurance mandates that exclude same sex couples and single individuals, as well as
restrict access to infertility services by those using surrogates who will never fall under the
definition of infertile. The institute of law and the institute of medicine (not the formal one, the
all-encompassing ‘institute’ that is the practice of medicine), then, combine to create
“requirements” that must be met in order for someone wanting to use alternative forms of human
reproduction to receive health insurance coverage, This places the state directly in the way of
reproductive autonomy.
The history of how sex is constructed in American society led to the construction of health
policy that represses non-traditional family development (Carabine, 1992; Stabile, 2016). What is
required are methods of “studying through” policy to understand its historic and political
foundations that led to the creation of knowledge on which the policies are based (Bernstein &
Razon, 2019, pg 76; Wright & Reinhold, 2011, pg 86). As stated by Wright & Reinhold (2011),
methods of research must be attuned to this form of observation to conceptualize how the current
form of policy will affect the future. It is important to observe through policy that one needs to
have “an awareness of the wider historical and political context in which actors and events are
framed, and analytical openness not only to the conditions that have produced the present but to
what the present is producing” (pg 102). In this context are the lived experiences of people
attempting to access insurance coverage for infertility services.
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Practice-based Implications

Accessing Infertility Services: The Roles of the Employers and Clinicians
Both employers and clinicians play a role in the facilitation of insurance coverage for
infertility services, and this research identified three distinct modes of influence, one for employers
and two for clinicians which are 1) employers establish insurance packages for their employees
and can therefore choose to include or not include infertility benefits; 2) the establishment of
fertility clinics near places of employment were perceived as beneficial by patients; and 3)
clinicians can choose medical billing codes that will increase the likelihood of having certain
infertility services and medications covered by insurance.
Results from Mercer’s 2018 National Survey of Employer-Sponsored Health Plans show
that nearly 56% of U.S. based employers with at least 500+ employees do cover varying degrees
of infertility services, but that only 26% of them cover the more advanced (and more expensive)
procedures such as IVF (Ferreira, 2018). Employers establish insurance policies for their
employees, so they can facilitate the degree of infertility insurance benefits. It was reported in the
informal and expert interviews that a perceived reluctance to include infertility health insurance
benefits is that it would be costly to the employer, who is often in the position to establish
healthcare packages that the ‘majority’ of employees tend to use. One company that avoided this
obstacle is Progyny, which offers infertility services through benefits packages that can be
integrated into an existing insurance package as optional coverage. According to representatives
from Progyny, their insurance benefits packages do not cost employers more than it would if an
employee had an ACL surgery,
“…they pay their monthly premium and then they pay their financial
responsibility in the same exact way they would if they were having ACL
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surgery. They’re paying deductible co-insurance and co-pay. But, there’s
no added fee for them to access Progyny” (Progyny, fertility benefits
administrator)
Mercer’s 2019 National Survey of Employer-Sponsored Health Plans found that health
benefit packages will reach nearly $13,000 per employee starting in 2019, which is a 3% increase
from the previous year (Lee, 2019). Their data did not distinguish between those with or without
infertility services benefits, but it shows that the healthcare cost to employers will continue to
increase regardless of the addition of infertility services. However, their survey also found that, of
the 2,000+ employers surveyed that have 500+ employees, making healthcare more affordable for
low-wage employees was an important to very important strategy for them (based on a Likert-type
scale) (Carsen, 2019). It seems that employers are aware of the high cost of healthcare, and many
seem to be willing to invest in methods to manage those costs to facilitate affordable healthcare
for employees. However, such goals may be more specific to employers with 500+ employees.
The organization RESOLVE lists resources for people to review before approaching their
employer about the need to include infertility services in their health insurance plan. This also
includes facts for employers who are considering including those benefits (RESOLVE: The
National Infertility Association, 2020a). Although this information was not discussed in the
interviews, advocacy organizations already seem to know the role that employers play in
facilitating access to these services and are active in political advocacy for more inclusive
mandates. Those organizations are also active in empowering individuals to initiate change within
their own organization – again bringing back the idea of collective efficacy between people using
infertility services and organizations that exist to facilitate increased financial accessibility to
infertility services.
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Besides the regulatory nature of patient residence and employer residence, another aspect
of place is the location of fertility clinics. Distances to fertility clinics were not described as
prohibitive, although some people reported traveling over three hours one way to get to their
fertility clinic. People had desires to go to a high-quality clinic that was also close to either their
home or place of work, however they were often restricted to choosing in-network clinics that were
not always their preferred choice. Even in instances where clinics were close by, some people
chose international travel due to the high cost of infertility services. An analysis of distance related
to the use of fertility clinics might be better suited to be specific to a clinic network.
A notable facilitating factor discussed in the informal interviews that the business of
infertility would find informative was the location of fertility clinics. It was reported that the
ability to go to a clinic that was close to their employer – rather than residence – was perceived as
beneficial. Employer proximity to fertility clinics was facilitative in that appointments are often
early in the morning and scheduled at short notice. Also, depending on the type of service, missing
an appointment can result in poor outcomes of the services provided. The ability to leave work and
make it to a clinic in a short time was perceived as beneficial. Responses from interviewees are
included here as examples because they did not exactly fit with the seven research questions.
“They [clinic] do their monitoring appointments as early as 6:30 in the
morning and my husband and I both have jobs where our schedules are
not always our own. So, knowing that we were going to have to do a lot
of blood draws, a lot of ultrasounds, and a lot of procedures unexpectedly,
this is the only one that could really accommodate two professional
people’s work schedules” (Interview 060, Female, Caucasian, Nevada)
“So, it made sense to actually leave my state and search for a provider in
New York State just because I'm there many hours a week…It's just they're
just so many options in New York City versus in New Jersey that it just
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made sense to find a place that was relatively convenient within the City
versus having to drive somewhere kind of out of my way in New Jersey”
(Interview 054, Female, Caucasian, New Jersey)
“I live in the Washington D.C. metro area. So, we own a home in
Maryland, about a mile away of the D.C. border. So, we aren’t like Oregon
Trailing it or anything. We go into D.C. every day for work, and that is
also where our doctor is” (Interview 056, Female, Caucasian, Maryland)
“It [clinic] was right around the corner from my office, which is really
helpful for being able to pop out for appointments. Sometimes they’re not
always known in advance. It was really helpful that I was able to take an
early lunch or something like that. I don’t know how people do it when
they have to travel far and get up at 2:00 in the morning just to get out of
state” (Interview 063, Female, Caucasian, Texas)
“I’m in the process of possibly switching clinics. That one is a little farther
from my house. It’s about half an hour. But, it’s on my way to work. So,
it’s not really that big of a deal” (Interview 065, Female, Caucasian,
Illinois)
For those providing the infertility services, building clinics near places of business can
increase access. For employers, it is worth listening to employees to determine their needs and
perhaps change the approach to healthcare services so they are inclusive.

Limitations
This research observed lived experiences of people’s to access of infertility services,
however the sample size of 66 may not completely capture the reality of how people’s accessibility
to infertility services are affected by living in states with and without an infertility insurance
mandates. Although both domestic and international travel are not widely reported in this research,
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there were some mentions during informal interviews that extensive travel is part of the reality of
many people who access infertility services. This research does, however, suggest that the decision
to travel to access these services is affected by the high costs of these services, where it is still
cheaper to travel internationally than to use infertility services in the United States. It would be
worthwhile to obtain a greater perspective of how place acts as a regulatory factor that influences
people to travel long distances or change residences to access infertility services.
Although the expert interviews represented at least four different kinds of organizations
offering financial options, insurance benefits, or advocacy specifically for infertility services,
inclusion of more industry perspectives would give greater context to the role of these companies.
Also, and more importantly, perspectives on what other solutions might exist other than creating
more state-based infertility insurance mandates would be helpful. A perspective that should also
be captured are those of employers. For example, why do employers include these services? Were
they influenced by their state’s infertility insurance mandate, and if so, do they tend to exceed
benefits or only offer the minimum? Interestingly, the majority the interviewees (Table 4.1) and
survey respondents (Table 4.3) worked in healthcare, but many still did not have access to
insurance coverage for infertility services.
Regarding the spatial analyses, the data did not reflect current 2020 estimations of fertility
and excludes three states that now have infertility insurance mandates. It would be interesting to
see what the addition of Colorado, Delaware and New Hampshire would have on the comparisons
of fertility between mandated and non-mandated states. However, due to their small populations
sizes the effect may be minimal. Between the years of 2019-2020, some mandates have been
updated since their inception, including California (2019), Illinois (2019), Maryland (2020), New
Jersey (2019), New York (2020), and Utah (2020) (RESOLVE: The National Infertility
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Association, 2020b).Therefore, qualitative accounts of people using these new or updated
mandates could show how much more facilitative these mandates are at the individual level.

Conclusion

Adding the missing context to the access of infertility services: It’s not just about
policy

The problem statement on which this research is based is that accessibility of infertility
services is disproportionately experienced in the United States. In order to better understand why
such a disparity exists, the purpose of this study was to add context to the use of infertility services
in the United States by exploring the role of environmental context, or “place”, focusing on: 1) the
applicability of state-based infertility insurance mandates through the perspectives of people using
those services and organizations providing types of financial assistance for infertility services, 2)
spatial analysis of CDC reporting fertility clinics in the United States, and 3) spatial analyses of
census-tract level fertility counts in the United States to give context to future spatial analyses of
the use of infertility services.
Based on the analyses from the qualitative interviews, survey, and spatial analyses of
fertility clinics, more attention should be paid to the roles of employers and insurance agencies in
making decisions for what is and is not medically necessary. Even in situations where policies
exist and can be applicable to someone’s situation, the same issues persist. These services are very
expensive, health insurance rarely applies, and limit accessibility to people who do not have the
income to pay for those services. The survey from this research revealed that 47% of people who
accessed infertility services in a state with an infertility insurance mandate were disqualified from
accessing that mandate for one reason or another. The interview responses filled the contextual
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gap of why people were disqualified, including reasons related to employer headquarters being
located in states without an infertility mandate, the language in the mandates restricted them from
access based on sexual orientation, use of surrogacy, the employer had less than 500 employees,
or the “coverage” was not enough to sustain them throughout all the required procedures.
Although one could argue that the majority of respondent was able to access infertility
services, only 20.41% of people living in a mandated state reported having all infertility services
covered by health insurance (Table 4.23). Even when living in a state with an infertility insurance
mandate, out of pocket expenses had to be utilized in order to continue using high-tech options
such as IVF when the covered IUI procedures did not result in a pregnancy or when the maximum
amount of IUIs were exhausted. Those who had their procedures or medications somewhat covered
by health insurance still sacrificed money saved to achieve other adulthood milestones, such as
purchasing a house. These results suggest that the infertility insurance mandates still maintain
language that do not allow the mandates to be as effective as they are assumed to be.
Health policy is not static, it is “deeply historically contingent as well as continuously ‘in
the works’” (Bernstein & Razon, 2019, pg 76). Considering this, social constructionism and the
Glass and McAtee model of risk regulators are uniquely suited to observe the multi-level influence
that exists when someone seeks infertility services. Barriers mentioned in both informal and expert
interviews included the exclusionary language embedded within the statutes. As such, there are
prominent roles that both employers and insurance companies hold in facilitating the efficacy of
the existing infertility insurance mandates. In fact, in collaboration with their preferred insurance
provider, employers can create infertility benefit packages that exceed the minimum requirements
within a mandated state.
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At the same time, these insurance mandates tend to be interpreted to the benefit of the
insurance agency at the expense of the individual. However, employers can make decisions that
make these mandates irrelevant by offering infertility services as a de facto benefit. What is more,
they can develop benefits that supersede the mandated benefits of the respective state, or they can
choose to integrate infertility benefits into existing insurance plans through partnering with
companies such as Progyny. The quote from the IntegraMed representative rings optimistic in that
as advocacy continues and as preferences for the timing and makeup of family development
continues to shift, we will see insurance policies start to change and hopefully be more inclusive.
“Years ago, not all oncology services were covered. A number of years,
most bariatric coverages were not covered. Most of the time they are now.
I think most employers are going to begin covering fertility treatment”
(IntegraMed, MSA crisis management company)
Academic researchers must be cognizant of the roles that physicians, insurance companies,
politicians, and employers play in applying the infertility insurance mandates that exist if we are
to conceptualize how to reinvent access to infertility services in law, practice, and ideology. The
year is 2020. When one hears 2020, one easily thinks of having good vision, to be able to see
things clearly. Many things have been made clear this year. Two of the most prominent areas are
that racism is very much prominent and widespread, and that political bias can easily supersede
decades of scientific research. It is the hope of this researcher that the new social and spatial
contexts about the use of infertility services and distribution of fertility across the United States,
will make clear the connection between the intra-active nature of politics and human reproduction
so we can construct a society where our laws allow for reproductive autonomy.
The intent of this research is to expand the discourse on state-based infertility insurance
mandates in the United States beyond focusing on financial models that observe expenditure on
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infertility services, or the emotional toll seeking infertility services has on the individual. This
research warrants expansion of the discourse to perceive these infertility insurance mandates as
dynamic, implemented, and interpreted by different institutions and levels of human organization.
This research is also a call to action for employers and clinicians to disseminate the knowledge
and application of existing infertility insurance mandates and other options available to them to
increase financial accessibility to reproductive health services. Greater attention should be paid to
the types of policies employers make available, and the ways clinicians code certain procedures
related to infertility services. One could argue a more effective way to increase accessibility is
through a paradigm shift in the healthcare and insurance industries to perceive this type of medical
intervention as medically necessary, but such a shift takes time. We must allow our policies to
adapt to changes in parenting behavior in the United States and refrain from structuring them based
on narrow ideals of what is considered medically necessary. To those institutions influencing the
construction of health policy, perhaps a phrase from William Shakespeare’s Hamlet is most
appropriate:
“There are more things in heaven and earth [Horatio] than are dreamt of
in your philosophy” Hamlet (Shakespear, 1806)
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Appendix A. Alignment Matrix
Problem Statement: Accessibility of infertility services is disproportionately experienced in
the United States.
Purpose Statement: The purpose of this study is to add context to the use of infertility
services in the United States by exploring the role of environment as a risk regulator in
accessing those services. For the purpose of this study, environment refers to any influence
outside of an individual’s own behavior, but that may affect an individual’s behavior. This
study uses both qualitative and quantitative methods in order to fill the contextual gaps
present in the current literature on the use of infertility services. Qualitative inquiry observes
“environment” as a factor in reciprocal interplay between person, behavior, and environment.
Quantitative inquiry observes “environment” in terms of spatial location of variables related
to human fertility and location of infertility clinics reporting data to the CDC. The
overarching “environmental” factor observed in this research are the state-based infertility
insurance mandates because they are meant to increase accessibility to infertility services, but
there are not data to substantially support this proposition. From here on, anything related to
“environment” or “environmental influence” will be referred to as “place”.
Research Questions Data Collection
Item on that Instrument/Data Source(s)
Instrument/Method
used to answer the Research Question
R1: Why do people
One-on-one interviews Interview Questions:
access infertility
Survey instrument
- What prompted you to decide to use
services in the
an ART? (probe: infertility m/f/b?,
United States?
same-sex couple?, issue with
conception in general?)
Survey Instrument:
- Demographics Block
- Infertility Self-Efficacy Scale
R2: What influence
does geographic
location have on
access to infertility
services?

One-on-one interviews
Survey instrument

Interview Questions:
- Where do you access infertility
services?
- How much travel do you do when
seeking infertility services? (probe:
do you have to go out of state, do
you have to go to a different city,
are the clinics close to you)
Survey Instrument:
- Residence Block
- Insurance Coverage Block
- Travel for Services Block
- Infertility Self-Efficacy Scale
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R3: What influence
does living in a state
with mandated
insurance have on
access to infertility
services?

R4: What are the
roles of specialized
infertility specific
insurance or other
financial aid
organizations in
increasing access to
infertility services in
the United States?

One-on-one interviews
Survey instrument

Interview Questions:
- How do you [How do you intend to]
pay for infertility services? (probe:
what types of insurance have you
been able to use? Whose insurance
were you able to use?)
- Do you know if your state has
infertility insurance mandates? If
yes, have you benefited from them?
- What influence have the existing
infertility insurance mandates in
your state had on increasing your
access to those services?
- What types of legal issues, if any,
have you run into regarding access
to fertility services? (probe: What
types of interactions have you had
with your employer/HR department
in applying your insurance to
infertility services?
Survey instrument:
- Insurance Block
Expert interview questions:
- How is this type of insurance
applied to patients? (probe: is there
an employee number minimum?)
- How does this type of insurance
operate in states without an
infertility insurance mandate?
(probe: is it more difficult to apply
than states that do have an infertility
insurance mandate?)
- What effect does prior insurance
have on access to the services you
provide?
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R5: What is the
spatial relationship
between fertility of
women between the
years of 2013-2017
based on age,
education, ethnicity,
nativity, and
income?

American Community
Survey, 2013-2017 5
year

Fertility of women age 15-50 by State,
Census Tract

R6: What is the
spatial relationship
between fertility of
women between the
years of 2013-2017
and states with or
without infertility
insurance mandates?

American Community
Survey 2013-2017 5
year

Fertility of women age 15-50 by State,
Census Tract + type of infertility insurance
mandate, present/absent

R7: What is the
spatial relationship
between fertility of
women age 15-50
and the spatial
distribution of SART
reporting clinics
between the years of
2013-2017?

American Community
Survey 2013-2017 5year, public access
SART clinic reports,
2013-2017

Fertility of women age 15-50 by State,
Census Tract + geolocated SART reporting
clinics
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Appendix B. Online Survey Instrument
Access to Infertility Services in the United States
Start of Block: Demographics
Q1.1
Thank you for participating in this research about insurance for infertility services. The
information you provide will be used to inform our state legislatures about what works and does
not work in terms of finding ways to pay for infertility services in the United States. At the end
of the survey is an option to provide some more detail about your experience seeking or using
infertility services, should your experience not be accurately reflected in the survey response
options. All responses to the survey and the interview are anonymous.
Q1.2 Infertility services include medical procedures and medications used to assist in human
reproduction. They can include high-tech options, such as (but not limited to) in vitro
fertilization (IVF) and intracytoplasmic sperm injection (ICSI), third-party options such as
surrogacy, gestational carriers, and egg/sperm/embryo donation, or medications such as (but not
limited to) Clomid, Bravelle, Femara, and Dostinex.
Please select the description most applicable to you in accessing infertility services:

o I [We] have not yet used infertility services, but I am [we are] are looking into it (1)
o I [We] have only seen a physician to talk about using infertility services, but have not
used any type of assisted reproductive technology (ART) or medications (2)
o I am [We are] currently using infertility services (3)
o I [We] used infertility services and am [are] currently pregnant (6)
o I [We] used infertility services and had a successful pregnancy (live birth) (4)
o I [We] used infertility services but did not have a successful pregnancy and are looking
for other options (eg. adoption) (5)

Skip To: Q1.4 If Q1.2 = I [We] used infertility services and had a successful pregnancy (live
birth)
Skip To: Q1.4 If Q1.2 = I [We] used infertility services but did not have a successful pregnancy
and are looking for other options (eg. adoption)
Skip To: Q1.4 If Q1.2 = I [We] used infertility services and am [are] currently pregnant
Q1.3 What is the reason you are seeking infertility services?

▢
▢
▢

Male factor infertility (1)
Female factor infertility (2)
Dual (male and female) infertility (3)
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▢
▢
▢
▢
▢
▢

Same-sex couple (4)
Single individual (5)
Cancer-related infertility (male) (6)
Cancer-related infertility (female) (7)
Unexplained infertility (8)
Advanced age (9)

Skip To: Q1.5 If Q1.3 = Male factor infertility
Skip To: Q1.5 If Q1.3 = Female factor infertility
Skip To: Q1.5 If Q1.3 = Dual (male and female) infertility
Skip To: Q1.5 If Q1.3 = Same-sex couple
Skip To: Q1.5 If Q1.3 = Single individual
Skip To: Q1.5 If Q1.3 = Cancer-related infertility (male)
Skip To: Q1.5 If Q1.3 = Cancer-related infertility (female)
Q1.4 What was the reason you sought infertility services?

▢
▢
▢
▢
▢
▢
▢
▢
▢

Male factor infertility (1)
Female factor infertility (2)
Dual (male and female) infertility (3)
Same-sex couple (4)
Single individual (5)
Cancer-related infertility (male) (6)
Cancer related infertility (female) (7)
Unexplained infertility (11)
Advanced age (9)

Q1.5 What is your current gender identity?

o Male (1)
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o Female (2)
o Transgender (male at birth to female) (3)
o Transgender (female at birth to male) (4)
o Intersex (6)
o Other not listed (5) ________________________________________________
Q1.6 Please select your age range

o 18-19 (1)
o 20-25 (2)
o 26-30 (3)
o 31-35 (4)
o 36-40 (5)
o 41-45 (6)
o 46-50 (7)
o 51-55 (8)
o 56-60 (9)
o +60 (10)

Q1.7 What is your marital status?

o Single (1)
o In a relationship, not living together (2)
o In a relationship, living together (3)
o Married (4)
o Divorced (5)
o Widowed (6)

Q1.8 Are you Hispanic or Latino/a?

o Yes (1)
o No (4)
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Q1.9 Please select the ethnicity you identify with:

o African-American (1)
o Hispanic/Latino(a) (2)
o Native American, Pacific Islander (3)
o Asian (4)
o Middle Eastern (5)
o Caucasian (6)
o More than one ethnicity (7)
o Other not listed (8) ________________________________________________

Q1.10 What is your highest level of schooling completed?

o Some High School (1)
o High school (diploma or GED) (2)
o Bachelor's degree (3)
o Associate/Technical degree (4)
o Master's degree (5)
o Doctorate (PhD, SciD, DrPH, EdD, DDiv, ect) (6)
o Professional (Medicine, Vet, Dentistry, Pharmacy, Physical Therapy) (7)

Q1.11 Are you currently parenting?

o Yes (1)
o No (2)

Skip To: Q1.14 If Q1.11 = No
Q1.12 How many children do you have?

o 1 (2)
o 2 (3)
o 3 (4)
o 4+ (5)
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Q1.12.1 Are your children adopted?

o Yes (1)
o No (3)
o Some (5)
o Other answer (4) ________________________________________________

Skip To: Q1.14 If Q1.12.1 = Yes
Skip To: Q1.13 If Q1.12.1 = No
Skip To: Q1.14 If Q1.12.1 = Other answer
Skip To: Q1.13 If Q1.12.1 = Some
Q1.13 How many of your children were conceived using an assisted reproductive technology?

o 0 (6)
o 1 (2)
o 2 (3)
o 3 (4)
o 4+ (5)

Q1.14 What sexual orientation do you identify with?

o Heterosexual (1)
o Homosexual (2)
o Bisexual (3)
o Asexual (4)
o Other not listed (5) ________________________________________________

Q1.15 What is your religious identity?

o None (1)
o Christian (2)
o Muslim (3)
o Buddhist (4)
o Catholic (5)
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o Jewish (6)
o Other not listed (7) ________________________________________________
Q1.16 What is your level of employment?

o Full-time (1)
o Part-time (2)
o Multiple part-time jobs (3)
o Self-employed (4)
o Unemployed (5)
o Unemployed, but partner is working (6)
o Retired (7)
o Other not listed (8) ________________________________________________

Skip To: Q1.18 If Q1.16 = Retired
Skip To: Q1.18 If Q1.16 = Unemployed
Skip To: Q1.18 If Q1.16 = Unemployed, but partner is working
Q1.17 What is the industry in which you work?

o Hospital, Healthcare, or Social Assistance (1)
o College, University, or Adult education (2)
o Primary/Secondary (K-12) education (3)
o Retail or Wholesale (4)
o Hotel and Food Service (5)
o Government (local, state, or federal) (6)
o Arts, Entertainment, or Recreation (7)
o Information Technology (IT) (8)
o Military (9)
o Law Enforcement (10)
o Legal Services (11)
o Religious (12)
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o Non-profit (13)
o Homemaker (14)
o Other not listed: (15) ________________________________________________
Q1.18 What is your estimated annual household income?

o Below $50,000 (1)
o $51,000 - $65,999 (6)
o $66,000 - $75,999 (2)
o $76,000 - $85,999 (3)
o $86,000 - $99,999 (4)
o Above $100,000 (7)

End of Block: Demographics
Start of Block: Health Education
Q2.1 I received information about risks of fertility decreasing with age during health education
courses in: (check all that apply)

▢
▢
▢
▢
▢
▢

Elementary school (1)
Middle school (2)
High school (3)
College/University (4)
I did not receive this type of information at any level of schooling (5)
I do not remember (6)

Q2.2 In your opinion, what is the earliest grade at which to learn about the risks of infertility?

▢
▢
▢
▢

1st - 3rd grade (1)
4th - 7th grade (2)
High School (3)
College (4)
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▢

None (5)

End of Block: Health Education
Start of Block: Insurance Coverage
Q3.1 Does your state of residence have mandated insurance coverage for infertility services?

o Yes (1)
o No (2)
o I am not sure (3)

Skip To: Q3.3 If Q3.1 = No
Skip To: Q3.3 If Q3.1 = I am not sure
Q3.2 Were you able to apply the infertility insurance mandate to cover your expenses?

o Yes, everything was covered (2)
o Yes, but not everything was covered (5)
o No (3)

Q3.3 What is your current health insurance status?

▢
Currently covered by private health insurance individually or through your
employer, without MediGap. Medigap is extra health insurance that you buy from a private
company to pay health care costs not covered by Original Medicare, such as co-payments,
deductibles, and health care if you travel outside the U.S. (1)

▢
Currently covered by private health insurance individually or through your
employer, including MediGap. (2)
▢ Currently covered through the Affordable Care Act (aka. ObamaCare) (3)
▢
Currently covered by Medicaid or state sponsored health insurance plan.
Medicaid is health insurance program that is jointly funded by the federal and state
governments. Medicaid provides health insurance to millions of low-income individuals and
families, pregnant women, people with certain disabilities, as well as other qualified
individuals (4)

▢
Currently covered by Medicare. Medicare is the federally-funded health insurance
program for adults over age 65, qualifying, disabled younger people, and people who have
been diagnosed with End-Stage Renal Disease (ESRD) also called End-Stage Kidney
Disease (5)
313

▢ Currently covered by Tricare or through Veterans Affairs (6)
▢
Currently covered by a single service plan. (SSP) Single Service Plans are health
insurance coverage paid for by an individual or an employer that provides for only one type
of service (7)

▢
▢

Not covered by any health insurance (8)
Other not listed: (9) ________________________________________________

Q62 Do you have a different health insurance situation that cannot be captured in the
aforementioned health insurance types?
________________________________________________________________
Q3.4 Do you have private health insurance to cover any costs for medical help to become
pregnant?

o Yes (1)
o No (2)
o Not Sure (3)
o No, but my partner's insurance does (4)

Q3.5 Does your employer's insurance include coverage for infertility services?

o Yes (1)
o No (3)
o Not Sure (2)
o No, but my partner's insurance does (4)

Q3.6 Do you have health insurance that specifically covers infertility services?

o Yes (1)
o No (2)

Skip To: Q3.7 If Q3.6 = Yes
Skip To: Q3.8 If Q3.6 = No
Q3.7 What is the health insurance provider (name of the organization) that specifically covers
your infertility services?
________________________________________________________________
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Q3.8 Have you heard of grants or scholarships that provide financial assistance for infertility
services?

o Yes (1)
o No (4)

Skip To: End of Block If Q3.8 = No
Q3.9 Have you applied for a grant or scholarship to assist with paying for infertility services?

o Applied for and received a grant (1)
o Applied for and received a scholarship (2)
o Applied for but did not receive a grant (3)
o Applied for but did not receive a scholarship (4)
o Did not apply for a grant or scholarship (5)

End of Block: Insurance Coverage
Start of Block: Residence
Q4.1 What is your current state or U.S. Territory of residence
▼ Alabama (1) ... I do not reside in the United States (53)
Q4.2 Is your current state of residence the same state where you accessed infertility services?

o Yes (12)
o No (13)

Skip To: End of Block If Q4.2 = Yes
Skip To: Q4.3 If Q4.2 = No
Q4.3 What was your state of U.S. Territory of residence when you accessed infertility services?
▼ Alabama (1) ... I do not reside in the United States (53)
End of Block: Residence
Start of Block: Travel for Services
Q5.1 Which of the statements below most applies to you, regarding inter-state travel for
infertility services?

o I moved out of state to access infertility services (1)
o I intend to move out of state to access infertility services (2)
o I am considering moving out of state to access infertility services (3)
o I have not and do not intend to move out of state to access infertility services (4)
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o I traveled out of state to access infertility services (did not change residence) (6)
Q5.2 Which of the statements below most applies to you, regarding inter-state travel for higher
quality infertility services?

o I moved out of state to access a better physician or fertility clinic (1)
o I intend to move out of state to access a better physician or fertility clinic (2)
o I am considering moving out of state to access a better physician or fertility clinic (3)
o I have not and do not intend to move out of state to access a better physician or fertility
clinic (4)
o I traveled out of state to access higher quality infertility services (did not change
residence) (6)

Q5.3 Which of these statements below most applies to you, regarding international travel for
infertility services?

o I traveled internationally to access infertility services (1)
o I intend to travel internationally to access infertility services (2)
o I am considering traveling internationally to access infertility services (3)
o I have not and do not intend to travel internationally to access infertility services (4)

Skip To: Q5.5 If Q5.3 = I am considering traveling internationally to access infertility services
Skip To: Q5.5 If Q5.3 = I intend to travel internationally to access infertility services
Skip To: Q5.4 If Q5.3 = I traveled internationally to access infertility services
Skip To: End of Block If Q5.3 = I have not and do not intend to travel internationally to access
infertility services
Q5.4 What was the reason you traveled internationally to access infertility services? (choose all
that apply)

▢ Lower cost of services (1)
▢ Better physician (2)
▢ Heard from others that they had good experiences (3)
▢ Was a previous country of residence (4)
▢
Other reason not listed (5)
________________________________________________
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Skip To: Q5.6 If Q5.4 = Lower cost of services
Skip To: Q5.6 If Q5.4 = Better physician
Skip To: Q5.6 If Q5.4 = Heard from others that they had good experiences
Skip To: Q5.6 If Q5.4 = Other reason not listed
Q5.5 What is the reason you intend, or are considering, to travel internationally to access
infertility services? (choose all that apply)

▢ Lower cost of services (1)
▢ Better physician (2)
▢ Heard from others that they had good experiences (3)
▢ Is a previous country of residence (4)
▢
Other reason not listed (5)
________________________________________________
Skip To: Q5.7 If Q5.5 = Lower cost of services
Skip To: Q5.7 If Q5.5 = Better physician
Skip To: Q5.7 If Q5.5 = Heard from others that they had good experiences
Skip To: Q5.7 If Q5.5 = Other reason not listed
Q5.6 What is the country you traveled to for accessing infertility services?
________________________________________________________________
Q5.7 What is the country you intend to travel to for accessing infertility services?
________________________________________________________________
End of Block: Travel for Services
Start of Block: Online Communities
Q6.1 Please select your level of agreement or disagreement with the following statement: I use
online ART/infertility support forums to help me make decisions about what infertility services
to use.

o Strongly Agree (1)
o Agree (2)
o Neither agree nor disagree (3)
o Disagree (4)
o Strongly disagree (5)
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Q6.2 Please select your level of agreement or disagreement with the following statement: I talk
about my experience with using infertility services more online than I do with people in person.

o Strongly Agree (1)
o Agree (2)
o Neither agree nor disagree (3)
o Disagree (4)
o Strongly disagree (5)

Q6.3 Please select your level of agreement or disagreement with the following statement: I prefer
to access online support forums for ART/infertility before talking to a physician.

o Strongly Agree (1)
o Agree (2)
o Neither agree nor disagree (3)
o Disagree (4)
o Strongly disagree (5)

End of Block: Online Communities
Start of Block: Infertility Self-Efficacy Scale
Q7.1 Please answer the following statements as they relate to how you feel about your personal
experience with using infertility services by rating them from "Not at all confident" to "Very
confident":
I feel confident that I can...
Not at all
confident
(1)
Ignore or push
away unpleasant
thoughts that can
upset me during
medical procedures
(1)
Keep a sense of
humor (2)
Make meaning out
of my infertility
experience (3)
Handle mood
swings caused by
hormonal
treatments (4)

(2)

(3)

(4)

Neutral
(5)

(6)

(7)

(8)

Extremely
Confident
(9)

o

o o o o

o o o o

o
o
o

o o o o
o o o o
o o o o

o o o o
o o o o
o o o o
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Keep from getting
discouraged when
nothing I do seems
to make a
difference (5)
Accept that my best
efforts may not
change my/our
infertility (6)
Control negative
feelings about
infertility (7)
Cope with pregnant
friends and family
members (8)
Handle personal
feelings of anger or
hostility (9)
Keep a positive
attitude (10)
Lessen feelings of
self-blame, shame,
or defectiveness
(11)
Stay relaxed while
waiting for
appointments or
test results (12)
Do something to
make myself feel
better if I am sad or
discouraged (13)
Keep active with
my usual life
routine (14)
Feel good about my
body and myself
(15)
Feel like a sexual
individual (16)

o

o o o o

o o o o

o

o o o o

o o o o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

o

o o o o

o o o o

o

o o o o

o o o o

o
o
o

o o o o
o o o o
o o o o

o o o o
o o o o
o o o o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

End of Block: Infertility Self-Efficacy Scale
Start of Block: Interview Request
Q8.1 Where did you hear about this research?

o Family Equality Council (1)
o RESOLVE: Infertility Support Community (Inspire) (2)
o Friend (4)
o Physician (5)
o Craigslist (7)
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o Reddit (8)
o Other not listed (3) ________________________________________________
Q8.2 Are you interested in participating in an interview to talk about your experience in
accessing infertility services?

o Yes (1)
o No (2)

Skip To: Q8.3 If Q8.2 = Yes
Q8.3 Fantastic! What is your preferred e-mail?

o Preferred e-mail: (1) ________________________________________________

Q63 Do you have any other information about your situation with health insurance and paying
for infertility services you would like to explain?
________________________________________________________________
End of Block: Interview Request
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Appendix C. Informal Interview guide
Reason for using infertility services
1. What prompted you to decide to use an ART?
a. Probe: infertility male/female/both?, same-sex couple?, issue with conception in
general?
Questions about traveling to access infertility services
2. Where do you access infertility services?
a. Probe: How much travel do you do when seeking infertility services?
b. Probe: Do you have to go out of state, do you have to go to a different city, are the
clinics close to you?
3. What has been the biggest barrier to accessing the infertility services you need?
Questions about paying for infertility services and insurance
4. How do you [How do you intend to] pay for infertility services?
a. Probe: What types of insurance have you been able to use?
i. Whose insurance were you able to use?
5. Do you know if your state has infertility insurance mandates? If yes, have you benefited
from them?
6. What influence have the existing infertility insurance mandates in your state had on
increasing your access to those services?
7. What types of legal issues, if any, have you run into regarding access to fertility services?
a. Probe: What types of interactions have you had with your employer/HR
department in applying your insurance to infertility services?
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Appendix D. Informal Interview Codebook
Table A1. Code book for informal interviews
Code
Abbreviation
What it is
Environmental

Env

Self-Efficacy

SelfE

Behavioral
Capability
Levels and use of
knowledge

BeCap

Expectations

Expec

Observational
Learning

ObsL

Social Cognitive Theory (SCT)-based codes
Factors influencing access to/continued use of
infertility services outside of the person’s
actions, but that may affect the person’s actions;
can refer to legal or medical systems
The person’s belief they will be able to
overcome obstacles accessing/continuing to use
infertility services; belief that continuing to use
infertility services will result in the desired
outcome; can refer to tenacity
Facilitation. The person’s knowledge and ability
to access/continue to use infertility services; can
relate to financial capability – knowing how to
navigate finances, knowing how to navigate
insurance; can relate to changing, or ability to
change, residence, employer, or seeking other
resources to use infertility services
Anticipation of the outcomes of continuing to
use or attempting to access infertility services;
can be related to retrospective thinking about
expectations
Indicate if there is an outcome to the expectation
(Code: Outcome)
Using advice or mimicking actions of another
person/couple regarding their use of infertility
services or methods of seeking infertility

What it is not
Does not refer to the person’s own
behaviors related to accessing infertility
services
Does not refer to one’s belief in ability to
access things not related to infertility
services; does not refer to actual actions
(code as self-control if related to a
behavior)
Does not refer to capability of using
things unrelated to infertility services

Does not refer to expectations unrelated
to using infertility services

Does not refer to clinic recommendations
from primary physicians
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Table A1 (Continued)

Barrier

Bar

Something that acted
as a barrier of any
type to access
infertility services

Facilitator

Facil

Something that
increased any type of
access to infertility
services

services; can be related to places to move or
travel to access infertility services
Aspects of the person’s reality that inhibit the
ability to access/continue to use infertility
services; can be physical (place-based),
emotional, mental, financial

Does not refer barriers unrelated to
infertility services

Aspects of the person’s reality that facilitate
access or increased access to infertility services;

Does not refer facilitators unrelated to
infertility services

Survey based codes
Code
Insurance

Code Abbr.
Ins

Finances

Fin

Travel

Trvl

Employer

Emp

What it is
Anything related to the person’s health insurance
being applied or denied to infertility services; can
be positive or negative outcome
Anything related to a person or couple’s finances
used to pay for infertility services; can be related
to savings, credit cards, help from other family, or
plans for financial planning
Travel specifically related to accessing infertility
services; can be mentions of time or distance
traveled to access infertility services, can be
mentions of international travel; can be mentions
of plans to not travel for infertility services or not
having to travel very much
Aspects about the person’s employer that affect
the person’s ability to access health insurance for
infertility services; can refer to aspects of
residence and location of employer headquarters;
be can be related to spouse’s employer

What it is not
Does not related to things that are only
about finances. Must be specific to
health insurance
Does not related to things about health
insurance, only out of pocket costs

Does not refer to travel not associated
with accessing infertility services. Does
not refer to employer-related travel

Does not refer to things unrelated to the
person’s employer
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Table A1 (Continued)

Health Education

HealthEd

Legal

Legal

Any mention of health education specific to
infertility, sex education, or wishes to have heard
about infertility at an earlier age
Instances where someone had to seek legal
intervention in order to gain access to infertility
services; includes legal services related to thirdparty reproduction

Does not refer to education outside of
health education specific to human
sexual reproduction and infertility
Does not refer to thinking about seeking
legal services for infertility services,
does not include using legal services for
anything other than being able to access
services related to infertility services

Emergent codes
Code
Infertility Story

Abbreviation
InfSt

What it is
The information regarding why the person/couple
are searching for or using infertility services;
unexplained or diagnosed infertility, cancer
related, recessive genes, same sex couple

What it is not
Does not relate to the actual process of
using infertility services, only the
underlying reason(s) why
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Appendix E. IRB Approval Letter 1
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Appendix F. IRB Approval Letter 2

327

328

Appendix G. Expert Interview Guide
Services Offered
- Where is this organization located?
o Are only residents of that state/those states eligible for the financial assistance?
o Is it national (United States only)?
- What are the type of financial assistance services your company offers?
o Loans? Grants? Insurance?
o Do people have to pay anything back to the company?
o If you work primarily with employers, do employers pay to have your services
available to their employees?
Eligibility
- Are these services directed toward patients, employers, or actual clinics?
- How is this type of insurance applied to patients?
o Specific:
▪ Do patients finance their infertility services through this company, or does
this company navigate other potential loan/financing sources for patients?
▪ Is there an employee number minimum (for employer-based insurance)?
▪ Credit score minimum?
▪ Age min/max?
▪ Are patients at only certain physicians/clinics eligible for this type of
financing?
▪ Are there ethnicity specifications (must be from a specific ethnic group)?
▪ Are there residency requirements?
• For certain states?
▪ Are there citizenship requirements?
• Must be US citizen? (certain amount of time since being a US
citizen [4 years+]?)
- What types of infertility services can be paid for/covered?
o Are there restrictions?
o Are there caps on certain procedures?
o Do you all work with patients and/or their physician to determine what can or
cannot be paid for, or what procedure is necessary?
- What would disqualify someone from accessing the financing options provided by your
company?
o Can people use the money for services outside their state of residence?
o Are adoption services able to be paid for through this funding?
o Are surrogacy services able to be paid for through this funding?
o Are federal employees or members of military qualified?
- Regarding the people who use services at your company, do they typically have some
type of insurance already, or will having insurance disqualify a person from this financial
assistance?
- How does this type of insurance operate in states without an infertility insurance
mandate?
o Probes:
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▪

Is it more difficult to apply this type of financing in states that do or do not
have an infertility insurance mandate?
▪ If state mandates are inconsequential, how does the presence of any
insurance (some services already covered) affect the financing options
your company provides?
▪ Have you noticed increases or decreasing in funding requests in areas
with/without infertility insurance mandates?
- How does this type of insurance compare to something like MediGap? Aflac?
- What is the cost to individuals/couples who access the financing/insurance your company
provides?
- What is the cost to employers who make the financing/insurance your company provides
available to their employees?
Advertisement
- How do you advertise this type of financial assistance?
o Probe
▪ How do patients find out about this type of financing/insurance?
▪ How do employers find out about this type of financing/insurance?
Source of Funding
- [For companies that have scholarships or grants] How are the grants/scholarships funded?
o Is it only through donations?
Perspective
- Based on your knowledge of how this company operates, would the development of more
state-based insurance mandates increase the access to infertility services?
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